Background  ||| S:24 E:43 ||| NNP
Heterotrimeric  ||| S:43 E:58 ||| NNP
G  ||| S:58 E:60 ||| NNP
proteins  ||| S:60 E:69 ||| FW
couple  ||| S:69 E:76 ||| FW
agonist-activated  ||| S:76 E:102 ||| FW
heptahelical  ||| S:102 E:115 ||| FW
receptors  ||| S:115 E:125 ||| FW
to  ||| S:125 E:128 ||| TO
a  ||| S:128 E:130 ||| DT
variety  ||| S:130 E:138 ||| NN
of  ||| S:138 E:141 ||| IN
effector  ||| S:141 E:150 ||| JJ
responses ||| S:150 E:159 ||| NNS
.  ||| S:159 E:169 ||| .
For  ||| S:169 E:173 ||| IN
the  ||| S:173 E:177 ||| DT
most  ||| S:177 E:182 ||| JJS
part ||| S:182 E:186 ||| NN
,  ||| S:186 E:188 ||| ,
this  ||| S:188 E:193 ||| DT
signaling  ||| S:193 E:203 ||| JJ
activity  ||| S:203 E:212 ||| NN
takes  ||| S:212 E:218 ||| VBZ
place  ||| S:218 E:224 ||| NN
at  ||| S:224 E:235 ||| IN
the  ||| S:235 E:239 ||| DT
plasma  ||| S:239 E:246 ||| JJ
membranes  ||| S:246 E:256 ||| NN
of  ||| S:256 E:259 ||| IN
cells ||| S:259 E:264 ||| NNS
.  ||| S:264 E:266 ||| .
However ||| S:266 E:273 ||| RB
,  ||| S:273 E:275 ||| ,
G  ||| S:275 E:277 ||| NNP
proteins  ||| S:277 E:286 ||| NNS
have  ||| S:286 E:299 ||| VBP
been  ||| S:299 E:304 ||| VBN
detected  ||| S:304 E:313 ||| VBN
at  ||| S:313 E:316 ||| IN
a  ||| S:316 E:318 ||| DT
variety  ||| S:318 E:326 ||| NN
of  ||| S:326 E:329 ||| IN
subcellular  ||| S:329 E:341 ||| JJ
locations  ||| S:341 E:351 ||| NNS
and  ||| S:351 E:363 ||| CC
have  ||| S:363 E:368 ||| VBP
been  ||| S:368 E:373 ||| VBN
implicated  ||| S:373 E:384 ||| VBN
in  ||| S:384 E:387 ||| IN
numerous  ||| S:387 E:396 ||| JJ
membrane  ||| S:396 E:405 ||| JJ
trafficking  ||| S:405 E:425 ||| NN
activities  ||| S:425 E:436 ||| NNS
[  ||| S:436 E:438 ||| -LRB-
1  ||| S:438 E:440 ||| CD
2  ||| S:440 E:442 ||| CD
]  ||| S:442 E:444 ||| -RRB-
.  ||| S:444 E:446 ||| .
This  ||| S:446 E:451 ||| DT
suggests  ||| S:451 E:460 ||| VBZ
that  ||| S:460 E:465 ||| DT
distinct ||| S:465 E:473 ||| JJ
,  ||| S:473 E:475 ||| ,
though  ||| S:475 E:490 ||| RB
not  ||| S:490 E:494 ||| RB
yet  ||| S:494 E:498 ||| RB
determined ||| S:498 E:508 ||| VBN
,  ||| S:508 E:510 ||| ,
mechanisms  ||| S:510 E:521 ||| NNS
exist  ||| S:521 E:527 ||| VBP
to  ||| S:527 E:530 ||| TO
target  ||| S:530 E:537 ||| VB
G  ||| S:537 E:539 ||| NNP
protein  ||| S:539 E:555 ||| NN
subunits  ||| S:555 E:564 ||| NN
to  ||| S:564 E:567 ||| TO
subcellular  ||| S:567 E:579 ||| VB
locations  ||| S:579 E:589 ||| NNS
other  ||| S:589 E:595 ||| JJ
than  ||| S:595 E:600 ||| IN
plasma  ||| S:600 E:615 ||| JJ
membranes  ||| S:615 E:625 ||| NNS
( ||| S:625 E:626 ||| -LRB-
PM ||| S:626 E:628 ||| NNP
) ||| S:628 E:629 ||| -RRB-
.  ||| S:629 E:631 ||| .
Furthermore ||| S:631 E:642 ||| RB
,  ||| S:642 E:644 ||| ,
post-transcriptional  ||| S:644 E:665 ||| JJ
or  ||| S:665 E:676 ||| CC
post-translational  ||| S:676 E:695 ||| JJ
modifications  ||| S:695 E:709 ||| NNS
may  ||| S:709 E:713 ||| MD
play  ||| S:713 E:718 ||| VB
a  ||| S:718 E:720 ||| DT
role  ||| S:720 E:725 ||| NN
in  ||| S:725 E:736 ||| IN
directing  ||| S:736 E:746 ||| VBG
a  ||| S:746 E:748 ||| DT
G  ||| S:748 E:750 ||| NNP
protein  ||| S:750 E:758 ||| NN
subunit  ||| S:758 E:766 ||| NN
to  ||| S:766 E:769 ||| TO
a  ||| S:769 E:771 ||| DT
specific  ||| S:771 E:780 ||| JJ
intracellular  ||| S:780 E:802 ||| JJ
location ||| S:802 E:810 ||| NN
.  ||| S:810 E:820 ||| .
Unique  ||| S:820 E:827 ||| JJ
subcellular  ||| S:827 E:839 ||| JJ
localization  ||| S:839 E:852 ||| NN
has  ||| S:852 E:856 ||| VBZ
been  ||| S:856 E:861 ||| VBN
observed  ||| S:861 E:870 ||| VBN
for  ||| S:870 E:874 ||| IN
a  ||| S:874 E:884 ||| DT
novel  ||| S:884 E:890 ||| NN
alternative  ||| S:890 E:902 ||| NN
spliced  ||| S:902 E:910 ||| NN
form  ||| S:910 E:915 ||| NN
of  ||| S:915 E:918 ||| IN
the  ||| S:918 E:922 ||| DT
G  ||| S:922 E:924 ||| NNP
protein  ||| S:924 E:932 ||| FW
α  ||| S:932 E:934 ||| FW
subunit  ||| S:934 E:950 ||| FW
( ||| S:950 E:951 ||| -LRB-
Gα ||| S:951 E:953 ||| NNP
) ||| S:953 E:954 ||| -RRB-
,  ||| S:954 E:956 ||| ,
α  ||| S:956 E:967 ||| FW
i2  ||| S:967 E:970 ||| FW
[  ||| S:970 E:972 ||| -LRB-
3  ||| S:972 E:974 ||| LS
]  ||| S:974 E:976 ||| -RRB-
.  ||| S:976 E:978 ||| .
This  ||| S:978 E:983 ||| DT
α  ||| S:983 E:994 ||| FW
i2  ||| S:994 E:997 ||| FW
splice  ||| S:997 E:1004 ||| FW
variant ||| S:1004 E:1011 ||| FW
,  ||| S:1011 E:1013 ||| ,
termed  ||| S:1013 E:1020 ||| VBD
sα  ||| S:1020 E:1032 ||| CD
i2  ||| S:1032 E:1035 ||| CD
,  ||| S:1035 E:1037 ||| ,
contains  ||| S:1037 E:1046 ||| VBZ
a  ||| S:1046 E:1048 ||| DT
novel  ||| S:1048 E:1054 ||| NN
35  ||| S:1054 E:1057 ||| CD
amino  ||| S:1057 E:1063 ||| JJ
acid  ||| S:1063 E:1076 ||| NN
sequence  ||| S:1076 E:1085 ||| NN
that  ||| S:1085 E:1090 ||| WDT
replaces  ||| S:1090 E:1099 ||| VBZ
the  ||| S:1099 E:1103 ||| DT
C-terminal  ||| S:1103 E:1114 ||| JJ
24  ||| S:1114 E:1117 ||| CD
amino  ||| S:1117 E:1123 ||| CD
acids  ||| S:1123 E:1129 ||| NNS
of  ||| S:1129 E:1132 ||| IN
α  ||| S:1132 E:1143 ||| CD
i2  ||| S:1143 E:1146 ||| CD
[  ||| S:1146 E:1148 ||| -LRB-
3  ||| S:1148 E:1150 ||| LS
]  ||| S:1150 E:1152 ||| -RRB-
.  ||| S:1152 E:1154 ||| .
sα  ||| S:1154 E:1166 ||| FW
i2  ||| S:1166 E:1169 ||| FW
has  ||| S:1169 E:1173 ||| VBZ
been  ||| S:1173 E:1178 ||| VBN
observed  ||| S:1178 E:1187 ||| VBN
to  ||| S:1187 E:1190 ||| TO
localize  ||| S:1190 E:1199 ||| VB
to  ||| S:1199 E:1210 ||| TO
Golgi  ||| S:1210 E:1216 ||| NNP
membranes  ||| S:1216 E:1226 ||| NN
and  ||| S:1226 E:1230 ||| CC
other  ||| S:1230 E:1236 ||| JJ
intracellular  ||| S:1236 E:1250 ||| JJ
membranes  ||| S:1250 E:1260 ||| NNS
[  ||| S:1260 E:1262 ||| -LRB-
3  ||| S:1262 E:1264 ||| CD
4  ||| S:1264 E:1266 ||| CD
]  ||| S:1266 E:1268 ||| -RRB-
;  ||| S:1268 E:1278 ||| :
in  ||| S:1278 E:1281 ||| IN
contrast ||| S:1281 E:1289 ||| NN
,  ||| S:1289 E:1291 ||| ,
wild  ||| S:1291 E:1296 ||| JJ
type  ||| S:1296 E:1301 ||| NN
α  ||| S:1301 E:1312 ||| NN
i2  ||| S:1312 E:1315 ||| NN
is  ||| S:1315 E:1318 ||| VBZ
typically  ||| S:1318 E:1328 ||| RB
found  ||| S:1328 E:1334 ||| VBN
at  ||| S:1334 E:1337 ||| IN
PM ||| S:1337 E:1339 ||| NNP
.  ||| S:1339 E:1341 ||| .
Based  ||| S:1341 E:1347 ||| VBN
on  ||| S:1347 E:1358 ||| IN
this  ||| S:1358 E:1363 ||| DT
unique  ||| S:1363 E:1370 ||| JJ
localization  ||| S:1370 E:1383 ||| NN
of  ||| S:1383 E:1386 ||| IN
sα  ||| S:1386 E:1398 ||| CD
i2  ||| S:1398 E:1401 ||| CD
,  ||| S:1401 E:1403 ||| ,
a  ||| S:1403 E:1405 ||| DT
prominent  ||| S:1405 E:1415 ||| JJ
role  ||| S:1415 E:1420 ||| NN
in  ||| S:1420 E:1423 ||| IN
membrane  ||| S:1423 E:1440 ||| JJ
trafficking  ||| S:1440 E:1452 ||| NN
has  ||| S:1452 E:1456 ||| VBZ
been  ||| S:1456 E:1461 ||| VBN
proposed  ||| S:1461 E:1470 ||| VBN
for  ||| S:1470 E:1474 ||| IN
this  ||| S:1474 E:1479 ||| DT
subunit  ||| S:1479 E:1487 ||| NN
[  ||| S:1487 E:1489 ||| -LRB-
3  ||| S:1489 E:1491 ||| LS
]  ||| S:1491 E:1493 ||| -RRB-
.  ||| S:1493 E:1503 ||| .
However ||| S:1503 E:1510 ||| RB
,  ||| S:1510 E:1512 ||| ,
no  ||| S:1512 E:1515 ||| DT
report  ||| S:1515 E:1522 ||| NN
to  ||| S:1522 E:1525 ||| TO
date  ||| S:1525 E:1530 ||| NN
has  ||| S:1530 E:1534 ||| VBZ
supported  ||| S:1534 E:1544 ||| VBN
a  ||| S:1544 E:1546 ||| DT
functional  ||| S:1546 E:1557 ||| JJ
role  ||| S:1557 E:1570 ||| NN
for  ||| S:1570 E:1574 ||| IN
sα  ||| S:1574 E:1586 ||| JJ
i2  ||| S:1586 E:1589 ||| NN
in  ||| S:1589 E:1592 ||| IN
vesicular  ||| S:1592 E:1602 ||| JJ
transport ||| S:1602 E:1611 ||| NN
,  ||| S:1611 E:1613 ||| ,
although  ||| S:1613 E:1622 ||| IN
a  ||| S:1622 E:1632 ||| DT
variety  ||| S:1632 E:1640 ||| NN
of  ||| S:1640 E:1643 ||| IN
functional  ||| S:1643 E:1654 ||| JJ
assays  ||| S:1654 E:1661 ||| NNS
have  ||| S:1661 E:1666 ||| VBP
implicated  ||| S:1666 E:1677 ||| VBN
other  ||| S:1677 E:1683 ||| JJ
Gα ||| S:1683 E:1685 ||| NNP
,  ||| S:1685 E:1695 ||| ,
including  ||| S:1695 E:1705 ||| VBG
α  ||| S:1705 E:1716 ||| JJ
s  ||| S:1716 E:1718 ||| NN
and  ||| S:1718 E:1722 ||| CC
α  ||| S:1722 E:1733 ||| CD
i3  ||| S:1733 E:1736 ||| CD
,  ||| S:1736 E:1738 ||| ,
in  ||| S:1738 E:1741 ||| IN
vesicle  ||| S:1741 E:1749 ||| JJ
trafficking  ||| S:1749 E:1761 ||| NN
pathways  ||| S:1761 E:1770 ||| NNS
[  ||| S:1770 E:1772 ||| -LRB-
1  ||| S:1772 E:1782 ||| CD
2  ||| S:1782 E:1784 ||| CD
]  ||| S:1784 E:1786 ||| -RRB-
.  ||| S:1786 E:1796 ||| .
In  ||| S:1796 E:1799 ||| IN
spite  ||| S:1799 E:1805 ||| NN
of  ||| S:1805 E:1808 ||| IN
its  ||| S:1808 E:1812 ||| PRP$
unknown  ||| S:1812 E:1820 ||| JJ
functional  ||| S:1820 E:1831 ||| JJ
significance ||| S:1831 E:1843 ||| NN
,  ||| S:1843 E:1845 ||| ,
sα  ||| S:1845 E:1857 ||| JJ
i2  ||| S:1857 E:1860 ||| NN
provides  ||| S:1860 E:1869 ||| VBZ
a  ||| S:1869 E:1871 ||| DT
potential  ||| S:1871 E:1881 ||| JJ
model  ||| S:1881 E:1887 ||| NN
for  ||| S:1887 E:1899 ||| IN
studying  ||| S:1899 E:1908 ||| VBG
mechanisms  ||| S:1908 E:1919 ||| NNS
of  ||| S:1919 E:1922 ||| IN
subcellular  ||| S:1922 E:1934 ||| JJ
localization  ||| S:1934 E:1947 ||| NN
of  ||| S:1947 E:1950 ||| IN
Gα ||| S:1950 E:1952 ||| NNP
.  ||| S:1952 E:1962 ||| .
Clearly ||| S:1962 E:1969 ||| RB
,  ||| S:1969 E:1971 ||| ,
some  ||| S:1971 E:1976 ||| DT
aspect  ||| S:1976 E:1983 ||| NN
of  ||| S:1983 E:1986 ||| IN
the  ||| S:1986 E:1990 ||| DT
novel  ||| S:1990 E:1996 ||| NN
splicing  ||| S:1996 E:2005 ||| NN
is  ||| S:2005 E:2008 ||| VBZ
responsible  ||| S:2008 E:2028 ||| JJ
for  ||| S:2028 E:2032 ||| IN
the  ||| S:2032 E:2036 ||| DT
difference  ||| S:2036 E:2047 ||| NN
in  ||| S:2047 E:2050 ||| IN
subcellular  ||| S:2050 E:2062 ||| JJ
targeting  ||| S:2062 E:2072 ||| NN
of  ||| S:2072 E:2075 ||| IN
sα  ||| S:2075 E:2087 ||| CD
i2  ||| S:2087 E:2090 ||| CD
(  ||| S:2090 E:2101 ||| -LRB-
i.e.  ||| S:2101 E:2106 ||| FW
,  ||| S:2106 E:2108 ||| ,
Golgi  ||| S:2108 E:2114 ||| NNP
and  ||| S:2114 E:2118 ||| CC
intracellular  ||| S:2118 E:2140 ||| JJ
membranes ||| S:2140 E:2149 ||| NN
)  ||| S:2149 E:2151 ||| -RRB-
compared  ||| S:2151 E:2160 ||| VBN
to  ||| S:2160 E:2163 ||| TO
wild  ||| S:2163 E:2168 ||| JJ
type  ||| S:2168 E:2173 ||| NN
α  ||| S:2173 E:2184 ||| VBD
i2  ||| S:2184 E:2187 ||| CD
(  ||| S:2187 E:2198 ||| -LRB-
i.e. ||| S:2198 E:2202 ||| FW
,  ||| S:2202 E:2204 ||| ,
PM ||| S:2204 E:2206 ||| NNP
) ||| S:2206 E:2207 ||| -RRB-
.  ||| S:2207 E:2209 ||| .
To  ||| S:2209 E:2212 ||| TO
address  ||| S:2212 E:2220 ||| VB
the  ||| S:2220 E:2224 ||| DT
mechanism  ||| S:2224 E:2242 ||| NN
of  ||| S:2242 E:2245 ||| IN
subcellular  ||| S:2245 E:2257 ||| JJ
localization  ||| S:2257 E:2270 ||| NN
of  ||| S:2270 E:2273 ||| IN
sα  ||| S:2273 E:2285 ||| CD
i2  ||| S:2285 E:2288 ||| CD
,  ||| S:2288 E:2290 ||| ,
two  ||| S:2290 E:2294 ||| CD
hypotheses  ||| S:2294 E:2305 ||| NNS
were  ||| S:2305 E:2310 ||| VBD
tested  ||| S:2310 E:2317 ||| VBN
herein ||| S:2317 E:2323 ||| NN
.  ||| S:2323 E:2333 ||| .
First ||| S:2333 E:2338 ||| NNP
,  ||| S:2338 E:2340 ||| ,
the  ||| S:2340 E:2344 ||| DT
possibility  ||| S:2344 E:2356 ||| NN
was  ||| S:2356 E:2360 ||| VBD
tested  ||| S:2360 E:2367 ||| VBN
that  ||| S:2367 E:2372 ||| IN
the  ||| S:2372 E:2376 ||| DT
novel  ||| S:2376 E:2382 ||| NN
35  ||| S:2382 E:2385 ||| CD
amino  ||| S:2385 E:2399 ||| JJ
acid  ||| S:2399 E:2404 ||| NN
sequence  ||| S:2404 E:2413 ||| NN
found  ||| S:2413 E:2419 ||| VBD
at  ||| S:2419 E:2422 ||| IN
the  ||| S:2422 E:2426 ||| DT
C-terminus  ||| S:2426 E:2437 ||| JJ
of  ||| S:2437 E:2440 ||| IN
sα  ||| S:2440 E:2452 ||| CD
i2  ||| S:2452 E:2455 ||| CD
functions  ||| S:2455 E:2465 ||| NNS
as  ||| S:2465 E:2468 ||| IN
a  ||| S:2468 E:2470 ||| DT
specific  ||| S:2470 E:2479 ||| JJ
Golgi  ||| S:2479 E:2485 ||| NNP
or  ||| S:2485 E:2496 ||| CC
intracellular  ||| S:2496 E:2510 ||| JJ
membrane  ||| S:2510 E:2519 ||| NNS
targeting  ||| S:2519 E:2529 ||| VBG
motif ||| S:2529 E:2534 ||| NN
.  ||| S:2534 E:2536 ||| .
A  ||| S:2536 E:2538 ||| DT
second  ||| S:2538 E:2553 ||| JJ
possibility  ||| S:2553 E:2565 ||| NN
was  ||| S:2565 E:2569 ||| VBD
suggested  ||| S:2569 E:2579 ||| VBN
by  ||| S:2579 E:2582 ||| IN
considering  ||| S:2582 E:2594 ||| VBG
the  ||| S:2594 E:2598 ||| DT
location  ||| S:2598 E:2607 ||| NN
of  ||| S:2607 E:2618 ||| IN
the  ||| S:2618 E:2622 ||| DT
splice  ||| S:2622 E:2629 ||| JJ
site ||| S:2629 E:2633 ||| NN
.  ||| S:2633 E:2635 ||| .
Several  ||| S:2635 E:2643 ||| JJ
studies  ||| S:2643 E:2651 ||| NNS
have  ||| S:2651 E:2656 ||| VBP
shown  ||| S:2656 E:2662 ||| VBN
that  ||| S:2662 E:2667 ||| IN
deletions  ||| S:2667 E:2685 ||| NNS
or  ||| S:2685 E:2688 ||| CC
amino  ||| S:2688 E:2694 ||| JJ
acid  ||| S:2694 E:2699 ||| NN
substitutions  ||| S:2699 E:2713 ||| NN
in  ||| S:2713 E:2716 ||| IN
the  ||| S:2716 E:2720 ||| DT
extreme  ||| S:2720 E:2728 ||| JJ
C-terminal  ||| S:2728 E:2747 ||| JJ
region  ||| S:2747 E:2754 ||| NN
of  ||| S:2754 E:2757 ||| IN
Gα  ||| S:2757 E:2760 ||| NNP
creates  ||| S:2760 E:2768 ||| VBZ
a  ||| S:2768 E:2770 ||| DT
protein  ||| S:2770 E:2778 ||| NN
defective  ||| S:2778 E:2788 ||| NN
in  ||| S:2788 E:2799 ||| IN
guanine-nucleotide  ||| S:2799 E:2818 ||| JJ
binding  ||| S:2818 E:2826 ||| NNS
[  ||| S:2826 E:2828 ||| -LRB-
5  ||| S:2828 E:2830 ||| CD
6  ||| S:2830 E:2832 ||| CD
7  ||| S:2832 E:2834 ||| CD
8  ||| S:2834 E:2836 ||| CD
9  ||| S:2836 E:2838 ||| CD
10  ||| S:2838 E:2841 ||| CD
]  ||| S:2841 E:2843 ||| -RRB-
.  ||| S:2843 E:2845 ||| .
Rapid  ||| S:2845 E:2851 ||| JJ
release  ||| S:2851 E:2867 ||| NN
of  ||| S:2867 E:2870 ||| IN
guanine-nucleotides  ||| S:2870 E:2890 ||| NNP
can  ||| S:2890 E:2894 ||| MD
result  ||| S:2894 E:2901 ||| VB
in  ||| S:2901 E:2904 ||| IN
an  ||| S:2904 E:2907 ||| DT
unstable  ||| S:2907 E:2916 ||| JJ
Gα  ||| S:2916 E:2919 ||| NNP
[  ||| S:2919 E:2921 ||| -LRB-
9  ||| S:2921 E:2923 ||| CD
10  ||| S:2923 E:2934 ||| CD
]  ||| S:2934 E:2936 ||| -RRB-
.  ||| S:2936 E:2938 ||| .
This  ||| S:2938 E:2943 ||| DT
leads  ||| S:2943 E:2949 ||| VBZ
to  ||| S:2949 E:2952 ||| TO
the  ||| S:2952 E:2956 ||| DT
prediction  ||| S:2956 E:2967 ||| NN
that  ||| S:2967 E:2972 ||| IN
sα  ||| S:2972 E:2984 ||| JJ
i2  ||| S:2984 E:2987 ||| NN
is  ||| S:2987 E:2990 ||| VBZ
also  ||| S:2990 E:2995 ||| RB
unstable  ||| S:2995 E:3004 ||| JJ
due  ||| S:3004 E:3008 ||| JJ
to  ||| S:3008 E:3011 ||| TO
a  ||| S:3011 E:3013 ||| DT
disruption  ||| S:3013 E:3032 ||| NN
in  ||| S:3032 E:3035 ||| IN
the  ||| S:3035 E:3039 ||| DT
structure  ||| S:3039 E:3049 ||| NN
of  ||| S:3049 E:3052 ||| IN
its  ||| S:3052 E:3056 ||| PRP$
C-terminus  ||| S:3056 E:3067 ||| JJ
caused  ||| S:3067 E:3074 ||| VBN
by  ||| S:3074 E:3077 ||| IN
the  ||| S:3077 E:3081 ||| DT
novel  ||| S:3081 E:3095 ||| NN
splice  ||| S:3095 E:3102 ||| NN
sequence ||| S:3102 E:3110 ||| NN
.  ||| S:3110 E:3112 ||| .
Thus ||| S:3112 E:3116 ||| RB
,  ||| S:3116 E:3118 ||| ,
the  ||| S:3118 E:3122 ||| DT
second  ||| S:3122 E:3129 ||| JJ
possibility  ||| S:3129 E:3141 ||| NN
is  ||| S:3141 E:3144 ||| VBZ
that  ||| S:3144 E:3157 ||| DT
failure  ||| S:3157 E:3165 ||| NN
of  ||| S:3165 E:3168 ||| IN
sα  ||| S:3168 E:3180 ||| CD
i2  ||| S:3180 E:3183 ||| CD
to  ||| S:3183 E:3186 ||| TO
localize  ||| S:3186 E:3195 ||| VB
at  ||| S:3195 E:3198 ||| IN
the  ||| S:3198 E:3202 ||| DT
PM  ||| S:3202 E:3205 ||| NNP
but  ||| S:3205 E:3209 ||| CC
instead  ||| S:3209 E:3225 ||| RB
localize  ||| S:3225 E:3234 ||| VBN
at  ||| S:3234 E:3237 ||| IN
intracellular  ||| S:3237 E:3251 ||| JJ
membranes  ||| S:3251 E:3261 ||| NN
is  ||| S:3261 E:3264 ||| VBZ
the  ||| S:3264 E:3268 ||| DT
result  ||| S:3268 E:3275 ||| NN
of  ||| S:3275 E:3278 ||| IN
a  ||| S:3278 E:3288 ||| DT
general  ||| S:3288 E:3296 ||| JJ
defect  ||| S:3296 E:3303 ||| NN
in  ||| S:3303 E:3306 ||| IN
protein  ||| S:3306 E:3314 ||| NN
stability ||| S:3314 E:3323 ||| NN
.  ||| S:3323 E:3325 ||| .
Results  ||| S:3325 E:3333 ||| NNS
presented  ||| S:3333 E:3351 ||| VBN
herein  ||| S:3351 E:3358 ||| NNS
are  ||| S:3358 E:3362 ||| VBP
consistent  ||| S:3362 E:3373 ||| JJ
with  ||| S:3373 E:3378 ||| IN
this  ||| S:3378 E:3383 ||| DT
second  ||| S:3383 E:3390 ||| JJ
hypothesis ||| S:3390 E:3400 ||| NN
.  ||| S:3400 E:3424 ||| .
Results  ||| S:3424 E:3440 ||| NNS
α  ||| S:3440 E:3451 ||| VBD
i2  ||| S:3451 E:3454 ||| CD
and  ||| S:3454 E:3458 ||| CC
sα  ||| S:3458 E:3470 ||| JJ
i2  ||| S:3470 E:3473 ||| NN
differ  ||| S:3473 E:3480 ||| VBP
only  ||| S:3480 E:3485 ||| RB
at  ||| S:3485 E:3488 ||| IN
their  ||| S:3488 E:3494 ||| PRP$
extreme  ||| S:3494 E:3510 ||| JJ
C-termini ||| S:3510 E:3519 ||| NN
.  ||| S:3519 E:3521 ||| .
Alternative  ||| S:3521 E:3533 ||| JJ
splicing  ||| S:3533 E:3542 ||| JJ
results  ||| S:3542 E:3550 ||| NNS
in  ||| S:3550 E:3553 ||| IN
a  ||| S:3553 E:3555 ||| DT
novel  ||| S:3555 E:3561 ||| NN
35  ||| S:3561 E:3564 ||| CD
amino  ||| S:3564 E:3578 ||| CD
acids  ||| S:3578 E:3584 ||| NNS
in  ||| S:3584 E:3587 ||| IN
sα  ||| S:3587 E:3599 ||| JJ
i2  ||| S:3599 E:3602 ||| NN
that  ||| S:3602 E:3607 ||| WDT
replace  ||| S:3607 E:3615 ||| VBP
the  ||| S:3615 E:3619 ||| DT
C-terminal  ||| S:3619 E:3630 ||| JJ
24  ||| S:3630 E:3633 ||| CD
amino  ||| S:3633 E:3647 ||| CD
acids  ||| S:3647 E:3653 ||| NNS
of  ||| S:3653 E:3656 ||| IN
α  ||| S:3656 E:3667 ||| CD
i2  ||| S:3667 E:3670 ||| CD
( ||| S:3670 E:3671 ||| -LRB-
Figure  ||| S:3671 E:3678 ||| NNP
1 ||| S:3678 E:3679 ||| CD
) ||| S:3679 E:3680 ||| -RRB-
.  ||| S:3680 E:3682 ||| .
In  ||| S:3682 E:3685 ||| IN
the  ||| S:3685 E:3689 ||| DT
studies  ||| S:3689 E:3697 ||| NNS
presented  ||| S:3697 E:3715 ||| VBD
here ||| S:3715 E:3719 ||| RB
,  ||| S:3719 E:3721 ||| ,
both  ||| S:3721 E:3726 ||| DT
α  ||| S:3726 E:3737 ||| JJ
i2  ||| S:3737 E:3740 ||| NN
and  ||| S:3740 E:3744 ||| CC
sα  ||| S:3744 E:3756 ||| VBP
i2  ||| S:3756 E:3759 ||| RB
contain  ||| S:3759 E:3767 ||| VB
an  ||| S:3767 E:3770 ||| DT
internal  ||| S:3770 E:3779 ||| JJ
EE  ||| S:3779 E:3782 ||| NNP
epitope ||| S:3782 E:3789 ||| NN
,  ||| S:3789 E:3791 ||| ,
as  ||| S:3791 E:3802 ||| RB
used  ||| S:3802 E:3807 ||| VBN
previously  ||| S:3807 E:3818 ||| RB
for  ||| S:3818 E:3822 ||| IN
α  ||| S:3822 E:3833 ||| CD
i2  ||| S:3833 E:3836 ||| CD
[  ||| S:3836 E:3838 ||| -LRB-
11  ||| S:3838 E:3841 ||| CD
12  ||| S:3841 E:3844 ||| CD
]  ||| S:3844 E:3846 ||| -RRB-
.  ||| S:3846 E:3848 ||| .
The  ||| S:3848 E:3852 ||| DT
use  ||| S:3852 E:3856 ||| NN
of  ||| S:3856 E:3859 ||| IN
the  ||| S:3859 E:3863 ||| DT
EE  ||| S:3863 E:3866 ||| NNP
epitope  ||| S:3866 E:3882 ||| NN
allows  ||| S:3882 E:3889 ||| VBZ
the  ||| S:3889 E:3893 ||| DT
direct  ||| S:3893 E:3900 ||| JJ
comparison  ||| S:3900 E:3911 ||| NN
of  ||| S:3911 E:3914 ||| IN
subcellular  ||| S:3914 E:3926 ||| JJ
localization  ||| S:3926 E:3947 ||| NN
and  ||| S:3947 E:3951 ||| CC
expression  ||| S:3951 E:3962 ||| NN
of  ||| S:3962 E:3965 ||| IN
α  ||| S:3965 E:3976 ||| JJ
i2  ||| S:3976 E:3979 ||| NN
and  ||| S:3979 E:3983 ||| CC
sα  ||| S:3983 E:3995 ||| CD
i2  ||| S:3995 E:3998 ||| CD
,  ||| S:3998 E:4000 ||| ,
and  ||| S:4000 E:4004 ||| CC
facilitates  ||| S:4004 E:4016 ||| JJ
immunoprecipitation  ||| S:4016 E:4044 ||| NN
of  ||| S:4044 E:4047 ||| IN
the  ||| S:4047 E:4051 ||| DT
two  ||| S:4051 E:4055 ||| CD
expressed  ||| S:4055 E:4065 ||| CD
proteins ||| S:4065 E:4073 ||| NNS
.  ||| S:4073 E:4075 ||| .
This  ||| S:4075 E:4080 ||| DT
is  ||| S:4080 E:4083 ||| VBZ
essential  ||| S:4083 E:4093 ||| JJ
since  ||| S:4093 E:4107 ||| IN
suitable  ||| S:4107 E:4116 ||| JJ
antibodies  ||| S:4116 E:4127 ||| NNS
to  ||| S:4127 E:4130 ||| TO
detect  ||| S:4130 E:4137 ||| VB
and  ||| S:4137 E:4141 ||| CC
immuno-isolate  ||| S:4141 E:4156 ||| JJ
sα  ||| S:4156 E:4168 ||| NNS
i2  ||| S:4168 E:4171 ||| RB
are  ||| S:4171 E:4175 ||| VBP
not  ||| S:4175 E:4179 ||| RB
readily  ||| S:4179 E:4187 ||| RB
available ||| S:4187 E:4196 ||| JJ
.  ||| S:4196 E:4198 ||| .
Attempts  ||| S:4198 E:4215 ||| NNS
to  ||| S:4215 E:4218 ||| TO
use  ||| S:4218 E:4222 ||| VB
a  ||| S:4222 E:4224 ||| DT
previously  ||| S:4224 E:4235 ||| RB
described  ||| S:4235 E:4245 ||| VBN
polyclonal  ||| S:4245 E:4256 ||| JJ
antibody  ||| S:4256 E:4265 ||| NN
directed  ||| S:4265 E:4282 ||| VBN
against  ||| S:4282 E:4290 ||| IN
the  ||| S:4290 E:4294 ||| DT
C-terminus  ||| S:4294 E:4305 ||| JJ
of  ||| S:4305 E:4308 ||| IN
sα  ||| S:4308 E:4320 ||| CD
i2  ||| S:4320 E:4323 ||| CD
[  ||| S:4323 E:4325 ||| -LRB-
3  ||| S:4325 E:4327 ||| CD
4  ||| S:4327 E:4329 ||| CD
]  ||| S:4329 E:4331 ||| -RRB-
were  ||| S:4331 E:4336 ||| VBD
unsatisfactory  ||| S:4336 E:4351 ||| VBN
in  ||| S:4351 E:4354 ||| IN
our  ||| S:4354 E:4366 ||| PRP$
hands ||| S:4366 E:4371 ||| NNS
.  ||| S:4371 E:4373 ||| .
In  ||| S:4373 E:4376 ||| IN
particular ||| S:4376 E:4386 ||| JJ
,  ||| S:4386 E:4388 ||| ,
attempts  ||| S:4388 E:4397 ||| VBZ
to  ||| S:4397 E:4400 ||| TO
detect  ||| S:4400 E:4407 ||| VB
endogenous  ||| S:4407 E:4418 ||| JJ
sα  ||| S:4418 E:4430 ||| JJ
i2  ||| S:4430 E:4433 ||| NN
by  ||| S:4433 E:4436 ||| IN
immunofluorescence  ||| S:4436 E:4455 ||| NN
failed  ||| S:4455 E:4462 ||| VBD
due  ||| S:4462 E:4466 ||| JJ
to  ||| S:4466 E:4477 ||| TO
faint  ||| S:4477 E:4483 ||| VB
detection  ||| S:4483 E:4493 ||| NNS
that  ||| S:4493 E:4498 ||| WDT
showed  ||| S:4498 E:4505 ||| VBD
drastically  ||| S:4505 E:4517 ||| RB
different  ||| S:4517 E:4527 ||| JJ
patterns  ||| S:4527 E:4544 ||| NNS
of  ||| S:4544 E:4547 ||| IN
staining  ||| S:4547 E:4556 ||| NNS
depending  ||| S:4556 E:4566 ||| VBG
upon  ||| S:4566 E:4571 ||| IN
fixation  ||| S:4571 E:4580 ||| JJ
technique ||| S:4580 E:4589 ||| NN
.  ||| S:4589 E:4599 ||| .
The  ||| S:4599 E:4603 ||| DT
subcellular  ||| S:4603 E:4615 ||| JJ
localization  ||| S:4615 E:4628 ||| NN
of  ||| S:4628 E:4631 ||| IN
expressed  ||| S:4631 E:4641 ||| VBN
α  ||| S:4641 E:4652 ||| JJ
i2  ||| S:4652 E:4655 ||| NN
and  ||| S:4655 E:4659 ||| CC
sα  ||| S:4659 E:4671 ||| JJ
i2  ||| S:4671 E:4674 ||| NN
was  ||| S:4674 E:4678 ||| VBD
compared  ||| S:4678 E:4687 ||| VBN
in  ||| S:4687 E:4690 ||| IN
COS  ||| S:4690 E:4694 ||| NNP
and  ||| S:4694 E:4698 ||| CC
BHK  ||| S:4698 E:4702 ||| NNP
cells  ||| S:4702 E:4716 ||| NNS
( ||| S:4716 E:4717 ||| -LRB-
Figure  ||| S:4717 E:4724 ||| NNP
2 ||| S:4724 E:4725 ||| CD
) ||| S:4725 E:4726 ||| -RRB-
.  ||| S:4726 E:4728 ||| .
In  ||| S:4728 E:4731 ||| IN
both  ||| S:4731 E:4736 ||| DT
cell  ||| S:4736 E:4741 ||| NN
types ||| S:4741 E:4746 ||| NNS
,  ||| S:4746 E:4748 ||| ,
α  ||| S:4748 E:4759 ||| JJ
i2  ||| S:4759 E:4762 ||| NN
was  ||| S:4762 E:4766 ||| VBD
detected  ||| S:4766 E:4775 ||| VBN
at  ||| S:4775 E:4778 ||| IN
cellular  ||| S:4778 E:4787 ||| JJ
plasma  ||| S:4787 E:4802 ||| NNS
membranes  ||| S:4802 E:4812 ||| VBP
as  ||| S:4812 E:4815 ||| RB
highlighted  ||| S:4815 E:4827 ||| VBN
by  ||| S:4827 E:4830 ||| IN
bright  ||| S:4830 E:4837 ||| JJ
staining  ||| S:4837 E:4846 ||| NN
at  ||| S:4846 E:4849 ||| IN
the  ||| S:4849 E:4853 ||| DT
cell  ||| S:4853 E:4866 ||| NN
periphery  ||| S:4866 E:4876 ||| NN
( ||| S:4876 E:4877 ||| -LRB-
Figure  ||| S:4877 E:4884 ||| NNP
2Aand  ||| S:4884 E:4890 ||| NNP
2C ||| S:4890 E:4892 ||| NNP
) ||| S:4892 E:4893 ||| -RRB-
.  ||| S:4893 E:4895 ||| .
In  ||| S:4895 E:4898 ||| IN
contrast ||| S:4898 E:4906 ||| NN
,  ||| S:4906 E:4908 ||| ,
sα  ||| S:4908 E:4920 ||| JJ
i2  ||| S:4920 E:4923 ||| NN
was  ||| S:4923 E:4927 ||| VBD
not  ||| S:4927 E:4931 ||| RB
detected  ||| S:4931 E:4940 ||| VBN
at  ||| S:4940 E:4943 ||| IN
plasma  ||| S:4943 E:4950 ||| JJ
membranes ||| S:4950 E:4959 ||| NN
,  ||| S:4959 E:4969 ||| ,
but  ||| S:4969 E:4973 ||| CC
instead  ||| S:4973 E:4981 ||| RB
typically  ||| S:4981 E:4991 ||| RB
displayed  ||| S:4991 E:5001 ||| VBN
an  ||| S:5001 E:5004 ||| DT
intracellular  ||| S:5004 E:5018 ||| NN
and  ||| S:5018 E:5030 ||| CC
perinuclear  ||| S:5030 E:5042 ||| JJ
staining  ||| S:5042 E:5051 ||| JJ
pattern  ||| S:5051 E:5059 ||| NN
( ||| S:5059 E:5060 ||| -LRB-
Figure  ||| S:5060 E:5067 ||| NNP
2Band  ||| S:5067 E:5073 ||| NNP
2D ||| S:5073 E:5075 ||| NNP
) ||| S:5075 E:5076 ||| -RRB-
,  ||| S:5076 E:5078 ||| ,
consistent  ||| S:5078 E:5097 ||| JJ
with  ||| S:5097 E:5102 ||| IN
localization  ||| S:5102 E:5115 ||| VBG
to  ||| S:5115 E:5118 ||| TO
intracellular  ||| S:5118 E:5132 ||| VB
membranes  ||| S:5132 E:5142 ||| VBN
as  ||| S:5142 E:5145 ||| IN
previously  ||| S:5145 E:5164 ||| RB
described  ||| S:5164 E:5174 ||| VBN
[  ||| S:5174 E:5176 ||| -LRB-
3  ||| S:5176 E:5178 ||| CD
4  ||| S:5178 E:5180 ||| CD
]  ||| S:5180 E:5182 ||| -RRB-
.  ||| S:5182 E:5184 ||| .
The  ||| S:5184 E:5188 ||| DT
subcellular  ||| S:5188 E:5200 ||| JJ
localization  ||| S:5200 E:5213 ||| NN
of  ||| S:5213 E:5216 ||| IN
sα  ||| S:5216 E:5228 ||| JJ
i2  ||| S:5228 E:5231 ||| NN
showed  ||| S:5231 E:5238 ||| VBD
overlap  ||| S:5238 E:5246 ||| VBN
in  ||| S:5246 E:5249 ||| IN
immunofluorescent  ||| S:5249 E:5275 ||| JJ
staining  ||| S:5275 E:5284 ||| NN
with  ||| S:5284 E:5289 ||| IN
the  ||| S:5289 E:5293 ||| DT
Golgi  ||| S:5293 E:5299 ||| JJ
protein ||| S:5299 E:5306 ||| NN
,  ||| S:5306 E:5308 ||| ,
β-COP  ||| S:5308 E:5314 ||| NNP
( ||| S:5314 E:5315 ||| -LRB-
Figure  ||| S:5315 E:5322 ||| NNP
3Aand  ||| S:5322 E:5328 ||| NNP
3B ||| S:5328 E:5330 ||| NNP
)  ||| S:5330 E:5340 ||| -RRB-
and  ||| S:5340 E:5344 ||| CC
the  ||| S:5344 E:5348 ||| DT
endoplasmic  ||| S:5348 E:5360 ||| FW
reticulum  ||| S:5360 E:5370 ||| FW
protein  ||| S:5370 E:5378 ||| FW
PDI  ||| S:5378 E:5382 ||| FW
( ||| S:5382 E:5383 ||| -LRB-
Figure  ||| S:5383 E:5390 ||| NNP
3Cand  ||| S:5390 E:5404 ||| NNP
3D ||| S:5404 E:5406 ||| NNP
) ||| S:5406 E:5407 ||| -RRB-
;  ||| S:5407 E:5409 ||| :
localization  ||| S:5409 E:5422 ||| NN
of  ||| S:5422 E:5425 ||| IN
sα  ||| S:5425 E:5437 ||| NNS
i2  ||| S:5437 E:5440 ||| VBP
exclusively  ||| S:5440 E:5452 ||| RB
to  ||| S:5452 E:5455 ||| TO
Golgi  ||| S:5455 E:5461 ||| NNP
was  ||| S:5461 E:5465 ||| VBD
not  ||| S:5465 E:5477 ||| RB
observed ||| S:5477 E:5485 ||| VBD
,  ||| S:5485 E:5487 ||| ,
even  ||| S:5487 E:5492 ||| RB
at  ||| S:5492 E:5495 ||| IN
the  ||| S:5495 E:5499 ||| DT
lowest  ||| S:5499 E:5506 ||| JJS
levels  ||| S:5506 E:5513 ||| NNS
of  ||| S:5513 E:5516 ||| IN
detection ||| S:5516 E:5525 ||| NN
.  ||| S:5525 E:5535 ||| .
Subcellular  ||| S:5535 E:5547 ||| NNP
fractionation  ||| S:5547 E:5561 ||| VBD
confirmed  ||| S:5561 E:5571 ||| VBN
that  ||| S:5571 E:5576 ||| IN
sα  ||| S:5576 E:5588 ||| JJ
i2  ||| S:5588 E:5591 ||| NN
was  ||| S:5591 E:5595 ||| VBD
localized ||| S:5595 E:5604 ||| VBN
,  ||| S:5604 E:5606 ||| ,
at  ||| S:5606 E:5609 ||| IN
least  ||| S:5609 E:5615 ||| JJS
partly ||| S:5615 E:5621 ||| RB
,  ||| S:5621 E:5623 ||| ,
to  ||| S:5623 E:5634 ||| TO
membranes  ||| S:5634 E:5644 ||| VB
( ||| S:5644 E:5645 ||| -LRB-
Figure  ||| S:5645 E:5652 ||| NNP
2E ||| S:5652 E:5654 ||| NNP
) ||| S:5654 E:5655 ||| -RRB-
.  ||| S:5655 E:5657 ||| .
After  ||| S:5657 E:5663 ||| IN
lysis  ||| S:5663 E:5669 ||| NN
of  ||| S:5669 E:5672 ||| IN
cells  ||| S:5672 E:5678 ||| NNS
in  ||| S:5678 E:5681 ||| IN
hypotonic  ||| S:5681 E:5699 ||| JJ
buffer  ||| S:5699 E:5706 ||| NN
followed  ||| S:5706 E:5715 ||| VBN
by  ||| S:5715 E:5718 ||| IN
high-speed  ||| S:5718 E:5729 ||| JJ
centrifugation ||| S:5729 E:5743 ||| NN
,  ||| S:5743 E:5745 ||| ,
α  ||| S:5745 E:5756 ||| JJ
i2  ||| S:5756 E:5759 ||| NN
was  ||| S:5759 E:5763 ||| VBD
found  ||| S:5763 E:5769 ||| VBN
predominantly  ||| S:5769 E:5783 ||| RB
in  ||| S:5783 E:5786 ||| IN
the  ||| S:5786 E:5798 ||| DT
particulate  ||| S:5798 E:5810 ||| JJ
fraction  ||| S:5810 E:5819 ||| NN
from  ||| S:5819 E:5824 ||| IN
COS  ||| S:5824 E:5828 ||| NNP
( ||| S:5828 E:5829 ||| -LRB-
Figure  ||| S:5829 E:5836 ||| NNP
2E ||| S:5836 E:5838 ||| NNP
,  ||| S:5838 E:5840 ||| ,
lanes  ||| S:5840 E:5846 ||| CD
3  ||| S:5846 E:5848 ||| CD
and  ||| S:5848 E:5852 ||| CC
4 ||| S:5852 E:5853 ||| LS
)  ||| S:5853 E:5855 ||| -RRB-
or  ||| S:5855 E:5866 ||| CC
BHK  ||| S:5866 E:5870 ||| NNP
cells  ||| S:5870 E:5876 ||| NNS
( ||| S:5876 E:5877 ||| -LRB-
Figure  ||| S:5877 E:5884 ||| NNP
2E ||| S:5884 E:5886 ||| NNP
,  ||| S:5886 E:5888 ||| ,
lanes  ||| S:5888 E:5894 ||| CD
9  ||| S:5894 E:5896 ||| CD
and  ||| S:5896 E:5900 ||| CC
10 ||| S:5900 E:5902 ||| CD
) ||| S:5902 E:5903 ||| -RRB-
.  ||| S:5903 E:5905 ||| .
A  ||| S:5905 E:5907 ||| DT
majority  ||| S:5907 E:5916 ||| NN
of  ||| S:5916 E:5919 ||| IN
sα  ||| S:5919 E:5931 ||| JJ
i2  ||| S:5931 E:5934 ||| NN
was  ||| S:5934 E:5938 ||| VBD
also  ||| S:5938 E:5943 ||| RB
detected  ||| S:5943 E:5952 ||| VBN
in  ||| S:5952 E:5955 ||| IN
the  ||| S:5955 E:5959 ||| DT
particulate  ||| S:5959 E:5979 ||| JJ
fraction  ||| S:5979 E:5988 ||| NN
from  ||| S:5988 E:5993 ||| IN
both  ||| S:5993 E:5998 ||| DT
COS  ||| S:5998 E:6002 ||| NNP
( ||| S:6002 E:6003 ||| -LRB-
Figure  ||| S:6003 E:6010 ||| NNP
2E ||| S:6010 E:6012 ||| NNP
,  ||| S:6012 E:6014 ||| ,
lanes  ||| S:6014 E:6020 ||| CD
5  ||| S:6020 E:6022 ||| CD
and  ||| S:6022 E:6026 ||| CC
6 ||| S:6026 E:6027 ||| CD
)  ||| S:6027 E:6029 ||| -RRB-
and  ||| S:6029 E:6033 ||| CC
BHK  ||| S:6033 E:6045 ||| NNP
cells  ||| S:6045 E:6051 ||| NNS
( ||| S:6051 E:6052 ||| -LRB-
Figure  ||| S:6052 E:6059 ||| NNP
2E ||| S:6059 E:6061 ||| NNP
,  ||| S:6061 E:6063 ||| ,
lanes  ||| S:6063 E:6069 ||| CD
11  ||| S:6069 E:6072 ||| CD
and  ||| S:6072 E:6076 ||| CC
12 ||| S:6076 E:6078 ||| CD
) ||| S:6078 E:6079 ||| -RRB-
,  ||| S:6079 E:6081 ||| ,
although  ||| S:6081 E:6090 ||| IN
some  ||| S:6090 E:6095 ||| DT
was  ||| S:6095 E:6099 ||| VBD
also  ||| S:6099 E:6112 ||| RB
found  ||| S:6112 E:6118 ||| VBN
in  ||| S:6118 E:6121 ||| IN
the  ||| S:6121 E:6125 ||| DT
soluble  ||| S:6125 E:6133 ||| JJ
fraction ||| S:6133 E:6141 ||| NN
.  ||| S:6141 E:6143 ||| .
As  ||| S:6143 E:6146 ||| IN
a  ||| S:6146 E:6148 ||| DT
comparison ||| S:6148 E:6158 ||| NN
,  ||| S:6158 E:6160 ||| ,
a  ||| S:6160 E:6170 ||| DT
non-palmitoylated  ||| S:6170 E:6188 ||| JJ
mutant  ||| S:6188 E:6195 ||| NN
of  ||| S:6195 E:6198 ||| IN
α  ||| S:6198 E:6209 ||| JJ
q  ||| S:6209 E:6211 ||| NN
,  ||| S:6211 E:6213 ||| ,
in  ||| S:6213 E:6216 ||| IN
which  ||| S:6216 E:6222 ||| WDT
cysteines  ||| S:6222 E:6232 ||| VBD
9  ||| S:6232 E:6234 ||| CD
and  ||| S:6234 E:6238 ||| CC
10  ||| S:6238 E:6241 ||| CD
have  ||| S:6241 E:6254 ||| VBP
been  ||| S:6254 E:6259 ||| VBN
substituted  ||| S:6259 E:6271 ||| VBN
with  ||| S:6271 E:6276 ||| IN
serines ||| S:6276 E:6283 ||| NN
,  ||| S:6283 E:6285 ||| ,
is  ||| S:6285 E:6288 ||| VBZ
found  ||| S:6288 E:6294 ||| VBN
predominantly  ||| S:6294 E:6308 ||| RB
in  ||| S:6308 E:6319 ||| IN
the  ||| S:6319 E:6323 ||| DT
soluble  ||| S:6323 E:6331 ||| JJ
fraction  ||| S:6331 E:6340 ||| NN
( ||| S:6340 E:6341 ||| -LRB-
Figure  ||| S:6341 E:6348 ||| NNP
2E ||| S:6348 E:6350 ||| NNP
,  ||| S:6350 E:6352 ||| ,
lanes  ||| S:6352 E:6358 ||| CD
7  ||| S:6358 E:6360 ||| CD
and  ||| S:6360 E:6364 ||| CC
8 ||| S:6364 E:6365 ||| CD
) ||| S:6365 E:6366 ||| -RRB-
,  ||| S:6366 E:6368 ||| ,
as  ||| S:6368 E:6379 ||| RB
described  ||| S:6379 E:6389 ||| VBN
previously  ||| S:6389 E:6400 ||| RB
[  ||| S:6400 E:6402 ||| -LRB-
13  ||| S:6402 E:6405 ||| CD
]  ||| S:6405 E:6407 ||| -RRB-
.  ||| S:6407 E:6409 ||| .
Surprisingly ||| S:6409 E:6421 ||| RB
,  ||| S:6421 E:6423 ||| ,
in  ||| S:6423 E:6426 ||| IN
comparison  ||| S:6426 E:6445 ||| NN
to  ||| S:6445 E:6448 ||| TO
α  ||| S:6448 E:6459 ||| CD
i2  ||| S:6459 E:6462 ||| CD
,  ||| S:6462 E:6464 ||| ,
sα  ||| S:6464 E:6476 ||| JJ
i2  ||| S:6476 E:6479 ||| NN
was  ||| S:6479 E:6483 ||| VBD
always  ||| S:6483 E:6490 ||| RB
detected  ||| S:6490 E:6499 ||| VBN
in  ||| S:6499 E:6502 ||| IN
fewer  ||| S:6502 E:6508 ||| JJR
cells ||| S:6508 E:6513 ||| NNS
,  ||| S:6513 E:6523 ||| ,
by  ||| S:6523 E:6526 ||| IN
immunofluorescence  ||| S:6526 E:6545 ||| JJ
analysis ||| S:6545 E:6553 ||| NN
,  ||| S:6553 E:6555 ||| ,
and  ||| S:6555 E:6559 ||| CC
showed  ||| S:6559 E:6566 ||| VBD
lower  ||| S:6566 E:6572 ||| JJR
levels  ||| S:6572 E:6579 ||| NNS
of  ||| S:6579 E:6590 ||| IN
protein  ||| S:6590 E:6598 ||| NN
expression ||| S:6598 E:6608 ||| NN
,  ||| S:6608 E:6610 ||| ,
by  ||| S:6610 E:6613 ||| IN
western  ||| S:6613 E:6621 ||| JJ
blot  ||| S:6621 E:6626 ||| JJ
analysis  ||| S:6626 E:6635 ||| NN
of  ||| S:6635 E:6638 ||| IN
subcellular  ||| S:6638 E:6658 ||| JJ
fractions  ||| S:6658 E:6668 ||| NNS
( ||| S:6668 E:6669 ||| -LRB-
Figure  ||| S:6669 E:6676 ||| NNP
2E ||| S:6676 E:6678 ||| NNP
)  ||| S:6678 E:6680 ||| -RRB-
or  ||| S:6680 E:6683 ||| CC
whole  ||| S:6683 E:6689 ||| JJ
cell  ||| S:6689 E:6694 ||| NN
lysates  ||| S:6694 E:6702 ||| NNS
( ||| S:6702 E:6703 ||| -LRB-
not  ||| S:6703 E:6707 ||| RB
shown ||| S:6707 E:6712 ||| VBN
) ||| S:6712 E:6713 ||| -RRB-
.  ||| S:6713 E:6723 ||| .
These  ||| S:6723 E:6729 ||| DT
expression  ||| S:6729 E:6740 ||| NN
differences  ||| S:6740 E:6752 ||| NNS
suggested  ||| S:6752 E:6762 ||| VBD
that  ||| S:6762 E:6767 ||| DT
sα  ||| S:6767 E:6779 ||| JJ
i2  ||| S:6779 E:6782 ||| NN
was  ||| S:6782 E:6786 ||| VBD
either  ||| S:6786 E:6793 ||| RB
less  ||| S:6793 E:6798 ||| RBR
efficiently  ||| S:6798 E:6810 ||| RB
expressed  ||| S:6810 E:6828 ||| VBN
or  ||| S:6828 E:6831 ||| CC
more  ||| S:6831 E:6836 ||| RBR
rapidly  ||| S:6836 E:6844 ||| RB
degraded  ||| S:6844 E:6853 ||| VB
compared  ||| S:6853 E:6862 ||| VBN
to  ||| S:6862 E:6865 ||| TO
α  ||| S:6865 E:6876 ||| CD
i2  ||| S:6876 E:6879 ||| CD
,  ||| S:6879 E:6881 ||| ,
as  ||| S:6881 E:6884 ||| RB
described  ||| S:6884 E:6894 ||| VBN
below ||| S:6894 E:6899 ||| RB
.  ||| S:6899 E:6909 ||| .
The  ||| S:6909 E:6913 ||| DT
C-terminal  ||| S:6913 E:6924 ||| JJ
35  ||| S:6924 E:6927 ||| CD
amino  ||| S:6927 E:6933 ||| CD
acids  ||| S:6933 E:6939 ||| NNS
of  ||| S:6939 E:6942 ||| IN
sα  ||| S:6942 E:6954 ||| CD
i2  ||| S:6954 E:6957 ||| CD
,  ||| S:6957 E:6959 ||| ,
which  ||| S:6959 E:6965 ||| WDT
replace  ||| S:6965 E:6973 ||| VBP
the  ||| S:6973 E:6977 ||| DT
C-terminal  ||| S:6977 E:6988 ||| JJ
24  ||| S:6988 E:6999 ||| CD
amino  ||| S:6999 E:7005 ||| CD
acids  ||| S:7005 E:7011 ||| NNS
of  ||| S:7011 E:7014 ||| IN
α  ||| S:7014 E:7025 ||| CD
i2  ||| S:7025 E:7028 ||| CD
( ||| S:7028 E:7029 ||| -LRB-
Figure  ||| S:7029 E:7036 ||| NNP
1 ||| S:7036 E:7037 ||| CD
) ||| S:7037 E:7038 ||| -RRB-
,  ||| S:7038 E:7040 ||| ,
have  ||| S:7040 E:7045 ||| VBP
been  ||| S:7045 E:7050 ||| VBN
proposed  ||| S:7050 E:7059 ||| VBN
to  ||| S:7059 E:7070 ||| TO
function  ||| S:7070 E:7079 ||| VB
as  ||| S:7079 E:7082 ||| IN
a  ||| S:7082 E:7084 ||| DT
Golgi  ||| S:7084 E:7090 ||| NNP
targeting  ||| S:7090 E:7100 ||| VBG
signal  ||| S:7100 E:7107 ||| NN
[  ||| S:7107 E:7109 ||| -LRB-
3  ||| S:7109 E:7111 ||| CD
4  ||| S:7111 E:7113 ||| CD
]  ||| S:7113 E:7115 ||| -RRB-
.  ||| S:7115 E:7117 ||| .
To  ||| S:7117 E:7120 ||| TO
test  ||| S:7120 E:7125 ||| VB
the  ||| S:7125 E:7137 ||| DT
potential  ||| S:7137 E:7147 ||| JJ
importance  ||| S:7147 E:7158 ||| NN
of  ||| S:7158 E:7161 ||| IN
this  ||| S:7161 E:7166 ||| DT
C-terminal  ||| S:7166 E:7177 ||| JJ
region  ||| S:7177 E:7184 ||| NN
in  ||| S:7184 E:7195 ||| IN
localization  ||| S:7195 E:7208 ||| NN
of  ||| S:7208 E:7211 ||| IN
sα  ||| S:7211 E:7223 ||| CD
i2  ||| S:7223 E:7226 ||| CD
to  ||| S:7226 E:7229 ||| TO
intracellular  ||| S:7229 E:7243 ||| VB
membranes  ||| S:7243 E:7253 ||| NNS
and  ||| S:7253 E:7265 ||| CC
prevention  ||| S:7265 E:7276 ||| NN
of  ||| S:7276 E:7279 ||| IN
sα  ||| S:7279 E:7291 ||| JJ
i2  ||| S:7291 E:7294 ||| NN
from  ||| S:7294 E:7299 ||| IN
localizing  ||| S:7299 E:7310 ||| VBG
to  ||| S:7310 E:7313 ||| TO
PM ||| S:7313 E:7315 ||| NNP
,  ||| S:7315 E:7317 ||| ,
a  ||| S:7317 E:7319 ||| DT
deletion  ||| S:7319 E:7336 ||| JJ
mutant  ||| S:7336 E:7343 ||| NN
of  ||| S:7343 E:7346 ||| IN
α  ||| S:7346 E:7357 ||| JJ
i2  ||| S:7357 E:7360 ||| NN
was  ||| S:7360 E:7364 ||| VBD
constructed  ||| S:7364 E:7376 ||| VBN
consisting  ||| S:7376 E:7387 ||| VBG
of  ||| S:7387 E:7390 ||| IN
amino  ||| S:7390 E:7404 ||| FW
acids  ||| S:7404 E:7410 ||| FW
1-331 ||| S:7410 E:7415 ||| FW
.  ||| S:7415 E:7417 ||| .
In  ||| S:7417 E:7420 ||| IN
sα  ||| S:7420 E:7432 ||| CD
i2  ||| S:7432 E:7435 ||| CD
,  ||| S:7435 E:7437 ||| ,
the  ||| S:7437 E:7441 ||| DT
C-terminal  ||| S:7441 E:7452 ||| JJ
splice  ||| S:7452 E:7459 ||| NN
occurs  ||| S:7459 E:7466 ||| VBZ
just  ||| S:7466 E:7479 ||| RB
after  ||| S:7479 E:7485 ||| IN
amino  ||| S:7485 E:7491 ||| JJ
acid  ||| S:7491 E:7496 ||| NN
331  ||| S:7496 E:7500 ||| CD
( ||| S:7500 E:7501 ||| -LRB-
Figure  ||| S:7501 E:7508 ||| NNP
1 ||| S:7508 E:7509 ||| CD
) ||| S:7509 E:7510 ||| -RRB-
,  ||| S:7510 E:7512 ||| ,
and  ||| S:7512 E:7516 ||| CC
thus  ||| S:7516 E:7521 ||| RB
the  ||| S:7521 E:7525 ||| DT
novel  ||| S:7525 E:7531 ||| NN
35  ||| S:7531 E:7542 ||| CD
amino  ||| S:7542 E:7548 ||| JJ
acid  ||| S:7548 E:7553 ||| NN
splice  ||| S:7553 E:7560 ||| NN
sequence  ||| S:7560 E:7569 ||| NN
is  ||| S:7569 E:7572 ||| VBZ
removed  ||| S:7572 E:7580 ||| VBN
in  ||| S:7580 E:7583 ||| IN
α  ||| S:7583 E:7594 ||| CD
i2  ||| S:7594 E:7597 ||| CD
( ||| S:7597 E:7598 ||| -LRB-
1-331 ||| S:7598 E:7603 ||| NNP
) ||| S:7603 E:7604 ||| -RRB-
.  ||| S:7604 E:7606 ||| .
Immunofluorescence  ||| S:7606 E:7633 ||| JJ
microscopy  ||| S:7633 E:7644 ||| NN
indicates  ||| S:7644 E:7654 ||| VBZ
that  ||| S:7654 E:7659 ||| IN
α  ||| S:7659 E:7670 ||| CD
i2  ||| S:7670 E:7673 ||| CD
( ||| S:7673 E:7674 ||| -LRB-
1-331 ||| S:7674 E:7679 ||| NNP
)  ||| S:7679 E:7681 ||| -RRB-
( ||| S:7681 E:7682 ||| -LRB-
Figure  ||| S:7682 E:7689 ||| NNP
4B ||| S:7689 E:7691 ||| NNP
)  ||| S:7691 E:7693 ||| -RRB-
displays  ||| S:7693 E:7702 ||| VBZ
a  ||| S:7702 E:7712 ||| DT
subcellular  ||| S:7712 E:7724 ||| JJ
localization  ||| S:7724 E:7737 ||| JJ
pattern  ||| S:7737 E:7745 ||| NN
very  ||| S:7745 E:7750 ||| RB
similar  ||| S:7750 E:7758 ||| JJ
to  ||| S:7758 E:7761 ||| TO
sα  ||| S:7761 E:7773 ||| VB
i2  ||| S:7773 E:7776 ||| NNP
( ||| S:7776 E:7777 ||| -LRB-
Figure  ||| S:7777 E:7784 ||| NNP
4A ||| S:7784 E:7786 ||| NNP
) ||| S:7786 E:7787 ||| -RRB-
.  ||| S:7787 E:7789 ||| .
This  ||| S:7789 E:7794 ||| DT
result  ||| S:7794 E:7801 ||| NN
is  ||| S:7801 E:7812 ||| VBZ
consistent  ||| S:7812 E:7823 ||| JJ
with  ||| S:7823 E:7828 ||| IN
the  ||| S:7828 E:7832 ||| DT
alternative  ||| S:7832 E:7844 ||| JJ
hypothesis  ||| S:7844 E:7855 ||| NN
that  ||| S:7855 E:7860 ||| IN
a  ||| S:7860 E:7870 ||| DT
disruption  ||| S:7870 E:7881 ||| NN
of  ||| S:7881 E:7884 ||| IN
α  ||| S:7884 E:7895 ||| JJ
i2  ||| S:7895 E:7898 ||| NN
at  ||| S:7898 E:7901 ||| IN
the  ||| S:7901 E:7905 ||| DT
C-terminus  ||| S:7905 E:7916 ||| NN
creates  ||| S:7916 E:7924 ||| VBZ
a  ||| S:7924 E:7926 ||| DT
protein  ||| S:7926 E:7942 ||| NN
unable  ||| S:7942 E:7949 ||| JJ
to  ||| S:7949 E:7952 ||| TO
localize  ||| S:7952 E:7961 ||| VB
at  ||| S:7961 E:7964 ||| IN
the  ||| S:7964 E:7968 ||| DT
PM ||| S:7968 E:7970 ||| NNP
.  ||| S:7970 E:7980 ||| .
If  ||| S:7980 E:7983 ||| IN
the  ||| S:7983 E:7987 ||| DT
unique  ||| S:7987 E:7994 ||| JJ
C-terminal  ||| S:7994 E:8005 ||| JJ
35  ||| S:8005 E:8008 ||| CD
amino  ||| S:8008 E:8014 ||| JJ
acid  ||| S:8014 E:8019 ||| NN
sequence  ||| S:8019 E:8028 ||| NN
of  ||| S:8028 E:8031 ||| IN
sα  ||| S:8031 E:8043 ||| CD
i2  ||| S:8043 E:8046 ||| CD
functions  ||| S:8046 E:8056 ||| NNS
as  ||| S:8056 E:8059 ||| IN
a  ||| S:8059 E:8061 ||| DT
Golgi  ||| S:8061 E:8067 ||| NNP
targeting  ||| S:8067 E:8085 ||| VBG
signal ||| S:8085 E:8091 ||| NN
,  ||| S:8091 E:8093 ||| ,
it  ||| S:8093 E:8096 ||| PRP
is  ||| S:8096 E:8099 ||| VBZ
important  ||| S:8099 E:8109 ||| JJ
to  ||| S:8109 E:8112 ||| TO
test  ||| S:8112 E:8117 ||| VB
whether  ||| S:8117 E:8125 ||| IN
it  ||| S:8125 E:8128 ||| PRP
is  ||| S:8128 E:8131 ||| VBZ
sufficient  ||| S:8131 E:8142 ||| JJ
to  ||| S:8142 E:8153 ||| TO
target  ||| S:8153 E:8160 ||| VB
a  ||| S:8160 E:8162 ||| DT
heterologous  ||| S:8162 E:8175 ||| JJ
protein  ||| S:8175 E:8183 ||| NN
to  ||| S:8183 E:8186 ||| TO
intracellular  ||| S:8186 E:8200 ||| VB
membranes ||| S:8200 E:8209 ||| NNS
.  ||| S:8209 E:8219 ||| .
When  ||| S:8219 E:8224 ||| WRB
the  ||| S:8224 E:8228 ||| DT
35  ||| S:8228 E:8231 ||| CD
amino  ||| S:8231 E:8237 ||| JJ
acid  ||| S:8237 E:8242 ||| NN
sequence  ||| S:8242 E:8251 ||| NN
was  ||| S:8251 E:8255 ||| VBD
fused  ||| S:8255 E:8261 ||| VBN
to  ||| S:8261 E:8264 ||| TO
the  ||| S:8264 E:8268 ||| DT
C-terminus  ||| S:8268 E:8287 ||| JJ
of  ||| S:8287 E:8290 ||| IN
GFP  ||| S:8290 E:8294 ||| NNP
( ||| S:8294 E:8295 ||| -LRB-
GFP-sα  ||| S:8295 E:8311 ||| NNP
i2  ||| S:8311 E:8314 ||| NNP
35aa ||| S:8314 E:8318 ||| NNP
) ||| S:8318 E:8319 ||| -RRB-
,  ||| S:8319 E:8321 ||| ,
this  ||| S:8321 E:8326 ||| DT
unique  ||| S:8326 E:8333 ||| JJ
sα  ||| S:8333 E:8345 ||| NN
i2  ||| S:8345 E:8348 ||| CD
sequence  ||| S:8348 E:8357 ||| NN
failed  ||| S:8357 E:8364 ||| VBD
to  ||| S:8364 E:8367 ||| TO
direct  ||| S:8367 E:8374 ||| VB
GFP  ||| S:8374 E:8378 ||| NNP
to  ||| S:8378 E:8389 ||| TO
intracellular  ||| S:8389 E:8403 ||| VB
membranes  ||| S:8403 E:8413 ||| NNS
( ||| S:8413 E:8414 ||| -LRB-
Figure  ||| S:8414 E:8421 ||| NNP
5B ||| S:8421 E:8423 ||| NNP
) ||| S:8423 E:8424 ||| -RRB-
;  ||| S:8424 E:8426 ||| :
GFP-sα  ||| S:8426 E:8442 ||| NNP
i2  ||| S:8442 E:8445 ||| NNP
35aa  ||| S:8445 E:8450 ||| NNP
was  ||| S:8450 E:8454 ||| VBD
diffusely  ||| S:8454 E:8464 ||| VBN
distributed  ||| S:8464 E:8484 ||| VBN
throughout  ||| S:8484 E:8495 ||| IN
the  ||| S:8495 E:8499 ||| DT
cytoplasm  ||| S:8499 E:8509 ||| NN
and  ||| S:8509 E:8513 ||| CC
nucleus ||| S:8513 E:8520 ||| NN
,  ||| S:8520 E:8522 ||| ,
similar  ||| S:8522 E:8530 ||| JJ
to  ||| S:8530 E:8533 ||| TO
what  ||| S:8533 E:8538 ||| WP
is  ||| S:8538 E:8549 ||| VBZ
observed  ||| S:8549 E:8558 ||| VBN
for  ||| S:8558 E:8562 ||| IN
GFP  ||| S:8562 E:8566 ||| NNP
alone  ||| S:8566 E:8572 ||| RB
( ||| S:8572 E:8573 ||| -LRB-
Figure  ||| S:8573 E:8580 ||| NNP
5A ||| S:8580 E:8582 ||| NNP
) ||| S:8582 E:8583 ||| -RRB-
.  ||| S:8583 E:8585 ||| .
On  ||| S:8585 E:8588 ||| IN
the  ||| S:8588 E:8592 ||| DT
other  ||| S:8592 E:8598 ||| JJ
hand ||| S:8598 E:8602 ||| NN
,  ||| S:8602 E:8604 ||| ,
when  ||| S:8604 E:8617 ||| WRB
the  ||| S:8617 E:8621 ||| DT
first  ||| S:8621 E:8627 ||| JJ
ten  ||| S:8627 E:8631 ||| JJ
amino  ||| S:8631 E:8637 ||| JJ
acids  ||| S:8637 E:8643 ||| NNS
of  ||| S:8643 E:8646 ||| IN
α  ||| S:8646 E:8657 ||| JJ
i2  ||| S:8657 E:8660 ||| NN
are  ||| S:8660 E:8664 ||| VBP
fused  ||| S:8664 E:8670 ||| VBN
to  ||| S:8670 E:8673 ||| TO
GFP  ||| S:8673 E:8677 ||| NNP
to  ||| S:8677 E:8680 ||| TO
create  ||| S:8680 E:8687 ||| VB
α  ||| S:8687 E:8698 ||| JJ
i2  ||| S:8698 E:8701 ||| NNP
( ||| S:8701 E:8702 ||| -LRB-
1-10 ||| S:8702 E:8706 ||| NNP
) ||| S:8706 E:8707 ||| -RRB-
-GFP ||| S:8707 E:8711 ||| NNP
,  ||| S:8711 E:8713 ||| ,
fluorescence  ||| S:8713 E:8726 ||| NN
is  ||| S:8726 E:8729 ||| VBZ
detected  ||| S:8729 E:8746 ||| VBN
strongly  ||| S:8746 E:8755 ||| RB
at  ||| S:8755 E:8758 ||| IN
the  ||| S:8758 E:8762 ||| DT
PM  ||| S:8762 E:8765 ||| NNP
( ||| S:8765 E:8766 ||| -LRB-
Figure  ||| S:8766 E:8773 ||| NNP
5C ||| S:8773 E:8775 ||| NNP
) ||| S:8775 E:8776 ||| -RRB-
,  ||| S:8776 E:8778 ||| ,
indicating  ||| S:8778 E:8789 ||| VBG
the  ||| S:8789 E:8793 ||| DT
N-terminus  ||| S:8793 E:8812 ||| JJ
of  ||| S:8812 E:8815 ||| IN
α  ||| S:8815 E:8826 ||| CD
i2  ||| S:8826 E:8829 ||| CD
,  ||| S:8829 E:8831 ||| ,
which  ||| S:8831 E:8837 ||| WDT
contains  ||| S:8837 E:8846 ||| VBZ
the  ||| S:8846 E:8850 ||| DT
sites  ||| S:8850 E:8856 ||| NNS
for  ||| S:8856 E:8868 ||| IN
myristoylation  ||| S:8868 E:8883 ||| NN
and  ||| S:8883 E:8887 ||| CC
palmitoylation  ||| S:8887 E:8902 ||| NNS
[  ||| S:8902 E:8904 ||| -LRB-
14  ||| S:8904 E:8907 ||| CD
]  ||| S:8907 E:8909 ||| -RRB-
,  ||| S:8909 E:8911 ||| ,
can  ||| S:8911 E:8915 ||| MD
be  ||| S:8915 E:8926 ||| VB
sufficient  ||| S:8926 E:8937 ||| JJ
for  ||| S:8937 E:8941 ||| IN
directing  ||| S:8941 E:8951 ||| VBG
PM  ||| S:8951 E:8954 ||| NNP
localization  ||| S:8954 E:8967 ||| NN
of  ||| S:8967 E:8970 ||| IN
a  ||| S:8970 E:8972 ||| DT
normally  ||| S:8972 E:8989 ||| RB
cytosolic  ||| S:8989 E:8999 ||| JJ
protein ||| S:8999 E:9006 ||| NN
.  ||| S:9006 E:9008 ||| .
In  ||| S:9008 E:9011 ||| IN
agreement  ||| S:9011 E:9021 ||| NN
with  ||| S:9021 E:9026 ||| IN
these  ||| S:9026 E:9032 ||| DT
results ||| S:9032 E:9039 ||| NNS
,  ||| S:9039 E:9041 ||| ,
the  ||| S:9041 E:9045 ||| DT
sα  ||| S:9045 E:9057 ||| JJ
i2  ||| S:9057 E:9060 ||| CD
C-terminal  ||| S:9060 E:9071 ||| JJ
sequence  ||| S:9071 E:9080 ||| NN
failed  ||| S:9080 E:9087 ||| VBD
to  ||| S:9087 E:9098 ||| TO
redirect  ||| S:9098 E:9107 ||| VB
the  ||| S:9107 E:9111 ||| DT
localization  ||| S:9111 E:9124 ||| NN
of  ||| S:9124 E:9127 ||| IN
a  ||| S:9127 E:9129 ||| DT
secreted  ||| S:9129 E:9138 ||| NN
or  ||| S:9138 E:9141 ||| CC
a  ||| S:9141 E:9143 ||| DT
nuclear  ||| S:9143 E:9159 ||| JJ
protein  ||| S:9159 E:9167 ||| NN
[  ||| S:9167 E:9169 ||| -LRB-
4  ||| S:9169 E:9171 ||| LS
]  ||| S:9171 E:9173 ||| -RRB-
.  ||| S:9173 E:9175 ||| .
Thus ||| S:9175 E:9179 ||| RB
,  ||| S:9179 E:9181 ||| ,
not  ||| S:9181 E:9185 ||| RB
only  ||| S:9185 E:9190 ||| RB
is  ||| S:9190 E:9193 ||| VBZ
the  ||| S:9193 E:9197 ||| DT
unique  ||| S:9197 E:9204 ||| JJ
sα  ||| S:9204 E:9216 ||| NNS
i2  ||| S:9216 E:9219 ||| VBP
sequence  ||| S:9219 E:9228 ||| JJ
unable  ||| S:9228 E:9235 ||| JJ
to  ||| S:9235 E:9238 ||| TO
override  ||| S:9238 E:9247 ||| VB
other  ||| S:9247 E:9261 ||| JJ
localization  ||| S:9261 E:9274 ||| JJ
signals ||| S:9274 E:9281 ||| NNS
,  ||| S:9281 E:9283 ||| ,
it  ||| S:9283 E:9286 ||| PRP
is  ||| S:9286 E:9289 ||| VBZ
unable  ||| S:9289 E:9296 ||| JJ
to  ||| S:9296 E:9299 ||| TO
target  ||| S:9299 E:9306 ||| VB
a  ||| S:9306 E:9308 ||| DT
cytoplasmic  ||| S:9308 E:9328 ||| JJ
protein  ||| S:9328 E:9336 ||| NN
to  ||| S:9336 E:9339 ||| TO
intracellular  ||| S:9339 E:9353 ||| VB
membranes ||| S:9353 E:9362 ||| NNS
.  ||| S:9362 E:9364 ||| .
These  ||| S:9364 E:9370 ||| DT
results  ||| S:9370 E:9378 ||| NNS
are  ||| S:9378 E:9390 ||| VBP
consistent  ||| S:9390 E:9401 ||| JJ
with  ||| S:9401 E:9406 ||| IN
a  ||| S:9406 E:9408 ||| DT
lack  ||| S:9408 E:9413 ||| NN
of  ||| S:9413 E:9416 ||| IN
a  ||| S:9416 E:9418 ||| DT
specific  ||| S:9418 E:9427 ||| JJ
role  ||| S:9427 E:9432 ||| NN
for  ||| S:9432 E:9436 ||| IN
the  ||| S:9436 E:9440 ||| DT
sα  ||| S:9440 E:9452 ||| FW
i2  ||| S:9452 E:9455 ||| FW
sequence  ||| S:9455 E:9464 ||| FW
in  ||| S:9464 E:9467 ||| FW
Golgi  ||| S:9467 E:9473 ||| FW
membrane  ||| S:9473 E:9490 ||| FW
targeting ||| S:9490 E:9499 ||| FW
.  ||| S:9499 E:9509 ||| .
The  ||| S:9509 E:9513 ||| DT
above  ||| S:9513 E:9519 ||| JJ
experimental  ||| S:9519 E:9532 ||| JJ
results  ||| S:9532 E:9540 ||| NNS
failed  ||| S:9540 E:9547 ||| VBD
to  ||| S:9547 E:9550 ||| TO
support  ||| S:9550 E:9558 ||| VB
the  ||| S:9558 E:9570 ||| DT
hypothesis  ||| S:9570 E:9581 ||| NN
that  ||| S:9581 E:9586 ||| IN
the  ||| S:9586 E:9590 ||| DT
unique  ||| S:9590 E:9597 ||| JJ
35  ||| S:9597 E:9600 ||| CD
amino  ||| S:9600 E:9606 ||| JJ
acid  ||| S:9606 E:9611 ||| NN
sequence  ||| S:9611 E:9620 ||| NN
from  ||| S:9620 E:9625 ||| IN
sα  ||| S:9625 E:9637 ||| JJ
i2  ||| S:9637 E:9640 ||| NN
serves  ||| S:9640 E:9647 ||| VBZ
as  ||| S:9647 E:9650 ||| IN
a  ||| S:9650 E:9652 ||| DT
specific  ||| S:9652 E:9661 ||| JJ
Golgi  ||| S:9661 E:9667 ||| NNP
or  ||| S:9667 E:9678 ||| CC
intracellular  ||| S:9678 E:9692 ||| JJ
membrane  ||| S:9692 E:9701 ||| NNS
targeting  ||| S:9701 E:9711 ||| VBG
motif ||| S:9711 E:9716 ||| NN
.  ||| S:9716 E:9718 ||| .
Thus ||| S:9718 E:9722 ||| RB
,  ||| S:9722 E:9724 ||| ,
the  ||| S:9724 E:9728 ||| DT
following  ||| S:9728 E:9746 ||| JJ
experiments  ||| S:9746 E:9758 ||| NNS
concentrated  ||| S:9758 E:9771 ||| VBN
on  ||| S:9771 E:9774 ||| IN
addressing  ||| S:9774 E:9785 ||| VBG
the  ||| S:9785 E:9789 ||| DT
alternative  ||| S:9789 E:9809 ||| JJ
hypothesis ||| S:9809 E:9819 ||| NN
:  ||| S:9819 E:9821 ||| :
sα  ||| S:9821 E:9833 ||| JJ
i2  ||| S:9833 E:9836 ||| NN
is  ||| S:9836 E:9839 ||| VBZ
unstable  ||| S:9839 E:9848 ||| JJ
and  ||| S:9848 E:9852 ||| CC
rapidly  ||| S:9852 E:9860 ||| RB
degraded  ||| S:9860 E:9869 ||| JJ
due  ||| S:9869 E:9881 ||| JJ
to  ||| S:9881 E:9884 ||| TO
disruptions  ||| S:9884 E:9896 ||| NNS
in  ||| S:9896 E:9899 ||| IN
the  ||| S:9899 E:9903 ||| DT
C-terminus ||| S:9903 E:9913 ||| JJ
,  ||| S:9913 E:9915 ||| ,
and  ||| S:9915 E:9919 ||| CC
such  ||| S:9919 E:9924 ||| JJ
instability  ||| S:9924 E:9944 ||| NN
results  ||| S:9944 E:9952 ||| NNS
in  ||| S:9952 E:9955 ||| IN
a  ||| S:9955 E:9957 ||| DT
failure  ||| S:9957 E:9965 ||| NN
of  ||| S:9965 E:9968 ||| IN
sα  ||| S:9968 E:9980 ||| CD
i2  ||| S:9980 E:9983 ||| CD
to  ||| S:9983 E:9986 ||| TO
reach  ||| S:9986 E:9992 ||| VB
its  ||| S:9992 E:9996 ||| PRP$
proper  ||| S:9996 E:10003 ||| JJ
place  ||| S:10003 E:10009 ||| NN
at  ||| S:10009 E:10012 ||| IN
the  ||| S:10012 E:10024 ||| DT
PM ||| S:10024 E:10026 ||| NNP
.  ||| S:10026 E:10036 ||| .
The  ||| S:10036 E:10040 ||| DT
ability  ||| S:10040 E:10048 ||| NN
of  ||| S:10048 E:10051 ||| IN
α  ||| S:10051 E:10062 ||| JJ
i2  ||| S:10062 E:10065 ||| NN
and  ||| S:10065 E:10069 ||| CC
sα  ||| S:10069 E:10081 ||| CD
i2  ||| S:10081 E:10084 ||| CD
to  ||| S:10084 E:10087 ||| TO
undergo  ||| S:10087 E:10095 ||| VB
N-terminal  ||| S:10095 E:10106 ||| JJ
lipid  ||| S:10106 E:10120 ||| NN
modifications  ||| S:10120 E:10134 ||| NNS
was  ||| S:10134 E:10138 ||| VBD
compared ||| S:10138 E:10146 ||| VBN
.  ||| S:10146 E:10148 ||| .
Myristoylation  ||| S:10148 E:10163 ||| NNP
occurs  ||| S:10163 E:10178 ||| VBZ
co-translationally  ||| S:10178 E:10197 ||| JJ
at  ||| S:10197 E:10200 ||| IN
the  ||| S:10200 E:10204 ||| DT
extreme  ||| S:10204 E:10212 ||| JJ
N-terminal  ||| S:10212 E:10223 ||| JJ
glycine ||| S:10223 E:10230 ||| NN
,  ||| S:10230 E:10232 ||| ,
while  ||| S:10232 E:10246 ||| IN
palmitoylation  ||| S:10246 E:10261 ||| NN
occurs  ||| S:10261 E:10268 ||| VBZ
post-translationally  ||| S:10268 E:10289 ||| JJ
at  ||| S:10289 E:10292 ||| IN
a  ||| S:10292 E:10294 ||| DT
cysteine  ||| S:10294 E:10311 ||| NN
immediately  ||| S:10311 E:10323 ||| RB
after  ||| S:10323 E:10329 ||| IN
the  ||| S:10329 E:10333 ||| DT
myristoylated  ||| S:10333 E:10347 ||| JJ
glycine  ||| S:10347 E:10355 ||| NNS
[  ||| S:10355 E:10357 ||| -LRB-
15  ||| S:10357 E:10360 ||| CD
]  ||| S:10360 E:10362 ||| -RRB-
.  ||| S:10362 E:10364 ||| .
The  ||| S:10364 E:10376 ||| DT
subcellular  ||| S:10376 E:10388 ||| JJ
site  ||| S:10388 E:10393 ||| NN
where  ||| S:10393 E:10399 ||| WRB
palmitoylation  ||| S:10399 E:10414 ||| JJ
occurs  ||| S:10414 E:10421 ||| NN
has  ||| S:10421 E:10425 ||| VBZ
not  ||| S:10425 E:10429 ||| RB
been  ||| S:10429 E:10442 ||| VBN
well  ||| S:10442 E:10447 ||| RB
defined ||| S:10447 E:10454 ||| VBN
,  ||| S:10454 E:10456 ||| ,
although  ||| S:10456 E:10465 ||| IN
in  ||| S:10465 E:10468 ||| IN
one  ||| S:10468 E:10472 ||| CD
model  ||| S:10472 E:10478 ||| NN
palmitoylation  ||| S:10478 E:10493 ||| NN
occurs  ||| S:10493 E:10508 ||| VBZ
at  ||| S:10508 E:10511 ||| IN
the  ||| S:10511 E:10515 ||| DT
PM  ||| S:10515 E:10518 ||| NNP
[  ||| S:10518 E:10520 ||| -LRB-
16  ||| S:10520 E:10523 ||| CD
]  ||| S:10523 E:10525 ||| -RRB-
.  ||| S:10525 E:10527 ||| .
Cells  ||| S:10527 E:10533 ||| NNS
expressing  ||| S:10533 E:10544 ||| VBG
α  ||| S:10544 E:10555 ||| JJ
i2  ||| S:10555 E:10558 ||| NN
or  ||| S:10558 E:10561 ||| CC
sα  ||| S:10561 E:10573 ||| JJ
i2  ||| S:10573 E:10576 ||| NN
were  ||| S:10576 E:10581 ||| VBD
metabolically  ||| S:10581 E:10595 ||| VBN
labeled  ||| S:10595 E:10603 ||| VBN
with  ||| S:10603 E:10616 ||| IN
3H-palmitate  ||| S:10616 E:10629 ||| NNP
or  ||| S:10629 E:10632 ||| CC
3H-myristate.  ||| S:10632 E:10646 ||| CD
α  ||| S:10646 E:10657 ||| CD
i2  ||| S:10657 E:10660 ||| CD
and  ||| S:10660 E:10664 ||| CC
sα  ||| S:10664 E:10676 ||| JJ
i2  ||| S:10676 E:10679 ||| NN
were  ||| S:10679 E:10684 ||| VBD
immunoprecipitated  ||| S:10684 E:10703 ||| VBN
from  ||| S:10703 E:10708 ||| IN
cell  ||| S:10708 E:10721 ||| NN
extracts ||| S:10721 E:10729 ||| NN
,  ||| S:10729 E:10731 ||| ,
and  ||| S:10731 E:10735 ||| CC
incorporation  ||| S:10735 E:10749 ||| NN
of  ||| S:10749 E:10752 ||| IN
radio-label  ||| S:10752 E:10764 ||| NNP
was  ||| S:10764 E:10768 ||| VBD
analyzed  ||| S:10768 E:10777 ||| VBN
by  ||| S:10777 E:10788 ||| IN
SDS-PAGE  ||| S:10788 E:10797 ||| NNP
followed  ||| S:10797 E:10806 ||| VBD
by  ||| S:10806 E:10809 ||| IN
fluorography  ||| S:10809 E:10822 ||| NNS
( ||| S:10822 E:10823 ||| -LRB-
Figure  ||| S:10823 E:10830 ||| NNP
6A ||| S:10830 E:10832 ||| NNP
) ||| S:10832 E:10833 ||| -RRB-
.  ||| S:10833 E:10835 ||| .
No  ||| S:10835 E:10846 ||| DT
palmitoylation  ||| S:10846 E:10861 ||| NN
of  ||| S:10861 E:10864 ||| IN
sα  ||| S:10864 E:10876 ||| JJ
i2  ||| S:10876 E:10879 ||| NN
was  ||| S:10879 E:10883 ||| VBD
detected  ||| S:10883 E:10892 ||| VBN
( ||| S:10892 E:10893 ||| -LRB-
Figure  ||| S:10893 E:10900 ||| NNP
6A ||| S:10900 E:10902 ||| NNP
,  ||| S:10902 E:10904 ||| ,
lane  ||| S:10904 E:10909 ||| CD
3 ||| S:10909 E:10910 ||| CD
) ||| S:10910 E:10911 ||| -RRB-
,  ||| S:10911 E:10921 ||| ,
although  ||| S:10921 E:10930 ||| IN
α  ||| S:10930 E:10941 ||| JJ
i2  ||| S:10941 E:10944 ||| NN
was  ||| S:10944 E:10948 ||| VBD
strongly  ||| S:10948 E:10957 ||| RB
palmitoylated  ||| S:10957 E:10971 ||| JJ
( ||| S:10971 E:10972 ||| -LRB-
Figure  ||| S:10972 E:10987 ||| NNP
6A ||| S:10987 E:10989 ||| NNP
,  ||| S:10989 E:10991 ||| ,
lane  ||| S:10991 E:10996 ||| CD
2 ||| S:10996 E:10997 ||| CD
) ||| S:10997 E:10998 ||| -RRB-
.  ||| S:10998 E:11000 ||| .
In  ||| S:11000 E:11003 ||| IN
contrast ||| S:11003 E:11011 ||| NN
,  ||| S:11011 E:11013 ||| ,
both  ||| S:11013 E:11018 ||| DT
α  ||| S:11018 E:11029 ||| JJ
i2  ||| S:11029 E:11032 ||| NN
and  ||| S:11032 E:11036 ||| CC
sα  ||| S:11036 E:11048 ||| NNS
i2  ||| S:11048 E:11051 ||| VBP
incorporated  ||| S:11051 E:11064 ||| VBN
similar  ||| S:11064 E:11072 ||| JJ
levels  ||| S:11072 E:11079 ||| NNS
or  ||| S:11079 E:11090 ||| CC
myristate  ||| S:11090 E:11100 ||| NNS
( ||| S:11100 E:11101 ||| -LRB-
Figure  ||| S:11101 E:11108 ||| NNP
6A ||| S:11108 E:11110 ||| NNP
,  ||| S:11110 E:11112 ||| ,
lanes  ||| S:11112 E:11118 ||| CD
5  ||| S:11118 E:11120 ||| CD
and  ||| S:11120 E:11124 ||| CC
6 ||| S:11124 E:11125 ||| CD
) ||| S:11125 E:11126 ||| -RRB-
.  ||| S:11126 E:11128 ||| .
The  ||| S:11128 E:11132 ||| DT
similar  ||| S:11132 E:11140 ||| JJ
level  ||| S:11140 E:11146 ||| NN
of  ||| S:11146 E:11157 ||| IN
myristoylation  ||| S:11157 E:11172 ||| NN
was  ||| S:11172 E:11176 ||| VBD
particularly  ||| S:11176 E:11189 ||| RB
surprising  ||| S:11189 E:11200 ||| JJ
since  ||| S:11200 E:11206 ||| IN
total  ||| S:11206 E:11212 ||| JJ
sα  ||| S:11212 E:11224 ||| NN
i2  ||| S:11224 E:11227 ||| CD
protein  ||| S:11227 E:11235 ||| NN
was  ||| S:11235 E:11239 ||| VBD
much  ||| S:11239 E:11244 ||| RB
lower  ||| S:11244 E:11250 ||| JJR
than  ||| S:11250 E:11255 ||| IN
α  ||| S:11255 E:11266 ||| JJ
i2  ||| S:11266 E:11269 ||| NN
as  ||| S:11269 E:11272 ||| IN
determined  ||| S:11272 E:11283 ||| VBN
by  ||| S:11283 E:11286 ||| IN
immunoblotting  ||| S:11286 E:11301 ||| NN
of  ||| S:11301 E:11312 ||| IN
the  ||| S:11312 E:11316 ||| DT
immunoprecipitates  ||| S:11316 E:11335 ||| NN
( ||| S:11335 E:11336 ||| -LRB-
Figure  ||| S:11336 E:11343 ||| NNP
6B ||| S:11343 E:11345 ||| NNP
,  ||| S:11345 E:11347 ||| ,
compare  ||| S:11347 E:11355 ||| VBP
lanes  ||| S:11355 E:11361 ||| RB
5  ||| S:11361 E:11363 ||| CD
and  ||| S:11363 E:11367 ||| CC
6 ||| S:11367 E:11368 ||| CD
) ||| S:11368 E:11369 ||| -RRB-
.  ||| S:11369 E:11379 ||| .
Myristoylation  ||| S:11379 E:11394 ||| NNP
is  ||| S:11394 E:11397 ||| VBZ
a  ||| S:11397 E:11399 ||| DT
co-translational  ||| S:11399 E:11416 ||| JJ
modification ||| S:11416 E:11428 ||| NN
,  ||| S:11428 E:11430 ||| ,
and  ||| S:11430 E:11442 ||| CC
levels  ||| S:11442 E:11449 ||| NNS
of  ||| S:11449 E:11452 ||| IN
radio-labeling  ||| S:11452 E:11467 ||| NNP
should  ||| S:11467 E:11474 ||| MD
thus  ||| S:11474 E:11479 ||| RB
reflect  ||| S:11479 E:11487 ||| VB
synthesis  ||| S:11487 E:11497 ||| VBN
of  ||| S:11497 E:11508 ||| IN
new  ||| S:11508 E:11512 ||| JJ
protein ||| S:11512 E:11519 ||| NN
.  ||| S:11519 E:11521 ||| .
Accordingly ||| S:11521 E:11532 ||| RB
,  ||| S:11532 E:11534 ||| ,
the  ||| S:11534 E:11538 ||| DT
myristoylation  ||| S:11538 E:11553 ||| JJ
results  ||| S:11553 E:11569 ||| NNS
( ||| S:11569 E:11570 ||| -LRB-
Figure  ||| S:11570 E:11577 ||| NNP
6Aand  ||| S:11577 E:11583 ||| NNP
6B ||| S:11583 E:11585 ||| NNP
,  ||| S:11585 E:11587 ||| ,
lanes  ||| S:11587 E:11593 ||| CD
5  ||| S:11593 E:11595 ||| CD
and  ||| S:11595 E:11599 ||| CC
6 ||| S:11599 E:11600 ||| CD
)  ||| S:11600 E:11602 ||| -RRB-
strongly  ||| S:11602 E:11611 ||| RB
suggested  ||| S:11611 E:11621 ||| VBN
that  ||| S:11621 E:11626 ||| IN
α  ||| S:11626 E:11637 ||| JJ
i2  ||| S:11637 E:11640 ||| NN
and  ||| S:11640 E:11644 ||| CC
sα  ||| S:11644 E:11656 ||| JJ
i2  ||| S:11656 E:11659 ||| NN
are  ||| S:11659 E:11663 ||| VBP
translated  ||| S:11663 E:11674 ||| VBN
equally  ||| S:11674 E:11682 ||| RB
well ||| S:11682 E:11686 ||| RB
,  ||| S:11686 E:11688 ||| ,
as  ||| S:11688 E:11699 ||| RB
evidenced  ||| S:11699 E:11709 ||| VBN
by  ||| S:11709 E:11712 ||| IN
similar  ||| S:11712 E:11720 ||| JJ
levels  ||| S:11720 E:11727 ||| NNS
of  ||| S:11727 E:11730 ||| IN
radiolabeled  ||| S:11730 E:11743 ||| JJ
myristate  ||| S:11743 E:11761 ||| JJ
incorporation  ||| S:11761 E:11775 ||| NN
during  ||| S:11775 E:11782 ||| IN
the  ||| S:11782 E:11786 ||| DT
labeling  ||| S:11786 E:11795 ||| JJ
period ||| S:11795 E:11801 ||| NN
,  ||| S:11801 E:11803 ||| ,
but  ||| S:11803 E:11807 ||| CC
sα  ||| S:11807 E:11819 ||| JJ
i2  ||| S:11819 E:11822 ||| NN
is  ||| S:11822 E:11825 ||| VBZ
more  ||| S:11825 E:11830 ||| RBR
rapidly  ||| S:11830 E:11838 ||| RB
degraded ||| S:11838 E:11846 ||| JJ
,  ||| S:11846 E:11848 ||| ,
as  ||| S:11848 E:11851 ||| RB
seen  ||| S:11851 E:11856 ||| VBN
by  ||| S:11856 E:11867 ||| IN
reduced  ||| S:11867 E:11875 ||| JJ
steady-state  ||| S:11875 E:11888 ||| JJ
levels  ||| S:11888 E:11895 ||| NNS
of  ||| S:11895 E:11898 ||| IN
immunoprecipitated  ||| S:11898 E:11917 ||| JJ
protein ||| S:11917 E:11924 ||| NN
.  ||| S:11924 E:11934 ||| .
The  ||| S:11934 E:11938 ||| DT
lack  ||| S:11938 E:11943 ||| NN
of  ||| S:11943 E:11946 ||| IN
palmitoylation  ||| S:11946 E:11961 ||| NN
of  ||| S:11961 E:11964 ||| IN
sα  ||| S:11964 E:11976 ||| JJ
i2  ||| S:11976 E:11979 ||| NN
is  ||| S:11979 E:11982 ||| VBZ
consistent  ||| S:11982 E:11993 ||| JJ
with  ||| S:11993 E:11998 ||| IN
at  ||| S:11998 E:12001 ||| IN
least  ||| S:12001 E:12007 ||| JJS
two ||| S:12007 E:12010 ||| CD
,  ||| S:12010 E:12012 ||| ,
not  ||| S:12012 E:12024 ||| RB
necessarily  ||| S:12024 E:12036 ||| RB
mutually  ||| S:12036 E:12045 ||| RB
exclusive ||| S:12045 E:12054 ||| JJ
,  ||| S:12054 E:12056 ||| ,
possibilities.  ||| S:12056 E:12071 ||| FW
sα  ||| S:12071 E:12083 ||| FW
i2  ||| S:12083 E:12086 ||| FW
may  ||| S:12086 E:12090 ||| MD
fail  ||| S:12090 E:12095 ||| VB
to  ||| S:12095 E:12098 ||| TO
undergo  ||| S:12098 E:12106 ||| VB
palmitoylation  ||| S:12106 E:12129 ||| VBN
because  ||| S:12129 E:12137 ||| IN
it  ||| S:12137 E:12140 ||| PRP
is  ||| S:12140 E:12143 ||| VBZ
not  ||| S:12143 E:12147 ||| RB
stable  ||| S:12147 E:12154 ||| JJ
long  ||| S:12154 E:12159 ||| JJ
enough  ||| S:12159 E:12166 ||| NN
for  ||| S:12166 E:12170 ||| IN
post-translational  ||| S:12170 E:12197 ||| JJ
palmitoylation  ||| S:12197 E:12212 ||| NN
to  ||| S:12212 E:12215 ||| TO
occur  ||| S:12215 E:12221 ||| VB
or  ||| S:12221 E:12224 ||| CC
because  ||| S:12224 E:12232 ||| IN
it  ||| S:12232 E:12235 ||| PRP
fails  ||| S:12235 E:12241 ||| VBZ
to  ||| S:12241 E:12244 ||| TO
reach  ||| S:12244 E:12250 ||| VB
a  ||| S:12250 E:12252 ||| DT
PM  ||| S:12252 E:12263 ||| NNP
site  ||| S:12263 E:12268 ||| NN
of  ||| S:12268 E:12271 ||| IN
palmitoylation ||| S:12271 E:12285 ||| NN
.  ||| S:12285 E:12287 ||| .
Alternatively ||| S:12287 E:12300 ||| RB
,  ||| S:12300 E:12302 ||| ,
the  ||| S:12302 E:12306 ||| DT
novel  ||| S:12306 E:12312 ||| NN
C-terminal  ||| S:12312 E:12331 ||| JJ
sequence  ||| S:12331 E:12340 ||| NN
of  ||| S:12340 E:12343 ||| IN
sα  ||| S:12343 E:12355 ||| JJ
i2  ||| S:12355 E:12358 ||| NN
may  ||| S:12358 E:12362 ||| MD
somehow  ||| S:12362 E:12370 ||| RB
prevent  ||| S:12370 E:12378 ||| VB
direct  ||| S:12378 E:12393 ||| JJ
recognition  ||| S:12393 E:12405 ||| NN
by  ||| S:12405 E:12408 ||| IN
a  ||| S:12408 E:12410 ||| DT
palmitoyl  ||| S:12410 E:12420 ||| JJ
transferase ||| S:12420 E:12431 ||| NN
.  ||| S:12431 E:12441 ||| .
Cells  ||| S:12441 E:12447 ||| NNS
expressing  ||| S:12447 E:12458 ||| VBG
high  ||| S:12458 E:12463 ||| JJ
levels  ||| S:12463 E:12470 ||| NNS
of  ||| S:12470 E:12473 ||| IN
sα  ||| S:12473 E:12485 ||| CD
i2  ||| S:12485 E:12488 ||| CD
,  ||| S:12488 E:12490 ||| ,
and  ||| S:12490 E:12494 ||| CC
to  ||| S:12494 E:12497 ||| TO
a  ||| S:12497 E:12499 ||| DT
much  ||| S:12499 E:12504 ||| RB
lesser  ||| S:12504 E:12511 ||| JJR
extent  ||| S:12511 E:12518 ||| NN
α  ||| S:12518 E:12529 ||| VBD
i2  ||| S:12529 E:12532 ||| CD
,  ||| S:12532 E:12534 ||| ,
often  ||| S:12534 E:12540 ||| RB
displayed  ||| S:12540 E:12550 ||| VBN
very  ||| S:12550 E:12555 ||| RB
bright  ||| S:12555 E:12570 ||| JJ
intracellular  ||| S:12570 E:12584 ||| JJ
accumulations  ||| S:12584 E:12598 ||| NN
of  ||| S:12598 E:12601 ||| IN
sα  ||| S:12601 E:12613 ||| JJ
i2  ||| S:12613 E:12616 ||| NN
as  ||| S:12616 E:12619 ||| IN
visualized  ||| S:12619 E:12630 ||| NN
by  ||| S:12630 E:12633 ||| IN
immunofluorescence ||| S:12633 E:12651 ||| NN
.  ||| S:12651 E:12661 ||| .
These  ||| S:12661 E:12667 ||| DT
large  ||| S:12667 E:12673 ||| JJ
spots  ||| S:12673 E:12679 ||| NNS
were  ||| S:12679 E:12684 ||| VBD
reminiscent  ||| S:12684 E:12696 ||| VBN
of  ||| S:12696 E:12699 ||| IN
recently  ||| S:12699 E:12708 ||| RB
described  ||| S:12708 E:12726 ||| VBN
aggresomes ||| S:12726 E:12736 ||| NN
,  ||| S:12736 E:12738 ||| ,
accumulations  ||| S:12738 E:12752 ||| VBG
of  ||| S:12752 E:12755 ||| IN
misfolded  ||| S:12755 E:12765 ||| JJ
protein  ||| S:12765 E:12773 ||| NN
that  ||| S:12773 E:12778 ||| WDT
are  ||| S:12778 E:12790 ||| VBP
being  ||| S:12790 E:12796 ||| VBG
targeted  ||| S:12796 E:12805 ||| VBN
for  ||| S:12805 E:12809 ||| IN
proteasome-dependent  ||| S:12809 E:12830 ||| JJ
degradation  ||| S:12830 E:12842 ||| NNS
[  ||| S:12842 E:12844 ||| -LRB-
17  ||| S:12844 E:12847 ||| CD
18  ||| S:12847 E:12858 ||| CD
]  ||| S:12858 E:12860 ||| -RRB-
.  ||| S:12860 E:12862 ||| .
This  ||| S:12862 E:12867 ||| DT
observation  ||| S:12867 E:12879 ||| NN
suggested  ||| S:12879 E:12889 ||| VBD
the  ||| S:12889 E:12893 ||| DT
possibility  ||| S:12893 E:12905 ||| NN
that  ||| S:12905 E:12918 ||| IN
intracellular  ||| S:12918 E:12932 ||| JJ
localization  ||| S:12932 E:12945 ||| NN
of  ||| S:12945 E:12948 ||| IN
sα  ||| S:12948 E:12960 ||| JJ
i2  ||| S:12960 E:12963 ||| NN
may  ||| S:12963 E:12967 ||| MD
reflect  ||| S:12967 E:12975 ||| VB
targeting  ||| S:12975 E:12985 ||| VBG
to  ||| S:12985 E:12988 ||| TO
a  ||| S:12988 E:12998 ||| DT
proteasome-dependent  ||| S:12998 E:13019 ||| JJ
degradative  ||| S:13019 E:13031 ||| JJ
pathway ||| S:13031 E:13038 ||| NN
.  ||| S:13038 E:13040 ||| .
To  ||| S:13040 E:13043 ||| TO
test  ||| S:13043 E:13048 ||| VB
this  ||| S:13048 E:13053 ||| DT
idea  ||| S:13053 E:13066 ||| NN
further ||| S:13066 E:13073 ||| RBR
,  ||| S:13073 E:13075 ||| ,
cells  ||| S:13075 E:13081 ||| NNS
expressing  ||| S:13081 E:13092 ||| VBG
α  ||| S:13092 E:13103 ||| JJ
i2  ||| S:13103 E:13106 ||| NN
or  ||| S:13106 E:13109 ||| CC
sα  ||| S:13109 E:13121 ||| JJ
i2  ||| S:13121 E:13124 ||| NN
were  ||| S:13124 E:13129 ||| VBD
treated  ||| S:13129 E:13137 ||| VBN
with  ||| S:13137 E:13142 ||| IN
the  ||| S:13142 E:13146 ||| DT
proteasome  ||| S:13146 E:13165 ||| FW
inhibitor  ||| S:13165 E:13175 ||| FW
acetyl-leucyl-leucyl-norleucinal  ||| S:13175 E:13208 ||| FW
( ||| S:13208 E:13209 ||| -LRB-
ALLN ||| S:13209 E:13213 ||| NNP
)  ||| S:13213 E:13215 ||| -RRB-
and  ||| S:13215 E:13227 ||| CC
changes  ||| S:13227 E:13235 ||| NNS
in  ||| S:13235 E:13238 ||| IN
localization  ||| S:13238 E:13251 ||| NN
of  ||| S:13251 E:13254 ||| IN
the  ||| S:13254 E:13258 ||| DT
α  ||| S:13258 E:13260 ||| JJ
subunit  ||| S:13260 E:13268 ||| NN
were  ||| S:13268 E:13273 ||| VBD
analyzed  ||| S:13273 E:13282 ||| VBN
by  ||| S:13282 E:13293 ||| IN
immunofluorescence  ||| S:13293 E:13312 ||| NNS
( ||| S:13312 E:13313 ||| -LRB-
Figure  ||| S:13313 E:13320 ||| NNP
7 ||| S:13320 E:13321 ||| CD
) ||| S:13321 E:13322 ||| -RRB-
.  ||| S:13322 E:13324 ||| .
After  ||| S:13324 E:13330 ||| IN
1h  ||| S:13330 E:13333 ||| CD
treatment  ||| S:13333 E:13343 ||| NN
with  ||| S:13343 E:13356 ||| IN
ALLN ||| S:13356 E:13360 ||| NNP
,  ||| S:13360 E:13362 ||| ,
α  ||| S:13362 E:13373 ||| FW
i2  ||| S:13373 E:13376 ||| FW
localization  ||| S:13376 E:13389 ||| FW
is  ||| S:13389 E:13392 ||| VBZ
relatively  ||| S:13392 E:13403 ||| RB
unaffected  ||| S:13403 E:13422 ||| JJ
( ||| S:13422 E:13423 ||| -LRB-
Figure  ||| S:13423 E:13430 ||| NNP
7C ||| S:13430 E:13432 ||| NNP
) ||| S:13432 E:13433 ||| -RRB-
,  ||| S:13433 E:13435 ||| ,
but  ||| S:13435 E:13439 ||| CC
sα  ||| S:13439 E:13451 ||| JJ
i2  ||| S:13451 E:13454 ||| NN
begins  ||| S:13454 E:13461 ||| VBZ
to  ||| S:13461 E:13464 ||| TO
show  ||| S:13464 E:13469 ||| VB
a  ||| S:13469 E:13471 ||| DT
slight  ||| S:13471 E:13478 ||| JJ
increase  ||| S:13478 E:13487 ||| NN
in  ||| S:13487 E:13498 ||| IN
distinct  ||| S:13498 E:13507 ||| JJ
intracellular  ||| S:13507 E:13521 ||| JJ
accumulations  ||| S:13521 E:13535 ||| NNS
( ||| S:13535 E:13536 ||| -LRB-
Figure  ||| S:13536 E:13543 ||| NNP
7D ||| S:13543 E:13545 ||| NNP
) ||| S:13545 E:13546 ||| -RRB-
.  ||| S:13546 E:13548 ||| .
At  ||| S:13548 E:13551 ||| IN
4  ||| S:13551 E:13553 ||| CD
h  ||| S:13553 E:13563 ||| JJ
ALLN  ||| S:13563 E:13568 ||| NNP
treatment ||| S:13568 E:13577 ||| NN
,  ||| S:13577 E:13579 ||| ,
many  ||| S:13579 E:13584 ||| JJ
cells  ||| S:13584 E:13590 ||| NNS
expressing  ||| S:13590 E:13601 ||| VBG
α  ||| S:13601 E:13612 ||| NNS
i2  ||| S:13612 E:13615 ||| RB
display  ||| S:13615 E:13623 ||| VB
a  ||| S:13623 E:13625 ||| DT
decrease  ||| S:13625 E:13634 ||| NN
in  ||| S:13634 E:13637 ||| IN
PM  ||| S:13637 E:13640 ||| NNP
localization  ||| S:13640 E:13661 ||| NN
and  ||| S:13661 E:13665 ||| CC
an  ||| S:13665 E:13668 ||| DT
increase  ||| S:13668 E:13677 ||| NN
in  ||| S:13677 E:13680 ||| IN
intracellular  ||| S:13680 E:13694 ||| JJ
staining  ||| S:13694 E:13703 ||| NNS
( ||| S:13703 E:13704 ||| -LRB-
Figure  ||| S:13704 E:13711 ||| NNP
7E ||| S:13711 E:13713 ||| NNP
) ||| S:13713 E:13714 ||| -RRB-
.  ||| S:13714 E:13716 ||| .
α  ||| S:13716 E:13727 ||| FW
i2  ||| S:13727 E:13730 ||| FW
is  ||| S:13730 E:13733 ||| VBZ
typically  ||| S:13733 E:13743 ||| RB
seen  ||| S:13743 E:13748 ||| VBN
in  ||| S:13748 E:13751 ||| IN
large  ||| S:13751 E:13757 ||| JJ
bright  ||| S:13757 E:13772 ||| JJ
spots  ||| S:13772 E:13778 ||| NNS
and  ||| S:13778 E:13782 ||| CC
in  ||| S:13782 E:13785 ||| IN
a  ||| S:13785 E:13787 ||| DT
perinuclear ||| S:13787 E:13798 ||| FW
/ ||| S:13798 E:13799 ||| FW
intracellular  ||| S:13799 E:13813 ||| FW
membrane  ||| S:13813 E:13822 ||| FW
staining  ||| S:13822 E:13839 ||| FW
pattern  ||| S:13839 E:13847 ||| NN
after  ||| S:13847 E:13853 ||| IN
incubation  ||| S:13853 E:13864 ||| NN
of  ||| S:13864 E:13867 ||| IN
cells  ||| S:13867 E:13873 ||| NNS
for  ||| S:13873 E:13877 ||| IN
4  ||| S:13877 E:13879 ||| CD
h  ||| S:13879 E:13881 ||| NN
with  ||| S:13881 E:13886 ||| IN
ALLN ||| S:13886 E:13890 ||| NNP
.  ||| S:13890 E:13892 ||| .
In  ||| S:13892 E:13903 ||| IN
fact ||| S:13903 E:13907 ||| NN
,  ||| S:13907 E:13909 ||| ,
the  ||| S:13909 E:13913 ||| DT
localization  ||| S:13913 E:13926 ||| JJ
pattern  ||| S:13926 E:13934 ||| NN
of  ||| S:13934 E:13937 ||| IN
α  ||| S:13937 E:13948 ||| JJ
i2  ||| S:13948 E:13951 ||| NN
after  ||| S:13951 E:13957 ||| IN
4  ||| S:13957 E:13959 ||| CD
h  ||| S:13959 E:13961 ||| JJ
incubation  ||| S:13961 E:13972 ||| NN
with  ||| S:13972 E:13977 ||| IN
ALLN  ||| S:13977 E:13990 ||| NNP
( ||| S:13990 E:13991 ||| -LRB-
Figure  ||| S:13991 E:13998 ||| NNP
7E ||| S:13998 E:14000 ||| NNP
)  ||| S:14000 E:14002 ||| -RRB-
is  ||| S:14002 E:14005 ||| VBZ
similar  ||| S:14005 E:14013 ||| JJ
to  ||| S:14013 E:14016 ||| TO
the  ||| S:14016 E:14020 ||| DT
observed  ||| S:14020 E:14029 ||| JJ
localization  ||| S:14029 E:14042 ||| NN
of  ||| S:14042 E:14045 ||| IN
sα  ||| S:14045 E:14057 ||| JJ
i2  ||| S:14057 E:14060 ||| NN
in  ||| S:14060 E:14063 ||| IN
the  ||| S:14063 E:14067 ||| DT
absence  ||| S:14067 E:14075 ||| NN
or  ||| S:14075 E:14078 ||| CC
presence  ||| S:14078 E:14087 ||| NN
of  ||| S:14087 E:14090 ||| IN
ALLN  ||| S:14090 E:14103 ||| NNP
treatment  ||| S:14103 E:14113 ||| NN
( ||| S:14113 E:14114 ||| -LRB-
Figure  ||| S:14114 E:14121 ||| NNP
7B ||| S:14121 E:14123 ||| NNP
,  ||| S:14123 E:14125 ||| ,
7D ||| S:14125 E:14127 ||| NNP
,  ||| S:14127 E:14129 ||| ,
and  ||| S:14129 E:14133 ||| CC
7F ||| S:14133 E:14135 ||| CD
) ||| S:14135 E:14136 ||| -RRB-
.  ||| S:14136 E:14138 ||| .
At  ||| S:14138 E:14141 ||| IN
8  ||| S:14141 E:14143 ||| CD
h  ||| S:14143 E:14145 ||| JJ
treatment  ||| S:14145 E:14155 ||| NN
with  ||| S:14155 E:14168 ||| IN
ALLN ||| S:14168 E:14172 ||| NNP
,  ||| S:14172 E:14174 ||| ,
both  ||| S:14174 E:14179 ||| DT
α  ||| S:14179 E:14190 ||| JJ
i2  ||| S:14190 E:14193 ||| NNP
( ||| S:14193 E:14194 ||| -LRB-
Figure  ||| S:14194 E:14201 ||| NNP
7G ||| S:14201 E:14203 ||| NNP
)  ||| S:14203 E:14205 ||| -RRB-
and  ||| S:14205 E:14209 ||| CC
sα  ||| S:14209 E:14221 ||| CD
i2  ||| S:14221 E:14224 ||| CD
( ||| S:14224 E:14225 ||| -LRB-
Figure  ||| S:14225 E:14232 ||| NNP
7H ||| S:14232 E:14234 ||| NNP
)  ||| S:14234 E:14236 ||| -RRB-
are  ||| S:14236 E:14240 ||| VBP
detected  ||| S:14240 E:14249 ||| VBN
almost  ||| S:14249 E:14264 ||| RB
exclusively  ||| S:14264 E:14276 ||| RB
as  ||| S:14276 E:14279 ||| IN
a  ||| S:14279 E:14281 ||| DT
large  ||| S:14281 E:14287 ||| JJ
bright  ||| S:14287 E:14294 ||| JJ
spot  ||| S:14294 E:14299 ||| NN
in  ||| S:14299 E:14302 ||| IN
each  ||| S:14302 E:14307 ||| DT
expressing  ||| S:14307 E:14318 ||| JJ
cell ||| S:14318 E:14322 ||| NN
.  ||| S:14322 E:14332 ||| .
Similar  ||| S:14332 E:14340 ||| JJ
results  ||| S:14340 E:14348 ||| NNS
were  ||| S:14348 E:14353 ||| VBD
obtained  ||| S:14353 E:14362 ||| VBN
using  ||| S:14362 E:14368 ||| VBG
another  ||| S:14368 E:14376 ||| DT
proteasome  ||| S:14376 E:14395 ||| JJ
inhibitor ||| S:14395 E:14404 ||| NN
,  ||| S:14404 E:14406 ||| ,
MG-132 ||| S:14406 E:14412 ||| NNP
.  ||| S:14412 E:14414 ||| .
Interestingly ||| S:14414 E:14427 ||| RB
,  ||| S:14427 E:14429 ||| ,
ALLN  ||| S:14429 E:14434 ||| NNP
treatment  ||| S:14434 E:14444 ||| NN
was  ||| S:14444 E:14456 ||| VBD
relatively  ||| S:14456 E:14467 ||| RB
ineffective  ||| S:14467 E:14479 ||| VBN
at  ||| S:14479 E:14482 ||| IN
promoting  ||| S:14482 E:14492 ||| VBG
accumulation  ||| S:14492 E:14505 ||| NN
of  ||| S:14505 E:14516 ||| IN
overexpressed  ||| S:14516 E:14530 ||| JJ
α  ||| S:14530 E:14541 ||| NN
s  ||| S:14541 E:14543 ||| VBZ
in  ||| S:14543 E:14546 ||| IN
aggresome-like  ||| S:14546 E:14561 ||| JJ
structures  ||| S:14561 E:14572 ||| NNS
( ||| S:14572 E:14573 ||| -LRB-
not  ||| S:14573 E:14585 ||| RB
shown ||| S:14585 E:14590 ||| VBN
) ||| S:14590 E:14591 ||| -RRB-
.  ||| S:14591 E:14593 ||| .
Thus ||| S:14593 E:14597 ||| RB
,  ||| S:14597 E:14599 ||| ,
the  ||| S:14599 E:14603 ||| DT
results  ||| S:14603 E:14611 ||| NNS
of  ||| S:14611 E:14614 ||| IN
Figure  ||| S:14614 E:14621 ||| NNP
7are  ||| S:14621 E:14626 ||| NNP
consistent  ||| S:14626 E:14637 ||| JJ
with  ||| S:14637 E:14650 ||| IN
the  ||| S:14650 E:14654 ||| DT
proposal  ||| S:14654 E:14663 ||| NN
that  ||| S:14663 E:14668 ||| IN
the  ||| S:14668 E:14672 ||| DT
intracellular  ||| S:14672 E:14686 ||| JJ
localization  ||| S:14686 E:14699 ||| NN
of  ||| S:14699 E:14702 ||| IN
sα  ||| S:14702 E:14714 ||| JJ
i2  ||| S:14714 E:14717 ||| NN
is  ||| S:14717 E:14720 ||| VBZ
due  ||| S:14720 E:14724 ||| JJ
to  ||| S:14724 E:14727 ||| TO
its  ||| S:14727 E:14731 ||| PRP$
targeting  ||| S:14731 E:14741 ||| VBG
to  ||| S:14741 E:14744 ||| TO
a  ||| S:14744 E:14754 ||| DT
degradative  ||| S:14754 E:14766 ||| JJ
pathway ||| S:14766 E:14773 ||| NN
,  ||| S:14773 E:14775 ||| ,
a  ||| S:14775 E:14777 ||| DT
pathway  ||| S:14777 E:14785 ||| NN
shared  ||| S:14785 E:14792 ||| VBN
by  ||| S:14792 E:14795 ||| IN
α  ||| S:14795 E:14806 ||| CD
i2  ||| S:14806 E:14809 ||| CD
.  ||| S:14809 E:14819 ||| .
The  ||| S:14819 E:14823 ||| DT
subcellular  ||| S:14823 E:14835 ||| JJ
localization  ||| S:14835 E:14848 ||| NN
of  ||| S:14848 E:14851 ||| IN
sα  ||| S:14851 E:14863 ||| JJ
i2  ||| S:14863 E:14866 ||| NN
was  ||| S:14866 E:14870 ||| VBD
compared  ||| S:14870 E:14879 ||| VBN
to  ||| S:14879 E:14882 ||| TO
α  ||| S:14882 E:14893 ||| CD
i2  ||| S:14893 E:14896 ||| CD
A327S ||| S:14896 E:14901 ||| CD
.  ||| S:14901 E:14903 ||| .
This  ||| S:14903 E:14908 ||| DT
alanine  ||| S:14908 E:14916 ||| NN
to  ||| S:14916 E:14919 ||| TO
serine  ||| S:14919 E:14934 ||| VB
mutation  ||| S:14934 E:14943 ||| VBN
in  ||| S:14943 E:14946 ||| IN
the  ||| S:14946 E:14950 ||| DT
C-terminal  ||| S:14950 E:14961 ||| JJ
region  ||| S:14961 E:14968 ||| NN
of  ||| S:14968 E:14971 ||| IN
α  ||| S:14971 E:14982 ||| CD
i1  ||| S:14982 E:14985 ||| CD
( ||| S:14985 E:14986 ||| -LRB-
A326S ||| S:14986 E:14991 ||| NNP
)  ||| S:14991 E:14993 ||| -RRB-
and  ||| S:14993 E:14997 ||| CC
α  ||| S:14997 E:15008 ||| JJ
s  ||| S:15008 E:15010 ||| NNS
( ||| S:15010 E:15011 ||| -LRB-
A366S ||| S:15011 E:15016 ||| NNP
)  ||| S:15016 E:15018 ||| -RRB-
has  ||| S:15018 E:15022 ||| VBZ
been  ||| S:15022 E:15027 ||| VBN
shown  ||| S:15027 E:15033 ||| VBN
to  ||| S:15033 E:15036 ||| TO
greatly  ||| S:15036 E:15052 ||| RB
accelerate  ||| S:15052 E:15063 ||| VB
GDP  ||| S:15063 E:15067 ||| NNP
release ||| S:15067 E:15074 ||| NN
,  ||| S:15074 E:15076 ||| ,
to  ||| S:15076 E:15079 ||| TO
accelerate  ||| S:15079 E:15090 ||| VB
irreversible  ||| S:15090 E:15111 ||| JJ
inactivation  ||| S:15111 E:15133 ||| NN
in  ||| S:15133 E:15136 ||| IN
vitro  ||| S:15136 E:15142 ||| NN
,  ||| S:15142 E:15144 ||| ,
and  ||| S:15144 E:15148 ||| CC
to  ||| S:15148 E:15151 ||| TO
cause  ||| S:15151 E:15157 ||| VB
rapid  ||| S:15157 E:15171 ||| JJ
turnover  ||| S:15171 E:15180 ||| NN
of  ||| S:15180 E:15183 ||| IN
the  ||| S:15183 E:15187 ||| DT
α  ||| S:15187 E:15189 ||| JJ
subunit  ||| S:15189 E:15197 ||| NN
in  ||| S:15197 E:15200 ||| IN
cultured  ||| S:15200 E:15209 ||| JJ
cells  ||| S:15209 E:15215 ||| NNS
[  ||| S:15215 E:15217 ||| -LRB-
9  ||| S:15217 E:15219 ||| CD
10  ||| S:15219 E:15222 ||| CD
]  ||| S:15222 E:15224 ||| -RRB-
.  ||| S:15224 E:15234 ||| .
Thus ||| S:15234 E:15238 ||| RB
,  ||| S:15238 E:15240 ||| ,
if  ||| S:15240 E:15243 ||| IN
the  ||| S:15243 E:15247 ||| DT
observed  ||| S:15247 E:15256 ||| JJ
intracellular  ||| S:15256 E:15270 ||| JJ
localization  ||| S:15270 E:15283 ||| NN
of  ||| S:15283 E:15286 ||| IN
sα  ||| S:15286 E:15298 ||| JJ
i2  ||| S:15298 E:15301 ||| NN
is  ||| S:15301 E:15304 ||| VBZ
caused  ||| S:15304 E:15311 ||| VBN
by  ||| S:15311 E:15314 ||| IN
instability  ||| S:15314 E:15326 ||| NN
of  ||| S:15326 E:15329 ||| IN
the  ||| S:15329 E:15341 ||| DT
protein  ||| S:15341 E:15349 ||| NN
due  ||| S:15349 E:15353 ||| JJ
to  ||| S:15353 E:15356 ||| TO
disruptions  ||| S:15356 E:15368 ||| NNS
at  ||| S:15368 E:15371 ||| IN
its  ||| S:15371 E:15375 ||| PRP$
C-terminus ||| S:15375 E:15385 ||| JJ
,  ||| S:15385 E:15387 ||| ,
then  ||| S:15387 E:15392 ||| RB
it  ||| S:15392 E:15403 ||| PRP
follows  ||| S:15403 E:15411 ||| VBZ
that  ||| S:15411 E:15416 ||| DT
α  ||| S:15416 E:15427 ||| JJ
i2  ||| S:15427 E:15430 ||| NNP
A327S  ||| S:15430 E:15436 ||| NNP
should  ||| S:15436 E:15443 ||| MD
show  ||| S:15443 E:15448 ||| VB
a  ||| S:15448 E:15450 ||| DT
similar  ||| S:15450 E:15458 ||| JJ
pattern  ||| S:15458 E:15474 ||| NN
of  ||| S:15474 E:15477 ||| IN
localization ||| S:15477 E:15489 ||| NN
.  ||| S:15489 E:15491 ||| .
Indeed ||| S:15491 E:15497 ||| RB
,  ||| S:15497 E:15499 ||| ,
immunofluorescence  ||| S:15499 E:15518 ||| JJ
microscopy  ||| S:15518 E:15537 ||| NN
revealed  ||| S:15537 E:15546 ||| VBD
a  ||| S:15546 E:15548 ||| DT
pronounced  ||| S:15548 E:15559 ||| JJ
intracellular  ||| S:15559 E:15573 ||| JJ
distribution  ||| S:15573 E:15586 ||| NN
for  ||| S:15586 E:15590 ||| IN
α  ||| S:15590 E:15601 ||| CD
i2  ||| S:15601 E:15604 ||| CD
A327S  ||| S:15604 E:15610 ||| CD
( ||| S:15610 E:15611 ||| -LRB-
Figure  ||| S:15611 E:15618 ||| NNP
8E ||| S:15618 E:15620 ||| NNP
) ||| S:15620 E:15621 ||| -RRB-
.  ||| S:15621 E:15623 ||| .
In  ||| S:15623 E:15626 ||| IN
addition  ||| S:15626 E:15635 ||| NN
to  ||| S:15635 E:15646 ||| TO
intracellular  ||| S:15646 E:15660 ||| VB
membrane  ||| S:15660 E:15669 ||| JJ
localization  ||| S:15669 E:15682 ||| JJ
similar  ||| S:15682 E:15690 ||| JJ
to  ||| S:15690 E:15693 ||| TO
sα  ||| S:15693 E:15705 ||| VB
i2  ||| S:15705 E:15708 ||| NNP
( ||| S:15708 E:15709 ||| -LRB-
Figure  ||| S:15709 E:15716 ||| NNP
8C ||| S:15716 E:15718 ||| NNP
) ||| S:15718 E:15719 ||| -RRB-
,  ||| S:15719 E:15721 ||| ,
α  ||| S:15721 E:15732 ||| VBG
i2  ||| S:15732 E:15735 ||| NNP
A327S  ||| S:15735 E:15741 ||| NNP
was  ||| S:15741 E:15745 ||| VBD
detected  ||| S:15745 E:15754 ||| VBN
weakly  ||| S:15754 E:15761 ||| NNS
but  ||| S:15761 E:15773 ||| CC
consistently  ||| S:15773 E:15786 ||| RB
at  ||| S:15786 E:15789 ||| IN
the  ||| S:15789 E:15793 ||| DT
PM ||| S:15793 E:15795 ||| NNP
.  ||| S:15795 E:15797 ||| .
It  ||| S:15797 E:15800 ||| PRP
seems  ||| S:15800 E:15806 ||| VBZ
likely  ||| S:15806 E:15813 ||| RB
that  ||| S:15813 E:15818 ||| IN
the  ||| S:15818 E:15822 ||| DT
C-terminal  ||| S:15822 E:15841 ||| JJ
disruption  ||| S:15841 E:15852 ||| NN
of  ||| S:15852 E:15855 ||| IN
sα  ||| S:15855 E:15867 ||| CD
i2  ||| S:15867 E:15870 ||| CD
( ||| S:15870 E:15871 ||| -LRB-
replacing  ||| S:15871 E:15881 ||| VBG
the  ||| S:15881 E:15885 ||| DT
24  ||| S:15885 E:15888 ||| CD
C-terminal  ||| S:15888 E:15899 ||| JJ
amino  ||| S:15899 E:15913 ||| JJ
acids ||| S:15913 E:15918 ||| NNS
)  ||| S:15918 E:15920 ||| -RRB-
is  ||| S:15920 E:15923 ||| VBZ
a  ||| S:15923 E:15925 ||| DT
more  ||| S:15925 E:15930 ||| RBR
severe  ||| S:15930 E:15937 ||| JJ
disruption  ||| S:15937 E:15948 ||| NN
than  ||| S:15948 E:15953 ||| IN
the  ||| S:15953 E:15957 ||| DT
A327S  ||| S:15957 E:15971 ||| JJ
substitution ||| S:15971 E:15983 ||| NN
.  ||| S:15983 E:15985 ||| .
Thus ||| S:15985 E:15989 ||| RB
,  ||| S:15989 E:15991 ||| ,
the  ||| S:15991 E:15995 ||| DT
similarity  ||| S:15995 E:16006 ||| NN
in  ||| S:16006 E:16009 ||| IN
localization  ||| S:16009 E:16022 ||| NN
of  ||| S:16022 E:16025 ||| IN
sα  ||| S:16025 E:16037 ||| JJ
i2  ||| S:16037 E:16040 ||| NN
and  ||| S:16040 E:16044 ||| CC
α  ||| S:16044 E:16055 ||| JJ
i2  ||| S:16055 E:16058 ||| NNP
A327S  ||| S:16058 E:16064 ||| NNP
bolsters  ||| S:16064 E:16073 ||| VBZ
the  ||| S:16073 E:16077 ||| DT
idea  ||| S:16077 E:16082 ||| NN
that  ||| S:16082 E:16095 ||| IN
mislocalization  ||| S:16095 E:16111 ||| NN
of  ||| S:16111 E:16114 ||| IN
sα  ||| S:16114 E:16126 ||| JJ
i2  ||| S:16126 E:16129 ||| NN
is  ||| S:16129 E:16132 ||| VBZ
caused  ||| S:16132 E:16139 ||| VBN
by  ||| S:16139 E:16142 ||| IN
its  ||| S:16142 E:16146 ||| PRP$
inherent  ||| S:16146 E:16163 ||| JJ
instability ||| S:16163 E:16174 ||| NN
.  ||| S:16174 E:16184 ||| .
G  ||| S:16184 E:16186 ||| NNP
protein  ||| S:16186 E:16194 ||| NN
βγ  ||| S:16194 E:16197 ||| NN
subunits  ||| S:16197 E:16206 ||| NNS
can  ||| S:16206 E:16210 ||| MD
stabilize  ||| S:16210 E:16220 ||| VB
wild  ||| S:16220 E:16225 ||| JJ
type  ||| S:16225 E:16230 ||| NN
and  ||| S:16230 E:16242 ||| CC
alanine  ||| S:16242 E:16250 ||| JJ
to  ||| S:16250 E:16253 ||| TO
serine  ||| S:16253 E:16260 ||| FW
mutant  ||| S:16260 E:16267 ||| FW
α  ||| S:16267 E:16269 ||| FW
subunits  ||| S:16269 E:16287 ||| FW
in  ||| S:16287 E:16290 ||| FW
vitro  ||| S:16290 E:16296 ||| FW
[  ||| S:16296 E:16298 ||| -LRB-
10  ||| S:16298 E:16301 ||| CD
]  ||| S:16301 E:16303 ||| -RRB-
.  ||| S:16303 E:16305 ||| .
Thus ||| S:16305 E:16309 ||| RB
,  ||| S:16309 E:16311 ||| ,
the  ||| S:16311 E:16315 ||| DT
effect  ||| S:16315 E:16322 ||| NN
of  ||| S:16322 E:16333 ||| IN
βγ  ||| S:16333 E:16336 ||| JJ
co-expression  ||| S:16336 E:16350 ||| NN
on  ||| S:16350 E:16353 ||| IN
subcellular  ||| S:16353 E:16365 ||| JJ
localization  ||| S:16365 E:16378 ||| NN
of  ||| S:16378 E:16381 ||| IN
α  ||| S:16381 E:16392 ||| CD
i2  ||| S:16392 E:16395 ||| CD
A327S  ||| S:16395 E:16401 ||| CD
and  ||| S:16401 E:16405 ||| CC
sα  ||| S:16405 E:16417 ||| JJ
i2  ||| S:16417 E:16420 ||| NN
was  ||| S:16420 E:16424 ||| VBD
tested.  ||| S:16424 E:16432 ||| CD
α  ||| S:16432 E:16443 ||| CD
i2  ||| S:16443 E:16446 ||| CD
localizes  ||| S:16446 E:16456 ||| NN
to  ||| S:16456 E:16459 ||| TO
the  ||| S:16459 E:16463 ||| DT
PM  ||| S:16463 E:16466 ||| NNP
efficiently  ||| S:16466 E:16478 ||| RB
when  ||| S:16478 E:16491 ||| WRB
expressed  ||| S:16491 E:16501 ||| VBD
alone  ||| S:16501 E:16507 ||| RB
( ||| S:16507 E:16508 ||| -LRB-
Figure  ||| S:16508 E:16515 ||| NNP
8A ||| S:16515 E:16517 ||| NNP
)  ||| S:16517 E:16519 ||| -RRB-
or  ||| S:16519 E:16522 ||| CC
when  ||| S:16522 E:16527 ||| WRB
co-expressed  ||| S:16527 E:16540 ||| JJ
with  ||| S:16540 E:16545 ||| IN
βγ  ||| S:16545 E:16556 ||| NNS
( ||| S:16556 E:16557 ||| -LRB-
Figure  ||| S:16557 E:16564 ||| NNP
8B ||| S:16564 E:16566 ||| NNP
) ||| S:16566 E:16567 ||| -RRB-
.  ||| S:16567 E:16569 ||| .
sα  ||| S:16569 E:16581 ||| FW
i2  ||| S:16581 E:16584 ||| FW
shows  ||| S:16584 E:16590 ||| VBZ
a  ||| S:16590 E:16592 ||| DT
dramatic  ||| S:16592 E:16601 ||| JJ
change  ||| S:16601 E:16608 ||| NN
in  ||| S:16608 E:16619 ||| IN
localization  ||| S:16619 E:16632 ||| NN
when  ||| S:16632 E:16637 ||| WRB
co-expressed  ||| S:16637 E:16650 ||| JJ
with  ||| S:16650 E:16655 ||| IN
βγ  ||| S:16655 E:16658 ||| NNS
( ||| S:16658 E:16659 ||| -LRB-
Figure  ||| S:16659 E:16666 ||| NNP
8D ||| S:16666 E:16668 ||| NNP
) ||| S:16668 E:16669 ||| -RRB-
,  ||| S:16669 E:16679 ||| ,
displaying  ||| S:16679 E:16690 ||| VBG
strong  ||| S:16690 E:16697 ||| JJ
PM  ||| S:16697 E:16700 ||| NNP
staining ||| S:16700 E:16708 ||| NN
.  ||| S:16708 E:16710 ||| .
Not  ||| S:16710 E:16714 ||| RB
only  ||| S:16714 E:16719 ||| RB
is  ||| S:16719 E:16722 ||| VBZ
sα  ||| S:16722 E:16734 ||| VBN
i2  ||| S:16734 E:16737 ||| RB
targeted  ||| S:16737 E:16746 ||| VBN
efficiently  ||| S:16746 E:16758 ||| RB
to  ||| S:16758 E:16761 ||| TO
the  ||| S:16761 E:16765 ||| DT
PM  ||| S:16765 E:16768 ||| NNP
when  ||| S:16768 E:16781 ||| WRB
co-expressed  ||| S:16781 E:16794 ||| JJ
with  ||| S:16794 E:16799 ||| IN
βγ ||| S:16799 E:16801 ||| NN
,  ||| S:16801 E:16803 ||| ,
but  ||| S:16803 E:16807 ||| CC
βγ  ||| S:16807 E:16810 ||| JJ
co-expression  ||| S:16810 E:16824 ||| JJ
increases  ||| S:16824 E:16842 ||| NNS
overall  ||| S:16842 E:16850 ||| JJ
levels  ||| S:16850 E:16857 ||| NNS
of  ||| S:16857 E:16860 ||| IN
transiently  ||| S:16860 E:16872 ||| NN
expressed  ||| S:16872 E:16882 ||| VBD
sα  ||| S:16882 E:16894 ||| CD
i2  ||| S:16894 E:16897 ||| CD
and  ||| S:16897 E:16901 ||| CC
α  ||| S:16901 E:16912 ||| CD
i2  ||| S:16912 E:16915 ||| CD
,  ||| S:16915 E:16917 ||| ,
as  ||| S:16917 E:16920 ||| RB
determined  ||| S:16920 E:16931 ||| VBN
by  ||| S:16931 E:16934 ||| IN
immunoblotting  ||| S:16934 E:16957 ||| NNS
( ||| S:16957 E:16958 ||| -LRB-
Figure  ||| S:16958 E:16965 ||| NNP
8G ||| S:16965 E:16967 ||| NNP
) ||| S:16967 E:16968 ||| -RRB-
,  ||| S:16968 E:16970 ||| ,
and  ||| S:16970 E:16974 ||| CC
increases  ||| S:16974 E:16984 ||| VBZ
the  ||| S:16984 E:16988 ||| DT
number  ||| S:16988 E:16995 ||| NN
of  ||| S:16995 E:16998 ||| IN
cells  ||| S:16998 E:17004 ||| NNS
expressing  ||| S:17004 E:17023 ||| VBG
sα  ||| S:17023 E:17035 ||| JJ
i2  ||| S:17035 E:17038 ||| NN
,  ||| S:17038 E:17040 ||| ,
as  ||| S:17040 E:17043 ||| RB
observed  ||| S:17043 E:17052 ||| VBN
by  ||| S:17052 E:17055 ||| IN
immunofluorescence  ||| S:17055 E:17082 ||| JJ
microscopy  ||| S:17082 E:17093 ||| NNS
( ||| S:17093 E:17094 ||| -LRB-
not  ||| S:17094 E:17098 ||| RB
shown ||| S:17098 E:17103 ||| VBN
) ||| S:17103 E:17104 ||| -RRB-
.  ||| S:17104 E:17106 ||| .
Similarly ||| S:17106 E:17115 ||| RB
,  ||| S:17115 E:17117 ||| ,
co-expression  ||| S:17117 E:17131 ||| JJ
of  ||| S:17131 E:17134 ||| IN
βγ  ||| S:17134 E:17145 ||| FW
efficiently  ||| S:17145 E:17157 ||| FW
promotes  ||| S:17157 E:17166 ||| FW
PM  ||| S:17166 E:17169 ||| FW
localization  ||| S:17169 E:17182 ||| FW
of  ||| S:17182 E:17185 ||| FW
α  ||| S:17185 E:17196 ||| FW
i2  ||| S:17196 E:17199 ||| FW
A327S  ||| S:17199 E:17205 ||| FW
( ||| S:17205 E:17206 ||| -LRB-
Figure  ||| S:17206 E:17213 ||| NNP
8F ||| S:17213 E:17215 ||| NNP
) ||| S:17215 E:17216 ||| -RRB-
.  ||| S:17216 E:17226 ||| .
The  ||| S:17226 E:17230 ||| DT
analysis  ||| S:17230 E:17239 ||| NN
of  ||| S:17239 E:17242 ||| IN
the  ||| S:17242 E:17246 ||| DT
effect  ||| S:17246 E:17253 ||| NN
of  ||| S:17253 E:17256 ||| IN
βγ  ||| S:17256 E:17259 ||| NN
was  ||| S:17259 E:17263 ||| VBD
extended  ||| S:17263 E:17272 ||| VBN
by  ||| S:17272 E:17283 ||| IN
examining  ||| S:17283 E:17293 ||| VBG
the  ||| S:17293 E:17297 ||| DT
localization  ||| S:17297 E:17310 ||| NN
of  ||| S:17310 E:17313 ||| IN
α  ||| S:17313 E:17324 ||| JJ
i2  ||| S:17324 E:17327 ||| NN
or  ||| S:17327 E:17330 ||| CC
sα  ||| S:17330 E:17342 ||| JJ
i2  ||| S:17342 E:17345 ||| NN
after  ||| S:17345 E:17351 ||| IN
co-transfection  ||| S:17351 E:17367 ||| JJ
with  ||| S:17367 E:17372 ||| IN
βγ  ||| S:17372 E:17375 ||| NN
and  ||| S:17375 E:17387 ||| CC
after  ||| S:17387 E:17393 ||| IN
treatment  ||| S:17393 E:17403 ||| NN
with  ||| S:17403 E:17408 ||| IN
ALLN ||| S:17408 E:17412 ||| NNP
.  ||| S:17412 E:17414 ||| .
In  ||| S:17414 E:17417 ||| IN
contrast  ||| S:17417 E:17426 ||| NN
to  ||| S:17426 E:17429 ||| TO
Figure  ||| S:17429 E:17436 ||| NNP
7 ||| S:17436 E:17437 ||| CD
,  ||| S:17437 E:17439 ||| ,
a  ||| S:17439 E:17449 ||| DT
marked  ||| S:17449 E:17456 ||| JJ
difference  ||| S:17456 E:17467 ||| NN
was  ||| S:17467 E:17471 ||| VBD
observed  ||| S:17471 E:17480 ||| VBN
between  ||| S:17480 E:17488 ||| IN
α  ||| S:17488 E:17499 ||| JJ
i2  ||| S:17499 E:17502 ||| NN
and  ||| S:17502 E:17506 ||| CC
sα  ||| S:17506 E:17518 ||| JJ
i2  ||| S:17518 E:17521 ||| NN
after  ||| S:17521 E:17527 ||| IN
ALLN  ||| S:17527 E:17532 ||| NNP
treatment ||| S:17532 E:17541 ||| NN
.  ||| S:17541 E:17543 ||| .
When  ||| S:17543 E:17548 ||| WRB
βγ  ||| S:17548 E:17551 ||| NN
is  ||| S:17551 E:17562 ||| VBZ
co-expressed  ||| S:17562 E:17575 ||| JJ
with  ||| S:17575 E:17580 ||| IN
α  ||| S:17580 E:17591 ||| CD
i2  ||| S:17591 E:17594 ||| CD
,  ||| S:17594 E:17596 ||| ,
PM  ||| S:17596 E:17599 ||| NNP
localization  ||| S:17599 E:17612 ||| NN
of  ||| S:17612 E:17615 ||| IN
α  ||| S:17615 E:17626 ||| JJ
i2  ||| S:17626 E:17629 ||| NN
is  ||| S:17629 E:17632 ||| VBZ
observed ||| S:17632 E:17640 ||| VBN
,  ||| S:17640 E:17642 ||| ,
as  ||| S:17642 E:17645 ||| RB
shown  ||| S:17645 E:17651 ||| VBN
in  ||| S:17651 E:17654 ||| IN
Figure  ||| S:17654 E:17661 ||| NNP
8B ||| S:17661 E:17663 ||| NNP
,  ||| S:17663 E:17673 ||| ,
and  ||| S:17673 E:17677 ||| CC
incubation  ||| S:17677 E:17688 ||| NN
with  ||| S:17688 E:17693 ||| IN
ALLN  ||| S:17693 E:17698 ||| NNP
for  ||| S:17698 E:17702 ||| IN
8  ||| S:17702 E:17704 ||| CD
h  ||| S:17704 E:17706 ||| NN
shows  ||| S:17706 E:17712 ||| VBZ
little  ||| S:17712 E:17719 ||| JJ
effect  ||| S:17719 E:17726 ||| NN
on  ||| S:17726 E:17729 ||| IN
PM  ||| S:17729 E:17740 ||| NNP
localization  ||| S:17740 E:17753 ||| NN
of  ||| S:17753 E:17756 ||| IN
α  ||| S:17756 E:17767 ||| CD
i2  ||| S:17767 E:17770 ||| CD
( ||| S:17770 E:17771 ||| -LRB-
Figure  ||| S:17771 E:17778 ||| NNP
9A ||| S:17778 E:17780 ||| NNP
) ||| S:17780 E:17781 ||| -RRB-
.  ||| S:17781 E:17783 ||| .
When  ||| S:17783 E:17788 ||| WRB
βγ  ||| S:17788 E:17791 ||| NN
is  ||| S:17791 E:17794 ||| VBZ
co-expressed  ||| S:17794 E:17815 ||| JJ
with  ||| S:17815 E:17820 ||| IN
sα  ||| S:17820 E:17832 ||| CD
i2  ||| S:17832 E:17835 ||| CD
,  ||| S:17835 E:17837 ||| ,
PM  ||| S:17837 E:17840 ||| NNP
localization  ||| S:17840 E:17853 ||| NN
of  ||| S:17853 E:17856 ||| IN
sα  ||| S:17856 E:17868 ||| JJ
i2  ||| S:17868 E:17871 ||| NN
is  ||| S:17871 E:17874 ||| VBZ
observed ||| S:17874 E:17882 ||| VBN
,  ||| S:17882 E:17884 ||| ,
as  ||| S:17884 E:17887 ||| RB
shown  ||| S:17887 E:17893 ||| VBN
in  ||| S:17893 E:17896 ||| IN
Figure  ||| S:17896 E:17903 ||| NNP
8D ||| S:17903 E:17905 ||| NNP
,  ||| S:17905 E:17915 ||| ,
but  ||| S:17915 E:17919 ||| CC
incubation  ||| S:17919 E:17930 ||| NN
with  ||| S:17930 E:17935 ||| IN
ALLN  ||| S:17935 E:17940 ||| NNP
for  ||| S:17940 E:17944 ||| IN
8  ||| S:17944 E:17946 ||| CD
h  ||| S:17946 E:17948 ||| NN
causes  ||| S:17948 E:17955 ||| VBZ
an  ||| S:17955 E:17958 ||| DT
increase  ||| S:17958 E:17967 ||| NN
in  ||| S:17967 E:17978 ||| IN
bright  ||| S:17978 E:17985 ||| JJ
intracellular  ||| S:17985 E:17999 ||| JJ
accumulations  ||| S:17999 E:18013 ||| NN
of  ||| S:18013 E:18016 ||| IN
sα  ||| S:18016 E:18028 ||| CD
i2  ||| S:18028 E:18031 ||| CD
( ||| S:18031 E:18032 ||| -LRB-
Figure  ||| S:18032 E:18039 ||| NNP
9B ||| S:18039 E:18041 ||| NNP
) ||| S:18041 E:18042 ||| -RRB-
.  ||| S:18042 E:18044 ||| .
Taken  ||| S:18044 E:18050 ||| VBN
together ||| S:18050 E:18058 ||| RB
,  ||| S:18058 E:18060 ||| ,
results  ||| S:18060 E:18076 ||| NNS
with  ||| S:18076 E:18081 ||| IN
βγ  ||| S:18081 E:18084 ||| JJ
co-expression  ||| S:18084 E:18098 ||| NNS
are  ||| S:18098 E:18102 ||| VBP
consistent  ||| S:18102 E:18113 ||| JJ
with  ||| S:18113 E:18118 ||| IN
the  ||| S:18118 E:18122 ||| DT
ability  ||| S:18122 E:18130 ||| NN
of  ||| S:18130 E:18133 ||| IN
βγ  ||| S:18133 E:18144 ||| VBG
to  ||| S:18144 E:18147 ||| TO
promote  ||| S:18147 E:18155 ||| VB
PM  ||| S:18155 E:18158 ||| NNP
targeting  ||| S:18158 E:18168 ||| VBG
of  ||| S:18168 E:18171 ||| IN
Gα ||| S:18171 E:18173 ||| NNP
,  ||| S:18173 E:18175 ||| ,
and  ||| S:18175 E:18179 ||| CC
further  ||| S:18179 E:18187 ||| RB
suggest  ||| S:18187 E:18195 ||| VB
that  ||| S:18195 E:18200 ||| DT
sα  ||| S:18200 E:18212 ||| JJ
i2  ||| S:18212 E:18215 ||| NN
is  ||| S:18215 E:18218 ||| VBZ
less  ||| S:18218 E:18223 ||| RBR
effectively  ||| S:18223 E:18235 ||| RB
stabilized  ||| S:18235 E:18246 ||| VBN
than  ||| S:18246 E:18251 ||| IN
α  ||| S:18251 E:18270 ||| JJ
i2  ||| S:18270 E:18273 ||| NN
by  ||| S:18273 E:18276 ||| IN
βγ ||| S:18276 E:18278 ||| NN
,  ||| S:18278 E:18280 ||| ,
as  ||| S:18280 E:18283 ||| RB
evidenced  ||| S:18283 E:18293 ||| VBN
by  ||| S:18293 E:18296 ||| IN
ALLN-induced  ||| S:18296 E:18317 ||| JJ
accumulation  ||| S:18317 E:18330 ||| NN
in  ||| S:18330 E:18333 ||| IN
intracellular  ||| S:18333 E:18347 ||| JJ
aggregates  ||| S:18347 E:18358 ||| NNS
( ||| S:18358 E:18359 ||| -LRB-
Figure  ||| S:18359 E:18366 ||| NNP
9B ||| S:18366 E:18368 ||| NNP
) ||| S:18368 E:18369 ||| -RRB-
.  ||| S:18369 E:18379 ||| .
Lastly ||| S:18379 E:18385 ||| NNP
,  ||| S:18385 E:18387 ||| ,
35S-methionine  ||| S:18387 E:18402 ||| CD
pulse-chase  ||| S:18402 E:18414 ||| JJ
labeling  ||| S:18414 E:18423 ||| JJ
studies  ||| S:18423 E:18439 ||| NNS
directly  ||| S:18439 E:18448 ||| RB
confirmed  ||| S:18448 E:18458 ||| VBN
that  ||| S:18458 E:18463 ||| IN
sα  ||| S:18463 E:18475 ||| JJ
i2  ||| S:18475 E:18478 ||| NN
was  ||| S:18478 E:18482 ||| VBD
more  ||| S:18482 E:18487 ||| RBR
rapidly  ||| S:18487 E:18495 ||| RB
degraded  ||| S:18495 E:18504 ||| VBN
than  ||| S:18504 E:18509 ||| IN
α  ||| S:18509 E:18520 ||| CD
i2  ||| S:18520 E:18523 ||| CD
( ||| S:18523 E:18524 ||| -LRB-
Figure  ||| S:18524 E:18531 ||| NNP
10 ||| S:18531 E:18533 ||| CD
) ||| S:18533 E:18534 ||| -RRB-
.  ||| S:18534 E:18536 ||| .
After  ||| S:18536 E:18542 ||| IN
transient  ||| S:18542 E:18560 ||| JJ
expression  ||| S:18560 E:18571 ||| NN
of  ||| S:18571 E:18574 ||| IN
the  ||| S:18574 E:18578 ||| DT
α  ||| S:18578 E:18580 ||| JJ
subunits ||| S:18580 E:18588 ||| NN
,  ||| S:18588 E:18590 ||| ,
cellular  ||| S:18590 E:18599 ||| JJ
proteins  ||| S:18599 E:18608 ||| NNS
were  ||| S:18608 E:18621 ||| VBD
radiolabeled  ||| S:18621 E:18634 ||| VBN
with  ||| S:18634 E:18639 ||| IN
a  ||| S:18639 E:18641 ||| DT
brief  ||| S:18641 E:18647 ||| JJ
pulse  ||| S:18647 E:18653 ||| NN
of  ||| S:18653 E:18656 ||| IN
35S-methionine  ||| S:18656 E:18671 ||| NNP
followed  ||| S:18671 E:18688 ||| VBD
by  ||| S:18688 E:18691 ||| IN
a  ||| S:18691 E:18693 ||| DT
chase ||| S:18693 E:18698 ||| NN
.  ||| S:18698 E:18700 ||| .
Immunoprecipitation  ||| S:18700 E:18720 ||| NNP
of  ||| S:18720 E:18723 ||| IN
the  ||| S:18723 E:18727 ||| DT
α  ||| S:18727 E:18729 ||| JJ
subunit  ||| S:18729 E:18737 ||| NN
after  ||| S:18737 E:18751 ||| IN
increasing  ||| S:18751 E:18762 ||| VBG
times  ||| S:18762 E:18768 ||| NNS
of  ||| S:18768 E:18771 ||| IN
chase ||| S:18771 E:18776 ||| NN
,  ||| S:18776 E:18778 ||| ,
followed  ||| S:18778 E:18787 ||| VBN
by  ||| S:18787 E:18790 ||| IN
SDS-PAGE  ||| S:18790 E:18799 ||| JJ
and  ||| S:18799 E:18811 ||| CC
fluorography  ||| S:18811 E:18824 ||| JJ
revealed  ||| S:18824 E:18833 ||| NN
that  ||| S:18833 E:18838 ||| IN
radiolabeled  ||| S:18838 E:18851 ||| JJ
sα  ||| S:18851 E:18863 ||| JJ
i2  ||| S:18863 E:18866 ||| NN
was  ||| S:18866 E:18870 ||| VBD
rapidly  ||| S:18870 E:18878 ||| RB
lost.  ||| S:18878 E:18884 ||| CD
α  ||| S:18884 E:18895 ||| NNS
i2  ||| S:18895 E:18898 ||| VBP
consistently  ||| S:18898 E:18911 ||| RB
displayed  ||| S:18911 E:18921 ||| VBN
a  ||| S:18921 E:18923 ||| DT
3-4  ||| S:18923 E:18927 ||| CD
fold  ||| S:18927 E:18940 ||| CD
longer  ||| S:18940 E:18947 ||| JJR
half-life  ||| S:18947 E:18957 ||| NN
compared  ||| S:18957 E:18966 ||| VBN
to  ||| S:18966 E:18969 ||| TO
sα  ||| S:18969 E:18981 ||| CD
i2  ||| S:18981 E:18984 ||| CD
,  ||| S:18984 E:18986 ||| ,
while  ||| S:18986 E:18992 ||| IN
α  ||| S:18992 E:19003 ||| JJ
i2  ||| S:19003 E:19006 ||| NNP
A327S  ||| S:19006 E:19012 ||| NNP
was  ||| S:19012 E:19016 ||| VBD
intermediate ||| S:19016 E:19028 ||| JJ
.  ||| S:19028 E:19030 ||| .
In  ||| S:19030 E:19033 ||| IN
the  ||| S:19033 E:19045 ||| DT
experiment  ||| S:19045 E:19056 ||| NN
presented  ||| S:19056 E:19066 ||| VBN
in  ||| S:19066 E:19069 ||| IN
Figure  ||| S:19069 E:19076 ||| NNP
10 ||| S:19076 E:19078 ||| CD
,  ||| S:19078 E:19080 ||| ,
the  ||| S:19080 E:19084 ||| DT
t  ||| S:19084 E:19095 ||| JJ
1 ||| S:19095 E:19096 ||| CD
/ ||| S:19096 E:19097 ||| CD
2  ||| S:19097 E:19099 ||| CD
was  ||| S:19099 E:19103 ||| VBD
determined  ||| S:19103 E:19114 ||| VBN
to  ||| S:19114 E:19117 ||| TO
be  ||| S:19117 E:19120 ||| VB
approximately  ||| S:19120 E:19142 ||| RB
90 ||| S:19142 E:19144 ||| CD
,  ||| S:19144 E:19146 ||| ,
180 ||| S:19146 E:19149 ||| CD
,  ||| S:19149 E:19151 ||| ,
and  ||| S:19151 E:19155 ||| CC
360  ||| S:19155 E:19159 ||| CD
min  ||| S:19159 E:19163 ||| NN
for  ||| S:19163 E:19167 ||| IN
sα  ||| S:19167 E:19179 ||| CD
i2  ||| S:19179 E:19182 ||| CD
,  ||| S:19182 E:19184 ||| ,
α  ||| S:19184 E:19195 ||| CD
i2  ||| S:19195 E:19198 ||| CD
A327S ||| S:19198 E:19203 ||| CD
,  ||| S:19203 E:19205 ||| ,
and  ||| S:19205 E:19209 ||| CC
α  ||| S:19209 E:19220 ||| CD
i2  ||| S:19220 E:19223 ||| CD
,  ||| S:19223 E:19225 ||| ,
respectively ||| S:19225 E:19237 ||| RB
.  ||| S:19237 E:19239 ||| .
Although  ||| S:19239 E:19248 ||| IN
this  ||| S:19248 E:19253 ||| DT
trend  ||| S:19253 E:19267 ||| NN
was  ||| S:19267 E:19271 ||| VBD
consistent ||| S:19271 E:19281 ||| JJ
,  ||| S:19281 E:19283 ||| ,
the  ||| S:19283 E:19287 ||| DT
exact  ||| S:19287 E:19293 ||| JJ
t  ||| S:19293 E:19304 ||| NN
1 ||| S:19304 E:19305 ||| CD
/ ||| S:19305 E:19306 ||| CD
2  ||| S:19306 E:19308 ||| CD
showed  ||| S:19308 E:19315 ||| VBD
some  ||| S:19315 E:19320 ||| DT
variability  ||| S:19320 E:19332 ||| NN
from  ||| S:19332 E:19345 ||| IN
experiment  ||| S:19345 E:19356 ||| NN
to  ||| S:19356 E:19359 ||| TO
experiment ||| S:19359 E:19369 ||| NN
,  ||| S:19369 E:19371 ||| ,
probably  ||| S:19371 E:19380 ||| RB
due  ||| S:19380 E:19384 ||| JJ
to  ||| S:19384 E:19387 ||| TO
varying  ||| S:19387 E:19395 ||| VB
levels  ||| S:19395 E:19402 ||| NNS
of  ||| S:19402 E:19413 ||| IN
transient  ||| S:19413 E:19423 ||| JJ
overexpression ||| S:19423 E:19437 ||| NN
.  ||| S:19437 E:19439 ||| .
It  ||| S:19439 E:19442 ||| PRP
is  ||| S:19442 E:19445 ||| VBZ
likely  ||| S:19445 E:19452 ||| RB
that  ||| S:19452 E:19457 ||| IN
the  ||| S:19457 E:19461 ||| DT
difference  ||| S:19461 E:19480 ||| NN
in  ||| S:19480 E:19483 ||| IN
turnover  ||| S:19483 E:19492 ||| NN
of  ||| S:19492 E:19495 ||| IN
sα  ||| S:19495 E:19507 ||| JJ
i2  ||| S:19507 E:19510 ||| NN
and  ||| S:19510 E:19514 ||| CC
α  ||| S:19514 E:19525 ||| JJ
i2  ||| S:19525 E:19528 ||| NN
is  ||| S:19528 E:19531 ||| VBZ
even  ||| S:19531 E:19536 ||| RB
more  ||| S:19536 E:19541 ||| RBR
profound  ||| S:19541 E:19550 ||| JJ
when  ||| S:19550 E:19555 ||| WRB
the  ||| S:19555 E:19567 ||| DT
proteins  ||| S:19567 E:19576 ||| NNS
are  ||| S:19576 E:19580 ||| VBP
expressed  ||| S:19580 E:19590 ||| VBN
at  ||| S:19590 E:19593 ||| IN
lower  ||| S:19593 E:19599 ||| JJR
levels ||| S:19599 E:19605 ||| NNS
.  ||| S:19605 E:19607 ||| .
Consistent  ||| S:19607 E:19618 ||| JJ
with  ||| S:19618 E:19631 ||| IN
this  ||| S:19631 E:19636 ||| DT
idea ||| S:19636 E:19640 ||| NN
,  ||| S:19640 E:19642 ||| ,
sα  ||| S:19642 E:19654 ||| JJ
i2  ||| S:19654 E:19657 ||| NN
was  ||| S:19657 E:19661 ||| VBD
refractory  ||| S:19661 E:19672 ||| VBN
to  ||| S:19672 E:19675 ||| TO
stable  ||| S:19675 E:19682 ||| JJ
expression  ||| S:19682 E:19701 ||| NN
even  ||| S:19701 E:19706 ||| RB
though  ||| S:19706 E:19713 ||| IN
cells  ||| S:19713 E:19719 ||| NNS
stably  ||| S:19719 E:19726 ||| VBP
expressing  ||| S:19726 E:19737 ||| VBG
α  ||| S:19737 E:19748 ||| JJ
i2  ||| S:19748 E:19751 ||| NN
were  ||| S:19751 E:19756 ||| VBD
easily  ||| S:19756 E:19763 ||| RB
selected  ||| S:19763 E:19772 ||| VBN
( ||| S:19772 E:19773 ||| -LRB-
not  ||| S:19773 E:19777 ||| RB
shown ||| S:19777 E:19782 ||| VBN
) ||| S:19782 E:19783 ||| -RRB-
.  ||| S:19783 E:19785 ||| .
The  ||| S:19785 E:19797 ||| DT
inability  ||| S:19797 E:19807 ||| NN
to  ||| S:19807 E:19810 ||| TO
isolate  ||| S:19810 E:19818 ||| VB
cells  ||| S:19818 E:19824 ||| NNS
stably  ||| S:19824 E:19831 ||| VBP
expressing  ||| S:19831 E:19842 ||| VBG
sα  ||| S:19842 E:19854 ||| JJ
i2  ||| S:19854 E:19857 ||| NN
can  ||| S:19857 E:19861 ||| MD
be  ||| S:19861 E:19864 ||| VB
attributed  ||| S:19864 E:19875 ||| VBN
to  ||| S:19875 E:19878 ||| TO
its  ||| S:19878 E:19882 ||| PRP$
rapid  ||| S:19882 E:19896 ||| JJ
degradation ||| S:19896 E:19907 ||| NN
.  ||| S:19907 E:19909 ||| .
Regardless ||| S:19909 E:19919 ||| RB
,  ||| S:19919 E:19921 ||| ,
35S-methionine  ||| S:19921 E:19936 ||| CD
pulse-chase  ||| S:19936 E:19956 ||| JJ
labeling  ||| S:19956 E:19965 ||| JJ
studies  ||| S:19965 E:19973 ||| NNS
( ||| S:19973 E:19974 ||| -LRB-
Figure  ||| S:19974 E:19981 ||| NNP
10 ||| S:19981 E:19983 ||| CD
)  ||| S:19983 E:19985 ||| -RRB-
demonstrate  ||| S:19985 E:19997 ||| VB
that  ||| S:19997 E:20002 ||| DT
sα  ||| S:20002 E:20014 ||| JJ
i2  ||| S:20014 E:20017 ||| NN
is  ||| S:20017 E:20020 ||| VBZ
indeed  ||| S:20020 E:20027 ||| RB
more  ||| S:20027 E:20032 ||| RBR
rapidly  ||| S:20032 E:20040 ||| RB
degraded  ||| S:20040 E:20049 ||| VBN
than  ||| S:20049 E:20062 ||| IN
α  ||| S:20062 E:20073 ||| CD
i2  ||| S:20073 E:20076 ||| CD
.  ||| S:20076 E:20100 ||| .
Discussion  ||| S:20100 E:20119 ||| NN
In  ||| S:20119 E:20122 ||| IN
addition  ||| S:20122 E:20131 ||| NN
to  ||| S:20131 E:20134 ||| TO
their  ||| S:20134 E:20140 ||| PRP$
well  ||| S:20140 E:20145 ||| RB
characterized  ||| S:20145 E:20159 ||| VBN
role  ||| S:20159 E:20164 ||| NN
at  ||| S:20164 E:20167 ||| IN
the  ||| S:20167 E:20171 ||| DT
PM  ||| S:20171 E:20182 ||| NNP
in  ||| S:20182 E:20185 ||| IN
coupling  ||| S:20185 E:20194 ||| JJ
activated  ||| S:20194 E:20204 ||| JJ
GPCRs  ||| S:20204 E:20210 ||| JJ
to  ||| S:20210 E:20213 ||| TO
effector  ||| S:20213 E:20222 ||| VB
proteins ||| S:20222 E:20230 ||| NNS
,  ||| S:20230 E:20240 ||| ,
heterotrimeric  ||| S:20240 E:20255 ||| VBG
G  ||| S:20255 E:20257 ||| NNP
proteins  ||| S:20257 E:20266 ||| NNS
have  ||| S:20266 E:20271 ||| VBP
been  ||| S:20271 E:20276 ||| VBN
implicated  ||| S:20276 E:20287 ||| VBN
in  ||| S:20287 E:20290 ||| IN
a  ||| S:20290 E:20292 ||| DT
variety  ||| S:20292 E:20308 ||| NN
of  ||| S:20308 E:20311 ||| IN
other  ||| S:20311 E:20317 ||| JJ
cellular  ||| S:20317 E:20326 ||| JJ
functions ||| S:20326 E:20335 ||| NNS
,  ||| S:20335 E:20337 ||| ,
including  ||| S:20337 E:20347 ||| VBG
membrane  ||| S:20347 E:20356 ||| JJ
trafficking  ||| S:20356 E:20376 ||| NN
pathways ||| S:20376 E:20384 ||| NN
.  ||| S:20384 E:20386 ||| .
A  ||| S:20386 E:20388 ||| DT
splice  ||| S:20388 E:20395 ||| JJ
variant  ||| S:20395 E:20403 ||| NN
of  ||| S:20403 E:20406 ||| IN
α  ||| S:20406 E:20417 ||| CD
i2  ||| S:20417 E:20420 ||| CD
,  ||| S:20420 E:20422 ||| ,
termed  ||| S:20422 E:20429 ||| VBD
sα  ||| S:20429 E:20441 ||| CD
i2  ||| S:20441 E:20444 ||| CD
,  ||| S:20444 E:20446 ||| ,
has  ||| S:20446 E:20450 ||| VBZ
been  ||| S:20450 E:20455 ||| VBN
proposed  ||| S:20455 E:20464 ||| VBN
as  ||| S:20464 E:20467 ||| IN
a  ||| S:20467 E:20469 ||| DT
candidate  ||| S:20469 E:20479 ||| NN
to  ||| S:20479 E:20490 ||| TO
regulate  ||| S:20490 E:20499 ||| VB
vesicle  ||| S:20499 E:20507 ||| JJ
transport  ||| S:20507 E:20517 ||| NN
due  ||| S:20517 E:20521 ||| JJ
to  ||| S:20521 E:20524 ||| TO
its  ||| S:20524 E:20528 ||| PRP$
localization  ||| S:20528 E:20541 ||| NN
at  ||| S:20541 E:20552 ||| IN
intracellular  ||| S:20552 E:20566 ||| JJ
membranes ||| S:20566 E:20575 ||| NN
.  ||| S:20575 E:20577 ||| .
The  ||| S:20577 E:20581 ||| DT
studies  ||| S:20581 E:20589 ||| NNS
described  ||| S:20589 E:20599 ||| VBN
in  ||| S:20599 E:20602 ||| IN
this  ||| S:20602 E:20615 ||| DT
report  ||| S:20615 E:20622 ||| NN
were  ||| S:20622 E:20627 ||| VBD
undertaken  ||| S:20627 E:20638 ||| VBN
to  ||| S:20638 E:20641 ||| TO
define  ||| S:20641 E:20648 ||| VB
mechanisms  ||| S:20648 E:20659 ||| NNS
that  ||| S:20659 E:20664 ||| IN
underlie  ||| S:20664 E:20681 ||| JJ
subcellular  ||| S:20681 E:20693 ||| JJ
localization  ||| S:20693 E:20706 ||| NN
of  ||| S:20706 E:20709 ||| IN
sα  ||| S:20709 E:20721 ||| CD
i2  ||| S:20721 E:20724 ||| CD
.  ||| S:20724 E:20726 ||| .
The  ||| S:20726 E:20730 ||| DT
novel  ||| S:20730 E:20736 ||| NN
35  ||| S:20736 E:20739 ||| CD
amino  ||| S:20739 E:20745 ||| NNS
acids  ||| S:20745 E:20751 ||| VBP
found  ||| S:20751 E:20757 ||| VBN
in  ||| S:20757 E:20768 ||| IN
sα  ||| S:20768 E:20780 ||| JJ
i2  ||| S:20780 E:20783 ||| NN
appear  ||| S:20783 E:20790 ||| VBP
not  ||| S:20790 E:20794 ||| RB
to  ||| S:20794 E:20797 ||| TO
function  ||| S:20797 E:20806 ||| VB
as  ||| S:20806 E:20809 ||| IN
a  ||| S:20809 E:20811 ||| DT
specific  ||| S:20811 E:20828 ||| JJ
Golgi  ||| S:20828 E:20834 ||| NNP
or  ||| S:20834 E:20837 ||| CC
endoplasmic  ||| S:20837 E:20849 ||| JJ
reticulum  ||| S:20849 E:20859 ||| NNS
targeting  ||| S:20859 E:20869 ||| VBG
sequence ||| S:20869 E:20877 ||| NN
.  ||| S:20877 E:20879 ||| .
Instead ||| S:20879 E:20886 ||| RB
,  ||| S:20886 E:20896 ||| ,
the  ||| S:20896 E:20900 ||| DT
results  ||| S:20900 E:20908 ||| NNS
in  ||| S:20908 E:20911 ||| IN
this  ||| S:20911 E:20916 ||| DT
study  ||| S:20916 E:20922 ||| NN
support  ||| S:20922 E:20930 ||| NN
the  ||| S:20930 E:20934 ||| DT
proposal  ||| S:20934 E:20943 ||| NN
that  ||| S:20943 E:20948 ||| IN
sα  ||| S:20948 E:20960 ||| JJ
i2  ||| S:20960 E:20963 ||| NN
fails  ||| S:20963 E:20969 ||| VBZ
to  ||| S:20969 E:20972 ||| TO
target  ||| S:20972 E:20979 ||| VB
to  ||| S:20979 E:20982 ||| TO
the  ||| S:20982 E:20986 ||| DT
PM  ||| S:20986 E:20989 ||| NNP
because  ||| S:20989 E:20997 ||| IN
it  ||| S:20997 E:21008 ||| PRP
is  ||| S:21008 E:21011 ||| VBZ
an  ||| S:21011 E:21014 ||| DT
unstable  ||| S:21014 E:21023 ||| JJ
protein ||| S:21023 E:21030 ||| NN
.  ||| S:21030 E:21032 ||| .
The  ||| S:21032 E:21036 ||| DT
following  ||| S:21036 E:21046 ||| JJ
results  ||| S:21046 E:21054 ||| NNS
support  ||| S:21054 E:21062 ||| VBP
this  ||| S:21062 E:21075 ||| DT
hypothesis ||| S:21075 E:21085 ||| NN
:  ||| S:21085 E:21087 ||| :
1 ||| S:21087 E:21088 ||| LS
)  ||| S:21088 E:21090 ||| -RRB-
sα  ||| S:21090 E:21102 ||| JJ
i2  ||| S:21102 E:21105 ||| NN
and  ||| S:21105 E:21109 ||| CC
α  ||| S:21109 E:21120 ||| JJ
i2  ||| S:21120 E:21123 ||| NN
are  ||| S:21123 E:21127 ||| VBP
equally  ||| S:21127 E:21135 ||| RB
labeled  ||| S:21135 E:21143 ||| VBN
by  ||| S:21143 E:21146 ||| IN
a  ||| S:21146 E:21148 ||| DT
pulse  ||| S:21148 E:21154 ||| NN
of  ||| S:21154 E:21165 ||| IN
3H-myristate ||| S:21165 E:21177 ||| NNP
,  ||| S:21177 E:21179 ||| ,
although  ||| S:21179 E:21188 ||| IN
much  ||| S:21188 E:21193 ||| RB
less  ||| S:21193 E:21198 ||| RBR
sα  ||| S:21198 E:21210 ||| JJ
i2  ||| S:21210 E:21213 ||| CD
protein  ||| S:21213 E:21221 ||| NN
is  ||| S:21221 E:21224 ||| VBZ
detected ||| S:21224 E:21232 ||| VBN
;  ||| S:21232 E:21234 ||| :
2 ||| S:21234 E:21235 ||| LS
)  ||| S:21235 E:21237 ||| -RRB-
sα  ||| S:21237 E:21249 ||| VBD
i2  ||| S:21249 E:21252 ||| CD
displays  ||| S:21252 E:21261 ||| NNS
a  ||| S:21261 E:21263 ||| DT
propensity  ||| S:21263 E:21274 ||| NN
to  ||| S:21274 E:21277 ||| TO
localize  ||| S:21277 E:21286 ||| VB
to  ||| S:21286 E:21297 ||| TO
potential  ||| S:21297 E:21307 ||| JJ
aggresome-like  ||| S:21307 E:21322 ||| JJ
structures ||| S:21322 E:21332 ||| NNS
,  ||| S:21332 E:21334 ||| ,
and  ||| S:21334 E:21338 ||| CC
this  ||| S:21338 E:21343 ||| DT
localization  ||| S:21343 E:21364 ||| NN
is  ||| S:21364 E:21367 ||| VBZ
greatly  ||| S:21367 E:21375 ||| RB
enhanced  ||| S:21375 E:21384 ||| VBN
by  ||| S:21384 E:21387 ||| IN
proteasome  ||| S:21387 E:21398 ||| JJ
inhibitor  ||| S:21398 E:21408 ||| JJ
treatment ||| S:21408 E:21417 ||| NN
;  ||| S:21417 E:21419 ||| :
3 ||| S:21419 E:21420 ||| LS
)  ||| S:21420 E:21430 ||| -RRB-
the  ||| S:21430 E:21434 ||| DT
α  ||| S:21434 E:21445 ||| FW
i2  ||| S:21445 E:21448 ||| FW
A327S  ||| S:21448 E:21454 ||| FW
mutant ||| S:21454 E:21460 ||| FW
,  ||| S:21460 E:21462 ||| ,
previously  ||| S:21462 E:21473 ||| RB
shown  ||| S:21473 E:21479 ||| VBN
to  ||| S:21479 E:21482 ||| TO
be  ||| S:21482 E:21493 ||| VB
unstable  ||| S:21493 E:21502 ||| JJ
and  ||| S:21502 E:21506 ||| CC
defective  ||| S:21506 E:21516 ||| JJ
in  ||| S:21516 E:21519 ||| IN
guanine-nucleotide  ||| S:21519 E:21538 ||| JJ
binding ||| S:21538 E:21545 ||| NN
,  ||| S:21545 E:21547 ||| ,
shows  ||| S:21547 E:21561 ||| VBZ
a  ||| S:21561 E:21563 ||| DT
similar  ||| S:21563 E:21571 ||| JJ
pattern  ||| S:21571 E:21579 ||| NN
of  ||| S:21579 E:21582 ||| IN
subcellular  ||| S:21582 E:21594 ||| JJ
localization  ||| S:21594 E:21607 ||| NNS
(  ||| S:21607 E:21618 ||| -LRB-
i.e. ||| S:21618 E:21622 ||| FW
,  ||| S:21622 E:21624 ||| ,
intracellular  ||| S:21624 E:21638 ||| JJ
membranes  ||| S:21638 E:21648 ||| NNS
rather  ||| S:21648 E:21663 ||| RB
than  ||| S:21663 E:21668 ||| IN
PM ||| S:21668 E:21670 ||| NNP
) ||| S:21670 E:21671 ||| -RRB-
;  ||| S:21671 E:21673 ||| :
4 ||| S:21673 E:21674 ||| LS
)  ||| S:21674 E:21676 ||| -RRB-
βγ  ||| S:21676 E:21679 ||| JJ
over-expression  ||| S:21679 E:21695 ||| JJ
increases  ||| S:21695 E:21705 ||| NNS
expression  ||| S:21705 E:21716 ||| NN
of  ||| S:21716 E:21719 ||| IN
sα  ||| S:21719 E:21731 ||| JJ
i2  ||| S:21731 E:21734 ||| NN
and  ||| S:21734 E:21738 ||| CC
promotes  ||| S:21738 E:21747 ||| VBZ
PM  ||| S:21747 E:21750 ||| NNP
localization  ||| S:21750 E:21763 ||| NN
of  ||| S:21763 E:21766 ||| IN
sα  ||| S:21766 E:21778 ||| JJ
i2  ||| S:21778 E:21781 ||| NN
and  ||| S:21781 E:21785 ||| CC
α  ||| S:21785 E:21796 ||| CD
i2  ||| S:21796 E:21799 ||| CD
A327S ||| S:21799 E:21804 ||| CD
,  ||| S:21804 E:21806 ||| ,
but  ||| S:21806 E:21810 ||| CC
βγ  ||| S:21810 E:21813 ||| JJ
co-expression  ||| S:21813 E:21827 ||| NN
does  ||| S:21827 E:21832 ||| VBZ
not  ||| S:21832 E:21844 ||| RB
prevent  ||| S:21844 E:21852 ||| VB
sα  ||| S:21852 E:21864 ||| CD
i2  ||| S:21864 E:21867 ||| CD
localization  ||| S:21867 E:21880 ||| NN
to  ||| S:21880 E:21883 ||| TO
potential  ||| S:21883 E:21901 ||| JJ
aggresome-like  ||| S:21901 E:21916 ||| JJ
structures  ||| S:21916 E:21927 ||| NNS
when  ||| S:21927 E:21932 ||| WRB
cells  ||| S:21932 E:21938 ||| NNS
are  ||| S:21938 E:21942 ||| VBP
treated  ||| S:21942 E:21950 ||| VBN
with  ||| S:21950 E:21963 ||| IN
proteasome  ||| S:21963 E:21974 ||| JJ
inhibitors ||| S:21974 E:21984 ||| NN
;  ||| S:21984 E:21986 ||| :
and  ||| S:21986 E:21990 ||| CC
5 ||| S:21990 E:21991 ||| CD
)  ||| S:21991 E:21993 ||| -RRB-
pulse-chase  ||| S:21993 E:22005 ||| JJ
analysis  ||| S:22005 E:22022 ||| NN
indicates  ||| S:22022 E:22032 ||| VBZ
that  ||| S:22032 E:22037 ||| DT
sα  ||| S:22037 E:22049 ||| JJ
i2  ||| S:22049 E:22052 ||| NN
is  ||| S:22052 E:22055 ||| VBZ
rapidly  ||| S:22055 E:22063 ||| RB
degraded ||| S:22063 E:22071 ||| JJ
.  ||| S:22071 E:22081 ||| .
A  ||| S:22081 E:22083 ||| DT
number  ||| S:22083 E:22090 ||| NN
of  ||| S:22090 E:22093 ||| IN
reports  ||| S:22093 E:22101 ||| NNS
have  ||| S:22101 E:22106 ||| VBP
demonstrated  ||| S:22106 E:22119 ||| VBN
that  ||| S:22119 E:22124 ||| IN
disruptions  ||| S:22124 E:22144 ||| NNS
in  ||| S:22144 E:22147 ||| IN
the  ||| S:22147 E:22151 ||| DT
C-termini  ||| S:22151 E:22161 ||| JJ
of  ||| S:22161 E:22164 ||| IN
Gα  ||| S:22164 E:22167 ||| NNP
cause  ||| S:22167 E:22173 ||| NN
reduced  ||| S:22173 E:22181 ||| VBD
affinity  ||| S:22181 E:22190 ||| VBN
for  ||| S:22190 E:22202 ||| IN
guanine-nucleotides  ||| S:22202 E:22222 ||| JJ
and  ||| S:22222 E:22226 ||| CC
protein  ||| S:22226 E:22234 ||| NN
instability ||| S:22234 E:22245 ||| NN
.  ||| S:22245 E:22247 ||| .
The  ||| S:22247 E:22251 ||| DT
C-terminal  ||| S:22251 E:22270 ||| JJ
30  ||| S:22270 E:22273 ||| CD
amino  ||| S:22273 E:22279 ||| CD
acids  ||| S:22279 E:22285 ||| NNS
of  ||| S:22285 E:22288 ||| IN
Gα  ||| S:22288 E:22291 ||| NNP
consist  ||| S:22291 E:22299 ||| VBP
of  ||| S:22299 E:22302 ||| IN
the  ||| S:22302 E:22306 ||| DT
β6-α5  ||| S:22306 E:22312 ||| JJ
loop ||| S:22312 E:22316 ||| NN
,  ||| S:22316 E:22318 ||| ,
followed  ||| S:22318 E:22327 ||| VBN
by  ||| S:22327 E:22338 ||| IN
the  ||| S:22338 E:22342 ||| DT
α5  ||| S:22342 E:22345 ||| JJ
helix  ||| S:22345 E:22351 ||| NN
and  ||| S:22351 E:22355 ||| CC
finally  ||| S:22355 E:22363 ||| RB
several  ||| S:22363 E:22371 ||| JJ
amino  ||| S:22371 E:22377 ||| JJ
acids  ||| S:22377 E:22383 ||| NNS
of  ||| S:22383 E:22386 ||| IN
flexible  ||| S:22386 E:22403 ||| JJ
structure  ||| S:22403 E:22413 ||| NN
( ||| S:22413 E:22414 ||| -LRB-
Figure  ||| S:22414 E:22421 ||| NNP
1 ||| S:22421 E:22422 ||| CD
)  ||| S:22422 E:22424 ||| -RRB-
[  ||| S:22424 E:22426 ||| -LRB-
19  ||| S:22426 E:22429 ||| CD
20  ||| S:22429 E:22432 ||| CD
21  ||| S:22432 E:22435 ||| CD
]  ||| S:22435 E:22437 ||| -RRB-
.  ||| S:22437 E:22439 ||| .
The  ||| S:22439 E:22443 ||| DT
β6-α5  ||| S:22443 E:22449 ||| JJ
loop  ||| S:22449 E:22462 ||| NN
stabilizes  ||| S:22462 E:22473 ||| VBZ
the  ||| S:22473 E:22477 ||| DT
guanine  ||| S:22477 E:22485 ||| JJ
ring  ||| S:22485 E:22490 ||| NN
of  ||| S:22490 E:22493 ||| IN
bound  ||| S:22493 E:22499 ||| VBN
GDP  ||| S:22499 E:22503 ||| NNP
or  ||| S:22503 E:22506 ||| CC
GTP ||| S:22506 E:22509 ||| NNP
,  ||| S:22509 E:22511 ||| ,
and  ||| S:22511 E:22523 ||| CC
mutations  ||| S:22523 E:22533 ||| NNS
in  ||| S:22533 E:22536 ||| IN
this  ||| S:22536 E:22541 ||| DT
region  ||| S:22541 E:22548 ||| NN
affect  ||| S:22548 E:22555 ||| VB
guanine-nucleotide  ||| S:22555 E:22574 ||| JJ
binding ||| S:22574 E:22581 ||| NN
.  ||| S:22581 E:22591 ||| .
The  ||| S:22591 E:22595 ||| DT
A326S  ||| S:22595 E:22601 ||| JJ
mutation  ||| S:22601 E:22610 ||| NN
of  ||| S:22610 E:22613 ||| IN
α  ||| S:22613 E:22624 ||| JJ
i1  ||| S:22624 E:22627 ||| NN
and  ||| S:22627 E:22631 ||| CC
A366S  ||| S:22631 E:22637 ||| CD
mutation  ||| S:22637 E:22646 ||| NN
of  ||| S:22646 E:22649 ||| IN
α  ||| S:22649 E:22660 ||| JJ
s  ||| S:22660 E:22662 ||| NNS
( ||| S:22662 E:22663 ||| -LRB-
cognate  ||| S:22663 E:22671 ||| VBN
to  ||| S:22671 E:22674 ||| TO
the  ||| S:22674 E:22678 ||| DT
α  ||| S:22678 E:22689 ||| JJ
i2  ||| S:22689 E:22692 ||| CD
A327S  ||| S:22692 E:22698 ||| CD
used  ||| S:22698 E:22703 ||| VBN
in  ||| S:22703 E:22706 ||| IN
this  ||| S:22706 E:22711 ||| DT
study ||| S:22711 E:22716 ||| NN
)  ||| S:22716 E:22718 ||| -RRB-
were  ||| S:22718 E:22723 ||| VBD
shown  ||| S:22723 E:22737 ||| VBN
to  ||| S:22737 E:22740 ||| TO
cause  ||| S:22740 E:22746 ||| VB
greatly  ||| S:22746 E:22754 ||| RB
decreased  ||| S:22754 E:22764 ||| VBD
affinity  ||| S:22764 E:22773 ||| VBN
for  ||| S:22773 E:22777 ||| IN
GDP  ||| S:22777 E:22781 ||| NNP
[  ||| S:22781 E:22783 ||| -LRB-
9  ||| S:22783 E:22785 ||| CD
10  ||| S:22785 E:22788 ||| CD
]  ||| S:22788 E:22790 ||| -RRB-
.  ||| S:22790 E:22800 ||| .
Defective  ||| S:22800 E:22810 ||| JJ
binding  ||| S:22810 E:22818 ||| NN
of  ||| S:22818 E:22821 ||| IN
GDP  ||| S:22821 E:22825 ||| NNP
leads  ||| S:22825 E:22831 ||| VBZ
to  ||| S:22831 E:22834 ||| TO
more  ||| S:22834 E:22839 ||| JJR
Gα  ||| S:22839 E:22842 ||| NNS
in  ||| S:22842 E:22845 ||| IN
the  ||| S:22845 E:22849 ||| DT
empty  ||| S:22849 E:22863 ||| JJ
state  ||| S:22863 E:22869 ||| NN
( ||| S:22869 E:22870 ||| -LRB-
no  ||| S:22870 E:22873 ||| DT
bound  ||| S:22873 E:22879 ||| JJ
guanine-nucleotide ||| S:22879 E:22897 ||| NN
) ||| S:22897 E:22898 ||| -RRB-
,  ||| S:22898 E:22900 ||| ,
and  ||| S:22900 E:22904 ||| CC
this  ||| S:22904 E:22909 ||| DT
form  ||| S:22909 E:22914 ||| NN
of  ||| S:22914 E:22917 ||| IN
Gα  ||| S:22917 E:22920 ||| NNP
is  ||| S:22920 E:22931 ||| VBZ
rapidly  ||| S:22931 E:22939 ||| RB
denatured  ||| S:22939 E:22958 ||| VBN
in  ||| S:22958 E:22961 ||| IN
vitro  ||| S:22961 E:22967 ||| NN
,  ||| S:22967 E:22969 ||| ,
as  ||| S:22969 E:22972 ||| RB
shown  ||| S:22972 E:22978 ||| VBN
for  ||| S:22978 E:22982 ||| IN
α  ||| S:22982 E:22993 ||| NN
s  ||| S:22993 E:22995 ||| VBZ
A366S  ||| S:22995 E:23001 ||| NNP
and  ||| S:23001 E:23005 ||| CC
α  ||| S:23005 E:23016 ||| CD
i1  ||| S:23016 E:23019 ||| CD
A326S  ||| S:23019 E:23025 ||| CD
[  ||| S:23025 E:23027 ||| -LRB-
9  ||| S:23027 E:23029 ||| CD
10  ||| S:23029 E:23032 ||| CD
]  ||| S:23032 E:23034 ||| -RRB-
.  ||| S:23034 E:23036 ||| .
Moreover ||| S:23036 E:23044 ||| RB
,  ||| S:23044 E:23046 ||| ,
α  ||| S:23046 E:23057 ||| NN
s  ||| S:23057 E:23059 ||| VBZ
A366S  ||| S:23059 E:23065 ||| NNP
was  ||| S:23065 E:23069 ||| VBD
demonstrated  ||| S:23069 E:23082 ||| VBN
to  ||| S:23082 E:23085 ||| TO
undergo  ||| S:23085 E:23101 ||| VB
rapid  ||| S:23101 E:23107 ||| JJ
degradation  ||| S:23107 E:23119 ||| NNS
( ||| S:23119 E:23120 ||| -LRB-
t  ||| S:23120 E:23131 ||| CD
1 ||| S:23131 E:23132 ||| CD
/ ||| S:23132 E:23133 ||| CD
2  ||| S:23133 E:23135 ||| CD
< ||| S:23135 E:23137 ||| SYM
1  ||| S:23137 E:23139 ||| CD
h ||| S:23139 E:23140 ||| CD
)  ||| S:23140 E:23142 ||| -RRB-
in  ||| S:23142 E:23145 ||| IN
stably  ||| S:23145 E:23152 ||| JJ
transfected  ||| S:23152 E:23172 ||| JJ
cells  ||| S:23172 E:23178 ||| NNS
[  ||| S:23178 E:23180 ||| -LRB-
9  ||| S:23180 E:23182 ||| CD
]  ||| S:23182 E:23184 ||| -RRB-
.  ||| S:23184 E:23186 ||| .
The  ||| S:23186 E:23190 ||| DT
same  ||| S:23190 E:23195 ||| JJ
mutation  ||| S:23195 E:23204 ||| NN
in  ||| S:23204 E:23207 ||| IN
α  ||| S:23207 E:23218 ||| JJ
t  ||| S:23218 E:23220 ||| NN
has  ||| S:23220 E:23224 ||| VBZ
also  ||| S:23224 E:23229 ||| RB
been  ||| S:23229 E:23234 ||| VBN
shown  ||| S:23234 E:23240 ||| VBN
to  ||| S:23240 E:23243 ||| TO
greatly  ||| S:23243 E:23259 ||| RB
decrease  ||| S:23259 E:23268 ||| VB
guanine-nucleotide  ||| S:23268 E:23287 ||| JJ
binding  ||| S:23287 E:23295 ||| NNS
[  ||| S:23295 E:23297 ||| -LRB-
5  ||| S:23297 E:23299 ||| CD
22  ||| S:23299 E:23302 ||| CD
]  ||| S:23302 E:23304 ||| -RRB-
.  ||| S:23304 E:23306 ||| .
Additional  ||| S:23306 E:23325 ||| JJ
amino  ||| S:23325 E:23331 ||| JJ
acids  ||| S:23331 E:23337 ||| NNS
in  ||| S:23337 E:23340 ||| IN
the  ||| S:23340 E:23344 ||| DT
critical  ||| S:23344 E:23353 ||| JJ
β6-α5  ||| S:23353 E:23359 ||| CD
loop  ||| S:23359 E:23364 ||| NNS
are  ||| S:23364 E:23368 ||| VBP
important  ||| S:23368 E:23378 ||| JJ
for  ||| S:23378 E:23390 ||| IN
maintaining  ||| S:23390 E:23402 ||| VBG
Gα  ||| S:23402 E:23405 ||| JJ
integrity  ||| S:23405 E:23415 ||| NN
[  ||| S:23415 E:23417 ||| -LRB-
7  ||| S:23417 E:23419 ||| CD
]  ||| S:23419 E:23421 ||| -RRB-
.  ||| S:23421 E:23431 ||| .
Although  ||| S:23431 E:23440 ||| IN
the  ||| S:23440 E:23444 ||| DT
α5  ||| S:23444 E:23447 ||| CD
helix  ||| S:23447 E:23453 ||| NNS
( ||| S:23453 E:23454 ||| -LRB-
Figure  ||| S:23454 E:23461 ||| NNP
1 ||| S:23461 E:23462 ||| CD
)  ||| S:23462 E:23464 ||| -RRB-
does  ||| S:23464 E:23469 ||| VBZ
not  ||| S:23469 E:23473 ||| RB
directly  ||| S:23473 E:23490 ||| RB
contact  ||| S:23490 E:23498 ||| VB
the  ||| S:23498 E:23502 ||| DT
bound  ||| S:23502 E:23508 ||| JJ
guanine-nucleotide  ||| S:23508 E:23527 ||| NN
[  ||| S:23527 E:23529 ||| -LRB-
19  ||| S:23529 E:23532 ||| CD
20  ||| S:23532 E:23535 ||| CD
21  ||| S:23535 E:23538 ||| CD
]  ||| S:23538 E:23540 ||| -RRB-
,  ||| S:23540 E:23542 ||| ,
it  ||| S:23542 E:23545 ||| PRP
is  ||| S:23545 E:23556 ||| VBZ
clearly  ||| S:23556 E:23564 ||| RB
important  ||| S:23564 E:23574 ||| JJ
for  ||| S:23574 E:23578 ||| IN
Gα  ||| S:23578 E:23581 ||| NNP
structure  ||| S:23581 E:23591 ||| NN
and  ||| S:23591 E:23595 ||| CC
to  ||| S:23595 E:23598 ||| TO
maintain  ||| S:23598 E:23607 ||| VB
the  ||| S:23607 E:23619 ||| DT
proper  ||| S:23619 E:23626 ||| JJ
orientation  ||| S:23626 E:23638 ||| NN
of  ||| S:23638 E:23641 ||| IN
the  ||| S:23641 E:23645 ||| DT
β6-α5  ||| S:23645 E:23651 ||| JJ
loop ||| S:23651 E:23655 ||| NN
.  ||| S:23655 E:23657 ||| .
A  ||| S:23657 E:23659 ||| DT
recent  ||| S:23659 E:23666 ||| JJ
study  ||| S:23666 E:23680 ||| NN
identified  ||| S:23680 E:23691 ||| VBD
a  ||| S:23691 E:23693 ||| DT
number  ||| S:23693 E:23700 ||| NN
of  ||| S:23700 E:23703 ||| IN
α5  ||| S:23703 E:23706 ||| CD
helix  ||| S:23706 E:23712 ||| CD
residues  ||| S:23712 E:23721 ||| NNS
in  ||| S:23721 E:23724 ||| IN
α  ||| S:23724 E:23735 ||| JJ
t  ||| S:23735 E:23737 ||| NN
that  ||| S:23737 E:23742 ||| IN
when  ||| S:23742 E:23747 ||| WRB
changed  ||| S:23747 E:23755 ||| VBN
to  ||| S:23755 E:23758 ||| TO
alanines  ||| S:23758 E:23775 ||| VB
increased  ||| S:23775 E:23785 ||| VBN
rates  ||| S:23785 E:23791 ||| NNS
of  ||| S:23791 E:23794 ||| IN
guanine-nucleotide  ||| S:23794 E:23813 ||| JJ
exchange  ||| S:23813 E:23822 ||| NN
(  ||| S:23822 E:23833 ||| -LRB-
i.e. ||| S:23833 E:23837 ||| FW
,  ||| S:23837 E:23839 ||| ,
decreased  ||| S:23839 E:23849 ||| VBD
affinity  ||| S:23849 E:23858 ||| VBN
for  ||| S:23858 E:23870 ||| IN
guanine-nucleotides ||| S:23870 E:23889 ||| NNP
)  ||| S:23889 E:23891 ||| -RRB-
[  ||| S:23891 E:23893 ||| -LRB-
5  ||| S:23893 E:23895 ||| LS
]  ||| S:23895 E:23897 ||| -RRB-
.  ||| S:23897 E:23899 ||| .
Individual  ||| S:23899 E:23910 ||| JJ
mutation  ||| S:23910 E:23919 ||| NN
of  ||| S:23919 E:23922 ||| IN
amino  ||| S:23922 E:23936 ||| JJ
acids  ||| S:23936 E:23942 ||| NNS
in  ||| S:23942 E:23945 ||| IN
α  ||| S:23945 E:23956 ||| JJ
t  ||| S:23956 E:23958 ||| NN
,  ||| S:23958 E:23960 ||| ,
cognate  ||| S:23960 E:23968 ||| VBG
to  ||| S:23968 E:23971 ||| TO
T330 ||| S:23971 E:23975 ||| CD
,  ||| S:23975 E:23977 ||| ,
N332 ||| S:23977 E:23981 ||| NNP
,  ||| S:23981 E:23983 ||| ,
V333 ||| S:23983 E:23987 ||| NNP
,  ||| S:23987 E:23989 ||| ,
F337  ||| S:23989 E:23994 ||| FW
in  ||| S:23994 E:24005 ||| FW
α  ||| S:24005 E:24016 ||| FW
i2  ||| S:24016 E:24019 ||| FW
( ||| S:24019 E:24020 ||| -LRB-
Figure  ||| S:24020 E:24027 ||| NNP
1 ||| S:24027 E:24028 ||| CD
) ||| S:24028 E:24029 ||| -RRB-
,  ||| S:24029 E:24031 ||| ,
increased  ||| S:24031 E:24041 ||| VBD
nucleotide  ||| S:24041 E:24060 ||| JJ
exchange  ||| S:24060 E:24069 ||| NN
rates  ||| S:24069 E:24075 ||| NNS
[  ||| S:24075 E:24077 ||| -LRB-
5  ||| S:24077 E:24079 ||| LS
]  ||| S:24079 E:24081 ||| -RRB-
.  ||| S:24081 E:24083 ||| .
Two  ||| S:24083 E:24087 ||| CD
of  ||| S:24087 E:24090 ||| IN
these  ||| S:24090 E:24096 ||| DT
critical  ||| S:24096 E:24105 ||| JJ
amino  ||| S:24105 E:24111 ||| JJ
acids ||| S:24111 E:24116 ||| NNS
,  ||| S:24116 E:24126 ||| ,
N332  ||| S:24126 E:24131 ||| NNP
and  ||| S:24131 E:24135 ||| CC
V333  ||| S:24135 E:24140 ||| CD
in  ||| S:24140 E:24143 ||| IN
α  ||| S:24143 E:24154 ||| CD
i2  ||| S:24154 E:24157 ||| CD
,  ||| S:24157 E:24159 ||| ,
are  ||| S:24159 E:24163 ||| VBP
in  ||| S:24163 E:24166 ||| IN
fact  ||| S:24166 E:24171 ||| NN
the  ||| S:24171 E:24175 ||| DT
first  ||| S:24175 E:24181 ||| JJ
two  ||| S:24181 E:24185 ||| CD
amino  ||| S:24185 E:24199 ||| CD
acids  ||| S:24199 E:24205 ||| NNS
that  ||| S:24205 E:24210 ||| WDT
are  ||| S:24210 E:24214 ||| VBP
replaced  ||| S:24214 E:24223 ||| VBN
by  ||| S:24223 E:24226 ||| IN
the  ||| S:24226 E:24230 ||| DT
novel  ||| S:24230 E:24236 ||| NN
splicing  ||| S:24236 E:24245 ||| NN
in  ||| S:24245 E:24248 ||| IN
sα  ||| S:24248 E:24260 ||| CD
i2  ||| S:24260 E:24263 ||| CD
( ||| S:24263 E:24264 ||| -LRB-
Figure  ||| S:24264 E:24271 ||| NNP
1 ||| S:24271 E:24272 ||| CD
) ||| S:24272 E:24273 ||| -RRB-
.  ||| S:24273 E:24275 ||| .
Thus ||| S:24275 E:24279 ||| RB
,  ||| S:24279 E:24281 ||| ,
one  ||| S:24281 E:24285 ||| PRP
might  ||| S:24285 E:24291 ||| MD
speculate  ||| S:24291 E:24309 ||| VB
that  ||| S:24309 E:24314 ||| IN
the  ||| S:24314 E:24318 ||| DT
novel  ||| S:24318 E:24324 ||| NN
35  ||| S:24324 E:24327 ||| CD
amino  ||| S:24327 E:24333 ||| JJ
acid  ||| S:24333 E:24338 ||| NN
sequence  ||| S:24338 E:24347 ||| NN
in  ||| S:24347 E:24350 ||| IN
sα  ||| S:24350 E:24362 ||| JJ
i2  ||| S:24362 E:24365 ||| NN
would  ||| S:24365 E:24371 ||| MD
impair  ||| S:24371 E:24378 ||| VB
guanine-nucleotide  ||| S:24378 E:24405 ||| JJ
binding  ||| S:24405 E:24413 ||| NN
and  ||| S:24413 E:24417 ||| CC
result  ||| S:24417 E:24424 ||| NN
in  ||| S:24424 E:24427 ||| IN
a  ||| S:24427 E:24429 ||| DT
unstable  ||| S:24429 E:24438 ||| JJ
protein ||| S:24438 E:24445 ||| NN
.  ||| S:24445 E:24447 ||| .
Unfortunately ||| S:24447 E:24460 ||| RB
,  ||| S:24460 E:24470 ||| ,
initial  ||| S:24470 E:24478 ||| JJ
attempts  ||| S:24478 E:24487 ||| NNS
to  ||| S:24487 E:24490 ||| TO
directly  ||| S:24490 E:24499 ||| RB
show  ||| S:24499 E:24504 ||| VB
a  ||| S:24504 E:24506 ||| DT
defect  ||| S:24506 E:24513 ||| NN
in  ||| S:24513 E:24524 ||| IN
guanine-nucleotide  ||| S:24524 E:24543 ||| JJ
binding  ||| S:24543 E:24551 ||| NN
by  ||| S:24551 E:24554 ||| IN
sα  ||| S:24554 E:24566 ||| CD
i2  ||| S:24566 E:24569 ||| CD
,  ||| S:24569 E:24571 ||| ,
using  ||| S:24571 E:24577 ||| VBG
a  ||| S:24577 E:24579 ||| DT
GTPγ  ||| S:24579 E:24584 ||| JJ
S-dependent  ||| S:24584 E:24596 ||| JJ
trypsin  ||| S:24596 E:24612 ||| JJ
protection  ||| S:24612 E:24623 ||| NN
assay  ||| S:24623 E:24629 ||| NNS
[  ||| S:24629 E:24631 ||| -LRB-
23  ||| S:24631 E:24634 ||| CD
]  ||| S:24634 E:24636 ||| -RRB-
,  ||| S:24636 E:24638 ||| ,
were  ||| S:24638 E:24643 ||| VBD
unsuccessful  ||| S:24643 E:24656 ||| JJ
due ||| S:24656 E:24659 ||| JJ
,  ||| S:24659 E:24661 ||| ,
at  ||| S:24661 E:24664 ||| IN
least  ||| S:24664 E:24678 ||| JJS
in  ||| S:24678 E:24681 ||| IN
part ||| S:24681 E:24685 ||| NN
,  ||| S:24685 E:24687 ||| ,
to  ||| S:24687 E:24690 ||| TO
the  ||| S:24690 E:24694 ||| DT
inability  ||| S:24694 E:24704 ||| NN
to  ||| S:24704 E:24707 ||| TO
solubilize  ||| S:24707 E:24718 ||| VB
expressed  ||| S:24718 E:24728 ||| VBN
sα  ||| S:24728 E:24740 ||| JJ
i2  ||| S:24740 E:24743 ||| NN
from  ||| S:24743 E:24748 ||| IN
membranes  ||| S:24748 E:24758 ||| NNS
using  ||| S:24758 E:24764 ||| VBG
a  ||| S:24764 E:24766 ||| DT
mild  ||| S:24766 E:24771 ||| JJ
detergent  ||| S:24771 E:24789 ||| NN
(  ||| S:24789 E:24800 ||| -LRB-
e.g. ||| S:24800 E:24804 ||| NNP
,  ||| S:24804 E:24806 ||| ,
lubrol ||| S:24806 E:24812 ||| FW
/ ||| S:24812 E:24813 ||| FW
polyoxyethylene  ||| S:24813 E:24837 ||| FW
10-lauryl  ||| S:24837 E:24847 ||| FW
ether ||| S:24847 E:24852 ||| FW
) ||| S:24852 E:24853 ||| -RRB-
.  ||| S:24853 E:24863 ||| .
The  ||| S:24863 E:24867 ||| DT
data  ||| S:24867 E:24872 ||| NNS
in  ||| S:24872 E:24875 ||| IN
this  ||| S:24875 E:24880 ||| DT
report  ||| S:24880 E:24887 ||| NN
are  ||| S:24887 E:24891 ||| VBP
consistent  ||| S:24891 E:24902 ||| JJ
with  ||| S:24902 E:24907 ||| IN
a  ||| S:24907 E:24909 ||| DT
scenario  ||| S:24909 E:24926 ||| NN
in  ||| S:24926 E:24929 ||| IN
which  ||| S:24929 E:24935 ||| WDT
intracellular  ||| S:24935 E:24949 ||| VBZ
Golgi ||| S:24949 E:24954 ||| NNP
/ ||| S:24954 E:24955 ||| NNP
ER  ||| S:24955 E:24958 ||| NNP
localization  ||| S:24958 E:24971 ||| NN
of  ||| S:24971 E:24974 ||| IN
sα  ||| S:24974 E:24986 ||| JJ
i2  ||| S:24986 E:24989 ||| NN
reflects  ||| S:24989 E:24998 ||| VBZ
its  ||| S:24998 E:25002 ||| PRP$
rapid  ||| S:25002 E:25008 ||| JJ
degradation  ||| S:25008 E:25020 ||| NN
rather  ||| S:25020 E:25035 ||| RB
than  ||| S:25035 E:25040 ||| IN
specific  ||| S:25040 E:25049 ||| JJ
targeting  ||| S:25049 E:25059 ||| VBG
to  ||| S:25059 E:25062 ||| TO
a  ||| S:25062 E:25064 ||| DT
subcellular  ||| S:25064 E:25076 ||| JJ
organelle ||| S:25076 E:25085 ||| NN
.  ||| S:25085 E:25095 ||| .
Particularly  ||| S:25095 E:25108 ||| RB
compelling  ||| S:25108 E:25119 ||| JJ
is  ||| S:25119 E:25122 ||| VBZ
the  ||| S:25122 E:25126 ||| DT
similarity  ||| S:25126 E:25137 ||| NN
in  ||| S:25137 E:25140 ||| IN
subcellular  ||| S:25140 E:25160 ||| JJ
localization  ||| S:25160 E:25173 ||| NN
of  ||| S:25173 E:25176 ||| IN
α  ||| S:25176 E:25187 ||| CD
i2  ||| S:25187 E:25190 ||| CD
A327S  ||| S:25190 E:25196 ||| CD
and  ||| S:25196 E:25200 ||| CC
sα  ||| S:25200 E:25212 ||| CD
i2  ||| S:25212 E:25215 ||| CD
( ||| S:25215 E:25216 ||| -LRB-
Figure  ||| S:25216 E:25223 ||| NNP
8 ||| S:25223 E:25224 ||| CD
) ||| S:25224 E:25225 ||| -RRB-
.  ||| S:25225 E:25227 ||| .
In  ||| S:25227 E:25230 ||| IN
addition ||| S:25230 E:25238 ||| NN
,  ||| S:25238 E:25240 ||| ,
the  ||| S:25240 E:25244 ||| DT
use  ||| S:25244 E:25248 ||| NN
of  ||| S:25248 E:25259 ||| IN
proteasome  ||| S:25259 E:25270 ||| JJ
inhibitors  ||| S:25270 E:25281 ||| NNS
( ||| S:25281 E:25282 ||| -LRB-
Figures  ||| S:25282 E:25290 ||| NNP
7and  ||| S:25290 E:25295 ||| CD
9 ||| S:25295 E:25296 ||| CD
)  ||| S:25296 E:25298 ||| -RRB-
suggest  ||| S:25298 E:25306 ||| VBP
that  ||| S:25306 E:25311 ||| IN
sα  ||| S:25311 E:25323 ||| JJ
i2  ||| S:25323 E:25326 ||| NN
is  ||| S:25326 E:25329 ||| VBZ
degraded  ||| S:25329 E:25338 ||| VBN
by  ||| S:25338 E:25341 ||| IN
a  ||| S:25341 E:25343 ||| DT
proteasome  ||| S:25343 E:25354 ||| JJ
pathway ||| S:25354 E:25361 ||| NN
.  ||| S:25361 E:25371 ||| .
The  ||| S:25371 E:25375 ||| DT
observed  ||| S:25375 E:25384 ||| JJ
intracellular  ||| S:25384 E:25398 ||| JJ
membrane  ||| S:25398 E:25407 ||| NNS
( ||| S:25407 E:25408 ||| -LRB-
ER ||| S:25408 E:25410 ||| NNP
)  ||| S:25410 E:25412 ||| -RRB-
localization  ||| S:25412 E:25425 ||| NN
and  ||| S:25425 E:25437 ||| CC
proteasome  ||| S:25437 E:25448 ||| FW
inhibitor-induced  ||| S:25448 E:25466 ||| FW
juxtanuclear  ||| S:25466 E:25479 ||| FW
aggregate  ||| S:25479 E:25497 ||| FW
accumulation  ||| S:25497 E:25510 ||| FW
( ||| S:25510 E:25511 ||| -LRB-
aggresome ||| S:25511 E:25520 ||| LS
)  ||| S:25520 E:25522 ||| -RRB-
is  ||| S:25522 E:25525 ||| VBZ
consistent  ||| S:25525 E:25536 ||| JJ
with  ||| S:25536 E:25541 ||| IN
that  ||| S:25541 E:25546 ||| WDT
reported  ||| S:25546 E:25563 ||| VBD
for  ||| S:25563 E:25567 ||| IN
other  ||| S:25567 E:25573 ||| JJ
proteins  ||| S:25573 E:25582 ||| NNS
being  ||| S:25582 E:25588 ||| VBG
degraded  ||| S:25588 E:25597 ||| NN
by  ||| S:25597 E:25600 ||| IN
such  ||| S:25600 E:25605 ||| PDT
a  ||| S:25605 E:25607 ||| DT
pathway  ||| S:25607 E:25615 ||| NN
[  ||| S:25615 E:25617 ||| -LRB-
18  ||| S:25617 E:25620 ||| CD
24  ||| S:25620 E:25631 ||| CD
]  ||| S:25631 E:25633 ||| -RRB-
.  ||| S:25633 E:25635 ||| .
When  ||| S:25635 E:25640 ||| WRB
treated  ||| S:25640 E:25648 ||| VBN
with  ||| S:25648 E:25653 ||| IN
proteasome  ||| S:25653 E:25664 ||| JJ
inhibitors ||| S:25664 E:25674 ||| NN
,  ||| S:25674 E:25676 ||| ,
overexpressed  ||| S:25676 E:25698 ||| JJ
wild  ||| S:25698 E:25703 ||| JJ
type  ||| S:25703 E:25708 ||| NN
α  ||| S:25708 E:25719 ||| NNS
i2  ||| S:25719 E:25722 ||| VBP
also  ||| S:25722 E:25727 ||| RB
accumulates  ||| S:25727 E:25739 ||| VBN
in  ||| S:25739 E:25742 ||| IN
aggresome-like  ||| S:25742 E:25765 ||| JJ
structures  ||| S:25765 E:25776 ||| NNS
( ||| S:25776 E:25777 ||| -LRB-
Figure  ||| S:25777 E:25784 ||| NNP
7 ||| S:25784 E:25785 ||| CD
) ||| S:25785 E:25786 ||| -RRB-
,  ||| S:25786 E:25788 ||| ,
suggesting  ||| S:25788 E:25799 ||| VBG
that  ||| S:25799 E:25804 ||| IN
Gα  ||| S:25804 E:25807 ||| NNP
may  ||| S:25807 E:25811 ||| MD
normally  ||| S:25811 E:25820 ||| RB
be  ||| S:25820 E:25831 ||| VB
degraded  ||| S:25831 E:25840 ||| VBN
by  ||| S:25840 E:25843 ||| IN
a  ||| S:25843 E:25845 ||| DT
proteasome-dependent  ||| S:25845 E:25866 ||| JJ
pathway ||| S:25866 E:25873 ||| NN
.  ||| S:25873 E:25875 ||| .
However ||| S:25875 E:25882 ||| RB
,  ||| S:25882 E:25892 ||| ,
over-expression  ||| S:25892 E:25908 ||| JJ
of  ||| S:25908 E:25911 ||| IN
βγ  ||| S:25911 E:25914 ||| NN
prevents  ||| S:25914 E:25923 ||| VBZ
ALLN-induced  ||| S:25923 E:25936 ||| JJ
juxtanuclear  ||| S:25936 E:25957 ||| JJ
accumulations  ||| S:25957 E:25971 ||| NN
of  ||| S:25971 E:25974 ||| IN
α  ||| S:25974 E:25985 ||| JJ
i2  ||| S:25985 E:25988 ||| NN
but  ||| S:25988 E:25992 ||| CC
not  ||| S:25992 E:25996 ||| RB
sα  ||| S:25996 E:26008 ||| CD
i2  ||| S:26008 E:26011 ||| CD
( ||| S:26011 E:26012 ||| -LRB-
Figure  ||| S:26012 E:26019 ||| NNP
9 ||| S:26019 E:26020 ||| CD
) ||| S:26020 E:26021 ||| -RRB-
.  ||| S:26021 E:26023 ||| .
Although  ||| S:26023 E:26032 ||| IN
little  ||| S:26032 E:26039 ||| RB
is  ||| S:26039 E:26042 ||| VBZ
known  ||| S:26042 E:26056 ||| VBN
regarding  ||| S:26056 E:26066 ||| VBG
degradative  ||| S:26066 E:26078 ||| JJ
pathways  ||| S:26078 E:26087 ||| NN
for  ||| S:26087 E:26091 ||| IN
G  ||| S:26091 E:26093 ||| NNP
proteins ||| S:26093 E:26101 ||| NNS
,  ||| S:26101 E:26103 ||| ,
sα  ||| S:26103 E:26115 ||| JJ
i2  ||| S:26115 E:26118 ||| NN
and  ||| S:26118 E:26122 ||| CC
other  ||| S:26122 E:26128 ||| JJ
mutants  ||| S:26128 E:26136 ||| NNS
(  ||| S:26136 E:26147 ||| -LRB-
e.g. ||| S:26147 E:26151 ||| NNP
,  ||| S:26151 E:26153 ||| ,
α  ||| S:26153 E:26164 ||| CD
i2  ||| S:26164 E:26167 ||| CD
A327S ||| S:26167 E:26172 ||| CD
)  ||| S:26172 E:26174 ||| -RRB-
may  ||| S:26174 E:26178 ||| MD
be  ||| S:26178 E:26181 ||| VB
valuable  ||| S:26181 E:26190 ||| JJ
tools  ||| S:26190 E:26196 ||| NNS
for  ||| S:26196 E:26208 ||| IN
defining  ||| S:26208 E:26217 ||| JJ
such  ||| S:26217 E:26222 ||| JJ
pathways ||| S:26222 E:26230 ||| NN
.  ||| S:26230 E:26240 ||| .
The  ||| S:26240 E:26244 ||| DT
data  ||| S:26244 E:26249 ||| NNS
presented  ||| S:26249 E:26259 ||| VBD
here  ||| S:26259 E:26264 ||| RB
argue  ||| S:26264 E:26270 ||| VBP
against  ||| S:26270 E:26278 ||| IN
a  ||| S:26278 E:26280 ||| DT
sequence  ||| S:26280 E:26297 ||| JJ
specific  ||| S:26297 E:26306 ||| JJ
Golgi  ||| S:26306 E:26312 ||| NNP
membrane  ||| S:26312 E:26321 ||| VBZ
targeting  ||| S:26321 E:26331 ||| VBG
function  ||| S:26331 E:26340 ||| NN
for  ||| S:26340 E:26344 ||| IN
the  ||| S:26344 E:26348 ||| DT
novel  ||| S:26348 E:26354 ||| NN
35  ||| S:26354 E:26365 ||| CD
amino  ||| S:26365 E:26371 ||| JJ
acid  ||| S:26371 E:26376 ||| NN
sequence  ||| S:26376 E:26385 ||| NN
found  ||| S:26385 E:26391 ||| VBD
in  ||| S:26391 E:26394 ||| IN
sα  ||| S:26394 E:26406 ||| CD
i2  ||| S:26406 E:26409 ||| CD
.  ||| S:26409 E:26411 ||| .
The  ||| S:26411 E:26415 ||| DT
novel  ||| S:26415 E:26421 ||| NN
sequence  ||| S:26421 E:26430 ||| NN
of  ||| S:26430 E:26433 ||| IN
sα  ||| S:26433 E:26445 ||| JJ
i2  ||| S:26445 E:26448 ||| NN
is  ||| S:26448 E:26451 ||| VBZ
not  ||| S:26451 E:26455 ||| RB
sufficient  ||| S:26455 E:26466 ||| JJ
to  ||| S:26466 E:26469 ||| TO
direct  ||| S:26469 E:26476 ||| VB
other  ||| S:26476 E:26490 ||| JJ
proteins  ||| S:26490 E:26499 ||| NNS
to  ||| S:26499 E:26502 ||| TO
Golgi ||| S:26502 E:26507 ||| NNP
/ ||| S:26507 E:26508 ||| NNP
ER  ||| S:26508 E:26511 ||| NNP
membranes ||| S:26511 E:26520 ||| NN
.  ||| S:26520 E:26522 ||| .
These  ||| S:26522 E:26528 ||| DT
35  ||| S:26528 E:26531 ||| CD
amino  ||| S:26531 E:26537 ||| CD
acids  ||| S:26537 E:26543 ||| NNS
did  ||| S:26543 E:26555 ||| VBD
not  ||| S:26555 E:26559 ||| RB
change  ||| S:26559 E:26566 ||| VB
the  ||| S:26566 E:26570 ||| DT
cytoplasmic  ||| S:26570 E:26582 ||| JJ
localization  ||| S:26582 E:26595 ||| NN
of  ||| S:26595 E:26598 ||| IN
GFP  ||| S:26598 E:26602 ||| NNP
( ||| S:26602 E:26603 ||| -LRB-
Figure  ||| S:26603 E:26610 ||| NNP
5 ||| S:26610 E:26611 ||| CD
) ||| S:26611 E:26612 ||| -RRB-
.  ||| S:26612 E:26622 ||| .
Similarly ||| S:26622 E:26631 ||| RB
,  ||| S:26631 E:26633 ||| ,
a  ||| S:26633 E:26635 ||| DT
recent  ||| S:26635 E:26642 ||| JJ
report  ||| S:26642 E:26649 ||| NN
showed  ||| S:26649 E:26656 ||| VBD
that  ||| S:26656 E:26661 ||| IN
the  ||| S:26661 E:26665 ||| DT
sα  ||| S:26665 E:26677 ||| JJ
i2  ||| S:26677 E:26680 ||| CD
35  ||| S:26680 E:26683 ||| CD
amino  ||| S:26683 E:26689 ||| CD
acids  ||| S:26689 E:26695 ||| NNS
were  ||| S:26695 E:26700 ||| VBD
unable  ||| S:26700 E:26707 ||| JJ
to  ||| S:26707 E:26710 ||| TO
retain  ||| S:26710 E:26725 ||| VB
a  ||| S:26725 E:26727 ||| DT
secreted  ||| S:26727 E:26736 ||| JJ
protein  ||| S:26736 E:26744 ||| NN
in  ||| S:26744 E:26747 ||| IN
intracellular  ||| S:26747 E:26761 ||| JJ
membranes  ||| S:26761 E:26771 ||| NN
and  ||| S:26771 E:26775 ||| CC
did  ||| S:26775 E:26779 ||| VBD
not  ||| S:26779 E:26791 ||| RB
affect  ||| S:26791 E:26798 ||| VB
localization  ||| S:26798 E:26811 ||| VBN
of  ||| S:26811 E:26814 ||| IN
a  ||| S:26814 E:26816 ||| DT
nuclear  ||| S:26816 E:26824 ||| JJ
protein  ||| S:26824 E:26832 ||| NN
[  ||| S:26832 E:26834 ||| -LRB-
4  ||| S:26834 E:26836 ||| LS
]  ||| S:26836 E:26838 ||| -RRB-
.  ||| S:26838 E:26840 ||| .
However ||| S:26840 E:26847 ||| RB
,  ||| S:26847 E:26857 ||| ,
in  ||| S:26857 E:26860 ||| IN
addition  ||| S:26860 E:26869 ||| NN
to  ||| S:26869 E:26872 ||| TO
causing  ||| S:26872 E:26880 ||| VBG
rapid  ||| S:26880 E:26886 ||| JJ
degradation ||| S:26886 E:26897 ||| NN
,  ||| S:26897 E:26899 ||| ,
one  ||| S:26899 E:26903 ||| CD
cannot  ||| S:26903 E:26910 ||| NNS
rule  ||| S:26910 E:26923 ||| VB
out  ||| S:26923 E:26927 ||| RP
that  ||| S:26927 E:26932 ||| IN
the  ||| S:26932 E:26936 ||| DT
35  ||| S:26936 E:26939 ||| CD
amino  ||| S:26939 E:26945 ||| JJ
acid  ||| S:26945 E:26950 ||| NN
sequence  ||| S:26950 E:26959 ||| NN
of  ||| S:26959 E:26962 ||| IN
sα  ||| S:26962 E:26974 ||| CD
i2  ||| S:26974 E:26977 ||| CD
functions  ||| S:26977 E:26987 ||| NNS
somehow  ||| S:26987 E:26995 ||| RB
as  ||| S:26995 E:26998 ||| IN
part  ||| S:26998 E:27003 ||| NN
of  ||| S:27003 E:27006 ||| IN
a  ||| S:27006 E:27008 ||| DT
Golgi  ||| S:27008 E:27022 ||| NNP
targeting  ||| S:27022 E:27032 ||| VBG
motif  ||| S:27032 E:27038 ||| NN
in  ||| S:27038 E:27041 ||| IN
the  ||| S:27041 E:27045 ||| DT
context  ||| S:27045 E:27053 ||| NN
of  ||| S:27053 E:27056 ||| IN
other  ||| S:27056 E:27062 ||| JJ
regions  ||| S:27062 E:27070 ||| NNS
of  ||| S:27070 E:27073 ||| IN
α  ||| S:27073 E:27084 ||| CD
i2  ||| S:27084 E:27087 ||| CD
,  ||| S:27087 E:27089 ||| ,
as  ||| S:27089 E:27092 ||| RB
suggested  ||| S:27092 E:27102 ||| VBD
[  ||| S:27102 E:27104 ||| -LRB-
4  ||| S:27104 E:27106 ||| LS
]  ||| S:27106 E:27108 ||| -RRB-
.  ||| S:27108 E:27110 ||| .
Other  ||| S:27110 E:27124 ||| JJ
researchers  ||| S:27124 E:27136 ||| NNS
have  ||| S:27136 E:27141 ||| VBP
described  ||| S:27141 E:27151 ||| VBN
a  ||| S:27151 E:27153 ||| DT
specific  ||| S:27153 E:27162 ||| JJ
Golgi  ||| S:27162 E:27168 ||| JJ
membrane  ||| S:27168 E:27185 ||| JJ
localization  ||| S:27185 E:27198 ||| NN
of  ||| S:27198 E:27201 ||| IN
sα  ||| S:27201 E:27213 ||| CD
i2  ||| S:27213 E:27216 ||| CD
[  ||| S:27216 E:27218 ||| -LRB-
4  ||| S:27218 E:27220 ||| LS
]  ||| S:27220 E:27222 ||| -RRB-
;  ||| S:27222 E:27224 ||| :
in  ||| S:27224 E:27227 ||| IN
contrast ||| S:27227 E:27235 ||| NN
,  ||| S:27235 E:27237 ||| ,
the  ||| S:27237 E:27241 ||| DT
results  ||| S:27241 E:27257 ||| NNS
presented  ||| S:27257 E:27267 ||| VBN
in  ||| S:27267 E:27270 ||| IN
this  ||| S:27270 E:27275 ||| DT
report  ||| S:27275 E:27282 ||| NN
always  ||| S:27282 E:27289 ||| RB
show  ||| S:27289 E:27294 ||| VB
a  ||| S:27294 E:27296 ||| DT
much  ||| S:27296 E:27301 ||| RB
more  ||| S:27301 E:27306 ||| RBR
disperse  ||| S:27306 E:27323 ||| JJ
subcellular  ||| S:27323 E:27335 ||| JJ
localization  ||| S:27335 E:27348 ||| NN
of  ||| S:27348 E:27351 ||| IN
sα  ||| S:27351 E:27363 ||| CD
i2  ||| S:27363 E:27366 ||| CD
to  ||| S:27366 E:27369 ||| TO
intracellular  ||| S:27369 E:27383 ||| VB
membranes  ||| S:27383 E:27393 ||| JJ
consistent  ||| S:27393 E:27412 ||| JJ
with  ||| S:27412 E:27417 ||| IN
staining  ||| S:27417 E:27426 ||| NN
of  ||| S:27426 E:27429 ||| IN
both  ||| S:27429 E:27434 ||| DT
Golgi  ||| S:27434 E:27440 ||| NNP
and  ||| S:27440 E:27444 ||| CC
ER ||| S:27444 E:27446 ||| NNP
.  ||| S:27446 E:27448 ||| .
The  ||| S:27448 E:27452 ||| DT
reason  ||| S:27452 E:27459 ||| NN
for  ||| S:27459 E:27463 ||| IN
this  ||| S:27463 E:27476 ||| DT
difference  ||| S:27476 E:27487 ||| NN
in  ||| S:27487 E:27490 ||| IN
localization  ||| S:27490 E:27503 ||| NN
is  ||| S:27503 E:27506 ||| VBZ
unclear ||| S:27506 E:27513 ||| JJ
.  ||| S:27513 E:27515 ||| .
Interestingly ||| S:27515 E:27528 ||| RB
,  ||| S:27528 E:27530 ||| ,
in  ||| S:27530 E:27541 ||| IN
the  ||| S:27541 E:27545 ||| DT
other  ||| S:27545 E:27551 ||| JJ
study ||| S:27551 E:27556 ||| NN
,  ||| S:27556 E:27558 ||| ,
the  ||| S:27558 E:27562 ||| DT
authors  ||| S:27562 E:27570 ||| NNS
found  ||| S:27570 E:27576 ||| VBD
that  ||| S:27576 E:27581 ||| DT
deletion  ||| S:27581 E:27590 ||| NN
of  ||| S:27590 E:27593 ||| IN
a  ||| S:27593 E:27603 ||| DT
proline-rich  ||| S:27603 E:27616 ||| JJ
sequence  ||| S:27616 E:27625 ||| JJ
corresponding  ||| S:27625 E:27639 ||| JJ
to  ||| S:27639 E:27642 ||| TO
sα  ||| S:27642 E:27654 ||| FW
i2  ||| S:27654 E:27657 ||| FW
amino  ||| S:27657 E:27663 ||| FW
acids  ||| S:27663 E:27669 ||| FW
348-359  ||| S:27669 E:27677 ||| FW
( ||| S:27677 E:27678 ||| -LRB-
Figure  ||| S:27678 E:27685 ||| NNP
1 ||| S:27685 E:27686 ||| CD
)  ||| S:27686 E:27696 ||| -RRB-
changed  ||| S:27696 E:27704 ||| VBD
localization  ||| S:27704 E:27717 ||| VBN
of  ||| S:27717 E:27720 ||| IN
sα  ||| S:27720 E:27732 ||| JJ
i2  ||| S:27732 E:27735 ||| NN
from  ||| S:27735 E:27740 ||| IN
Golgi  ||| S:27740 E:27746 ||| NNP
membranes  ||| S:27746 E:27756 ||| VBD
to  ||| S:27756 E:27759 ||| TO
a  ||| S:27759 E:27761 ||| DT
more  ||| S:27761 E:27774 ||| RBR
diffuse  ||| S:27774 E:27782 ||| JJ
localization  ||| S:27782 E:27795 ||| NN
throughout  ||| S:27795 E:27806 ||| IN
intracellular  ||| S:27806 E:27820 ||| JJ
membranes  ||| S:27820 E:27830 ||| NNS
[  ||| S:27830 E:27832 ||| -LRB-
4  ||| S:27832 E:27842 ||| LS
]  ||| S:27842 E:27844 ||| -RRB-
.  ||| S:27844 E:27846 ||| .
However ||| S:27846 E:27853 ||| RB
,  ||| S:27853 E:27855 ||| ,
mutation  ||| S:27855 E:27864 ||| NN
of  ||| S:27864 E:27867 ||| IN
proline  ||| S:27867 E:27875 ||| JJ
residues  ||| S:27875 E:27884 ||| NNS
to  ||| S:27884 E:27887 ||| TO
alanines  ||| S:27887 E:27904 ||| VB
failed  ||| S:27904 E:27911 ||| VBN
to  ||| S:27911 E:27914 ||| TO
affect  ||| S:27914 E:27921 ||| VB
sα  ||| S:27921 E:27933 ||| FW
i2  ||| S:27933 E:27936 ||| FW
localization  ||| S:27936 E:27949 ||| FW
[  ||| S:27949 E:27951 ||| -LRB-
4  ||| S:27951 E:27953 ||| LS
]  ||| S:27953 E:27955 ||| -RRB-
.  ||| S:27955 E:27957 ||| .
Thus ||| S:27957 E:27961 ||| RB
,  ||| S:27961 E:27963 ||| ,
little  ||| S:27963 E:27978 ||| JJ
evidence  ||| S:27978 E:27987 ||| NN
exists  ||| S:27987 E:27994 ||| VBZ
to  ||| S:27994 E:27997 ||| TO
support  ||| S:27997 E:28005 ||| VB
a  ||| S:28005 E:28007 ||| DT
specific  ||| S:28007 E:28016 ||| JJ
membrane  ||| S:28016 E:28025 ||| NNS
targeting  ||| S:28025 E:28043 ||| VBG
role  ||| S:28043 E:28048 ||| NN
for  ||| S:28048 E:28052 ||| IN
the  ||| S:28052 E:28056 ||| DT
novel  ||| S:28056 E:28062 ||| NN
sα  ||| S:28062 E:28074 ||| VBD
i2  ||| S:28074 E:28077 ||| CD
sequence.  ||| S:28077 E:28095 ||| CD
βγ  ||| S:28095 E:28098 ||| NNS
was  ||| S:28098 E:28102 ||| VBD
able  ||| S:28102 E:28107 ||| JJ
to  ||| S:28107 E:28110 ||| TO
promote  ||| S:28110 E:28118 ||| VB
plasma  ||| S:28118 E:28125 ||| JJ
membrane  ||| S:28125 E:28134 ||| JJ
localization  ||| S:28134 E:28147 ||| NN
of  ||| S:28147 E:28158 ||| IN
sα  ||| S:28158 E:28170 ||| CD
i2  ||| S:28170 E:28173 ||| CD
( ||| S:28173 E:28174 ||| -LRB-
Figure  ||| S:28174 E:28181 ||| NNP
8 ||| S:28181 E:28182 ||| CD
) ||| S:28182 E:28183 ||| -RRB-
.  ||| S:28183 E:28185 ||| .
βγ  ||| S:28185 E:28188 ||| FW
prevents  ||| S:28188 E:28197 ||| FW
irreversible  ||| S:28197 E:28218 ||| FW
inactivation  ||| S:28218 E:28231 ||| FW
of  ||| S:28231 E:28234 ||| IN
α  ||| S:28234 E:28245 ||| CD
i1  ||| S:28245 E:28248 ||| CD
,  ||| S:28248 E:28250 ||| ,
when  ||| S:28250 E:28255 ||| WRB
measured  ||| S:28255 E:28273 ||| VBN
in  ||| S:28273 E:28276 ||| IN
vitro  ||| S:28276 E:28282 ||| NN
at  ||| S:28282 E:28285 ||| IN
37°C ||| S:28285 E:28289 ||| NNP
,  ||| S:28289 E:28291 ||| ,
and  ||| S:28291 E:28295 ||| CC
slows  ||| S:28295 E:28301 ||| VBZ
the  ||| S:28301 E:28313 ||| DT
inactivation  ||| S:28313 E:28326 ||| NN
of  ||| S:28326 E:28329 ||| IN
α  ||| S:28329 E:28340 ||| CD
i1  ||| S:28340 E:28343 ||| CD
A326S  ||| S:28343 E:28349 ||| CD
[  ||| S:28349 E:28351 ||| -LRB-
10  ||| S:28351 E:28354 ||| CD
]  ||| S:28354 E:28356 ||| -RRB-
.  ||| S:28356 E:28358 ||| .
Thus ||| S:28358 E:28362 ||| RB
,  ||| S:28362 E:28364 ||| ,
βγ  ||| S:28364 E:28367 ||| NNS
may  ||| S:28367 E:28371 ||| MD
stabilize  ||| S:28371 E:28389 ||| VB
sα  ||| S:28389 E:28401 ||| JJ
i2  ||| S:28401 E:28404 ||| NN
and  ||| S:28404 E:28408 ||| CC
α  ||| S:28408 E:28419 ||| FW
i2  ||| S:28419 E:28422 ||| FW
A327S  ||| S:28422 E:28428 ||| FW
allowing  ||| S:28428 E:28437 ||| FW
βγ-dependent  ||| S:28437 E:28450 ||| FW
[  ||| S:28450 E:28452 ||| -LRB-
25  ||| S:28452 E:28455 ||| CD
26  ||| S:28455 E:28466 ||| CD
27  ||| S:28466 E:28469 ||| CD
28  ||| S:28469 E:28472 ||| CD
29  ||| S:28472 E:28475 ||| CD
]  ||| S:28475 E:28477 ||| -RRB-
PM  ||| S:28477 E:28480 ||| NNP
localization ||| S:28480 E:28492 ||| NN
.  ||| S:28492 E:28494 ||| .
These  ||| S:28494 E:28500 ||| DT
results  ||| S:28500 E:28508 ||| NNS
are  ||| S:28508 E:28512 ||| VBP
also  ||| S:28512 E:28525 ||| RB
consistent  ||| S:28525 E:28536 ||| JJ
with  ||| S:28536 E:28541 ||| IN
the  ||| S:28541 E:28545 ||| DT
possibility  ||| S:28545 E:28557 ||| NN
that  ||| S:28557 E:28562 ||| IN
the  ||| S:28562 E:28566 ||| DT
primary  ||| S:28566 E:28574 ||| JJ
defect  ||| S:28574 E:28581 ||| NN
in  ||| S:28581 E:28592 ||| IN
sα  ||| S:28592 E:28604 ||| JJ
i2  ||| S:28604 E:28607 ||| NN
is  ||| S:28607 E:28610 ||| VBZ
a  ||| S:28610 E:28612 ||| DT
reduced  ||| S:28612 E:28620 ||| JJ
ability  ||| S:28620 E:28628 ||| NN
to  ||| S:28628 E:28631 ||| TO
interact  ||| S:28631 E:28640 ||| VB
with  ||| S:28640 E:28653 ||| IN
βγ ||| S:28653 E:28655 ||| NNS
;  ||| S:28655 E:28657 ||| :
Gα  ||| S:28657 E:28660 ||| NNP
containing  ||| S:28660 E:28671 ||| VBG
mutations  ||| S:28671 E:28681 ||| NNS
in  ||| S:28681 E:28684 ||| IN
known  ||| S:28684 E:28690 ||| JJ
sites  ||| S:28690 E:28696 ||| NNS
of  ||| S:28696 E:28699 ||| IN
contact  ||| S:28699 E:28707 ||| NN
with  ||| S:28707 E:28720 ||| IN
βγ  ||| S:28720 E:28723 ||| NNS
fail  ||| S:28723 E:28728 ||| VBP
to  ||| S:28728 E:28731 ||| TO
localize  ||| S:28731 E:28740 ||| VB
to  ||| S:28740 E:28743 ||| TO
PM ||| S:28743 E:28745 ||| NNP
,  ||| S:28745 E:28747 ||| ,
but  ||| S:28747 E:28751 ||| CC
over-expression  ||| S:28751 E:28767 ||| JJ
of  ||| S:28767 E:28770 ||| IN
βγ  ||| S:28770 E:28773 ||| NNS
can  ||| S:28773 E:28785 ||| MD
rescue  ||| S:28785 E:28792 ||| VB
their  ||| S:28792 E:28798 ||| PRP$
PM  ||| S:28798 E:28801 ||| JJ
localization  ||| S:28801 E:28814 ||| NNS
[  ||| S:28814 E:28816 ||| -LRB-
28  ||| S:28816 E:28819 ||| CD
29  ||| S:28819 E:28822 ||| CD
]  ||| S:28822 E:28824 ||| -RRB-
.  ||| S:28824 E:28826 ||| .
However ||| S:28826 E:28833 ||| RB
,  ||| S:28833 E:28835 ||| ,
the  ||| S:28835 E:28847 ||| DT
crystal  ||| S:28847 E:28855 ||| NN
structures  ||| S:28855 E:28866 ||| NNS
[  ||| S:28866 E:28868 ||| -LRB-
30  ||| S:28868 E:28871 ||| CD
31  ||| S:28871 E:28874 ||| CD
]  ||| S:28874 E:28876 ||| -RRB-
show  ||| S:28876 E:28881 ||| NN
that  ||| S:28881 E:28886 ||| IN
the  ||| S:28886 E:28890 ||| DT
C-terminal  ||| S:28890 E:28901 ||| JJ
β6-α5  ||| S:28901 E:28915 ||| FW
loop ||| S:28915 E:28919 ||| FW
/ ||| S:28919 E:28920 ||| FW
α5  ||| S:28920 E:28923 ||| FW
helix  ||| S:28923 E:28929 ||| FW
region  ||| S:28929 E:28936 ||| NN
does  ||| S:28936 E:28941 ||| VBZ
not  ||| S:28941 E:28945 ||| RB
directly  ||| S:28945 E:28954 ||| RB
contact  ||| S:28954 E:28962 ||| JJ
βγ ||| S:28962 E:28964 ||| NN
.  ||| S:28964 E:28966 ||| .
Thus ||| S:28966 E:28970 ||| RB
,  ||| S:28970 E:28972 ||| ,
it  ||| S:28972 E:28983 ||| PRP
is  ||| S:28983 E:28986 ||| VBZ
more  ||| S:28986 E:28991 ||| RBR
likely  ||| S:28991 E:28998 ||| JJ
that  ||| S:28998 E:29003 ||| IN
indeed  ||| S:29003 E:29010 ||| RB
sα  ||| S:29010 E:29022 ||| JJ
i2  ||| S:29022 E:29025 ||| NN
is  ||| S:29025 E:29028 ||| VBZ
deficient  ||| S:29028 E:29038 ||| VBN
in  ||| S:29038 E:29041 ||| IN
binding  ||| S:29041 E:29049 ||| VBG
to  ||| S:29049 E:29052 ||| TO
βγ ||| S:29052 E:29054 ||| VB
,  ||| S:29054 E:29056 ||| ,
but  ||| S:29056 E:29068 ||| CC
this  ||| S:29068 E:29073 ||| DT
effect  ||| S:29073 E:29080 ||| NN
is  ||| S:29080 E:29083 ||| VBZ
a  ||| S:29083 E:29085 ||| DT
consequence  ||| S:29085 E:29097 ||| NN
of  ||| S:29097 E:29100 ||| IN
its  ||| S:29100 E:29104 ||| PRP$
instability.  ||| S:29104 E:29117 ||| FW
sα  ||| S:29117 E:29129 ||| FW
i2  ||| S:29129 E:29132 ||| FW
may  ||| S:29132 E:29136 ||| MD
exist  ||| S:29136 E:29142 ||| VB
in  ||| S:29142 E:29145 ||| IN
a  ||| S:29145 E:29147 ||| DT
state  ||| S:29147 E:29153 ||| NN
that  ||| S:29153 E:29158 ||| WDT
does  ||| S:29158 E:29163 ||| VBZ
not  ||| S:29163 E:29175 ||| RB
interact  ||| S:29175 E:29184 ||| VBN
well  ||| S:29184 E:29189 ||| RB
with  ||| S:29189 E:29194 ||| IN
βγ  ||| S:29194 E:29197 ||| VBG
simply  ||| S:29197 E:29204 ||| RB
because  ||| S:29204 E:29212 ||| IN
it  ||| S:29212 E:29215 ||| PRP
is  ||| S:29215 E:29218 ||| VBZ
in  ||| S:29218 E:29221 ||| IN
the  ||| S:29221 E:29225 ||| DT
process  ||| S:29225 E:29241 ||| NN
of  ||| S:29241 E:29244 ||| IN
being  ||| S:29244 E:29250 ||| VBG
irreversibly  ||| S:29250 E:29263 ||| JJ
inactivated  ||| S:29263 E:29275 ||| NNS
[  ||| S:29275 E:29277 ||| -LRB-
9  ||| S:29277 E:29279 ||| CD
10  ||| S:29279 E:29282 ||| CD
]  ||| S:29282 E:29284 ||| -RRB-
.  ||| S:29284 E:29286 ||| .
Similarly ||| S:29286 E:29295 ||| RB
,  ||| S:29295 E:29297 ||| ,
α  ||| S:29297 E:29308 ||| FW
i2  ||| S:29308 E:29311 ||| FW
A327S  ||| S:29311 E:29317 ||| FW
appears  ||| S:29317 E:29325 ||| VBZ
not  ||| S:29325 E:29329 ||| RB
to  ||| S:29329 E:29332 ||| TO
be  ||| S:29332 E:29335 ||| VB
defective  ||| S:29335 E:29345 ||| JJ
in  ||| S:29345 E:29356 ||| IN
its  ||| S:29356 E:29360 ||| PRP$
intrinsic  ||| S:29360 E:29370 ||| JJ
ability  ||| S:29370 E:29378 ||| NN
to  ||| S:29378 E:29381 ||| TO
interact  ||| S:29381 E:29390 ||| VB
βγ  ||| S:29390 E:29393 ||| NNS
[  ||| S:29393 E:29395 ||| -LRB-
10  ||| S:29395 E:29398 ||| CD
]  ||| S:29398 E:29400 ||| -RRB-
,  ||| S:29400 E:29402 ||| ,
and  ||| S:29402 E:29414 ||| CC
co-expression  ||| S:29414 E:29428 ||| JJ
of  ||| S:29428 E:29431 ||| IN
βγ  ||| S:29431 E:29434 ||| FW
shifts  ||| S:29434 E:29441 ||| FW
α  ||| S:29441 E:29452 ||| FW
i2  ||| S:29452 E:29455 ||| FW
A327S ||| S:29455 E:29460 ||| FW
,  ||| S:29460 E:29462 ||| ,
like  ||| S:29462 E:29467 ||| IN
sα  ||| S:29467 E:29479 ||| CD
i2  ||| S:29479 E:29482 ||| CD
,  ||| S:29482 E:29484 ||| ,
from  ||| S:29484 E:29489 ||| IN
intracellular  ||| S:29489 E:29503 ||| VBG
to  ||| S:29503 E:29506 ||| TO
plasma  ||| S:29506 E:29521 ||| VB
membranes  ||| S:29521 E:29531 ||| NNS
( ||| S:29531 E:29532 ||| -LRB-
Figure  ||| S:29532 E:29539 ||| NNP
8 ||| S:29539 E:29540 ||| CD
) ||| S:29540 E:29541 ||| -RRB-
.  ||| S:29541 E:29551 ||| .
What  ||| S:29551 E:29556 ||| WP
is  ||| S:29556 E:29559 ||| VBZ
the  ||| S:29559 E:29563 ||| DT
cellular  ||| S:29563 E:29572 ||| JJ
function  ||| S:29572 E:29581 ||| NN
of  ||| S:29581 E:29584 ||| IN
sα  ||| S:29584 E:29596 ||| CD
i2  ||| S:29596 E:29599 ||| CD
?  ||| S:29599 E:29601 ||| .
The  ||| S:29601 E:29605 ||| DT
ability  ||| S:29605 E:29613 ||| NN
of  ||| S:29613 E:29616 ||| IN
βγ  ||| S:29616 E:29619 ||| VBG
to  ||| S:29619 E:29622 ||| TO
promote  ||| S:29622 E:29630 ||| VB
PM  ||| S:29630 E:29641 ||| JJ
localization  ||| S:29641 E:29654 ||| NN
of  ||| S:29654 E:29657 ||| IN
sα  ||| S:29657 E:29669 ||| JJ
i2  ||| S:29669 E:29672 ||| NN
raises  ||| S:29672 E:29679 ||| VBZ
the  ||| S:29679 E:29683 ||| DT
possibility  ||| S:29683 E:29695 ||| NN
that  ||| S:29695 E:29708 ||| IN
endogenous  ||| S:29708 E:29719 ||| FW
sα  ||| S:29719 E:29731 ||| FW
i2  ||| S:29731 E:29734 ||| FW
is  ||| S:29734 E:29737 ||| VBZ
in  ||| S:29737 E:29740 ||| IN
fact  ||| S:29740 E:29745 ||| NN
localized  ||| S:29745 E:29755 ||| VBN
to  ||| S:29755 E:29758 ||| TO
PM  ||| S:29758 E:29761 ||| NNP
where  ||| S:29761 E:29767 ||| WRB
it  ||| S:29767 E:29778 ||| PRP
can  ||| S:29778 E:29782 ||| MD
interact  ||| S:29782 E:29791 ||| VB
with  ||| S:29791 E:29796 ||| IN
GPCRs  ||| S:29796 E:29802 ||| JJ
and  ||| S:29802 E:29806 ||| CC
effectors ||| S:29806 E:29815 ||| NN
.  ||| S:29815 E:29817 ||| .
Future  ||| S:29817 E:29824 ||| JJ
studies  ||| S:29824 E:29832 ||| NNS
will  ||| S:29832 E:29845 ||| MD
test  ||| S:29845 E:29850 ||| VB
the  ||| S:29850 E:29854 ||| DT
potential  ||| S:29854 E:29864 ||| NN
of  ||| S:29864 E:29867 ||| IN
sα  ||| S:29867 E:29879 ||| CD
i2  ||| S:29879 E:29882 ||| CD
,  ||| S:29882 E:29884 ||| ,
when  ||| S:29884 E:29889 ||| WRB
co-expressed  ||| S:29889 E:29902 ||| JJ
with  ||| S:29902 E:29907 ||| IN
βγ ||| S:29907 E:29909 ||| NN
,  ||| S:29909 E:29911 ||| ,
to  ||| S:29911 E:29922 ||| TO
productively  ||| S:29922 E:29935 ||| VB
interact  ||| S:29935 E:29944 ||| VBN
with  ||| S:29944 E:29949 ||| IN
receptors  ||| S:29949 E:29959 ||| NNS
and  ||| S:29959 E:29963 ||| CC
effectors ||| S:29963 E:29972 ||| NN
.  ||| S:29972 E:29982 ||| .
However ||| S:29982 E:29989 ||| RB
,  ||| S:29989 E:29991 ||| ,
this  ||| S:29991 E:29996 ||| DT
possibility  ||| S:29996 E:30008 ||| NN
is  ||| S:30008 E:30011 ||| VBZ
viewed  ||| S:30011 E:30018 ||| VBN
as  ||| S:30018 E:30021 ||| IN
unlikely  ||| S:30021 E:30030 ||| JJ
for  ||| S:30030 E:30034 ||| IN
several  ||| S:30034 E:30050 ||| JJ
reasons ||| S:30050 E:30057 ||| NNS
.  ||| S:30057 E:30059 ||| .
First ||| S:30059 E:30064 ||| NNP
,  ||| S:30064 E:30066 ||| ,
others  ||| S:30066 E:30073 ||| NNS
have  ||| S:30073 E:30078 ||| VBP
shown  ||| S:30078 E:30084 ||| VBN
that  ||| S:30084 E:30089 ||| IN
in  ||| S:30089 E:30092 ||| IN
COS-7  ||| S:30092 E:30098 ||| FW
cells  ||| S:30098 E:30112 ||| FW
endogenous  ||| S:30112 E:30123 ||| FW
sα  ||| S:30123 E:30135 ||| FW
i2  ||| S:30135 E:30138 ||| FW
is  ||| S:30138 E:30141 ||| VBZ
not  ||| S:30141 E:30145 ||| RB
detected  ||| S:30145 E:30154 ||| VBN
at  ||| S:30154 E:30157 ||| IN
PM  ||| S:30157 E:30160 ||| NNP
but  ||| S:30160 E:30164 ||| CC
only  ||| S:30164 E:30169 ||| RB
found  ||| S:30169 E:30183 ||| VBN
intracellularly  ||| S:30183 E:30199 ||| NNS
[  ||| S:30199 E:30201 ||| -LRB-
3  ||| S:30201 E:30203 ||| CD
4  ||| S:30203 E:30205 ||| CD
]  ||| S:30205 E:30207 ||| -RRB-
,  ||| S:30207 E:30209 ||| ,
although  ||| S:30209 E:30218 ||| IN
one  ||| S:30218 E:30222 ||| CD
cannot  ||| S:30222 E:30229 ||| NNS
rule  ||| S:30229 E:30234 ||| VB
out  ||| S:30234 E:30238 ||| RP
that  ||| S:30238 E:30251 ||| IN
a  ||| S:30251 E:30253 ||| DT
small  ||| S:30253 E:30259 ||| JJ
but  ||| S:30259 E:30263 ||| CC
functionally  ||| S:30263 E:30276 ||| JJ
significant  ||| S:30276 E:30288 ||| JJ
fraction  ||| S:30288 E:30297 ||| NN
of  ||| S:30297 E:30300 ||| IN
sα  ||| S:30300 E:30312 ||| JJ
i2  ||| S:30312 E:30315 ||| NN
reaches  ||| S:30315 E:30323 ||| VBZ
the  ||| S:30323 E:30327 ||| DT
PM ||| S:30327 E:30329 ||| NNP
.  ||| S:30329 E:30331 ||| .
Second ||| S:30331 E:30337 ||| LS
,  ||| S:30337 E:30339 ||| ,
the  ||| S:30339 E:30343 ||| DT
extreme  ||| S:30343 E:30359 ||| JJ
C-termini  ||| S:30359 E:30369 ||| NN
of  ||| S:30369 E:30372 ||| IN
Gα  ||| S:30372 E:30375 ||| NNP
are  ||| S:30375 E:30379 ||| VBP
critical  ||| S:30379 E:30388 ||| JJ
sites  ||| S:30388 E:30394 ||| NNS
for  ||| S:30394 E:30398 ||| IN
interaction  ||| S:30398 E:30410 ||| NN
with  ||| S:30410 E:30423 ||| IN
GPCRs  ||| S:30423 E:30429 ||| NNP
[  ||| S:30429 E:30431 ||| -LRB-
32  ||| S:30431 E:30434 ||| CD
]  ||| S:30434 E:30436 ||| -RRB-
,  ||| S:30436 E:30438 ||| ,
and  ||| S:30438 E:30442 ||| CC
the  ||| S:30442 E:30446 ||| DT
novel  ||| S:30446 E:30452 ||| NN
C-terminal  ||| S:30452 E:30463 ||| JJ
sequence  ||| S:30463 E:30472 ||| NN
found  ||| S:30472 E:30478 ||| VBD
in  ||| S:30478 E:30489 ||| IN
sα  ||| S:30489 E:30501 ||| JJ
i2  ||| S:30501 E:30504 ||| NN
would  ||| S:30504 E:30510 ||| MD
be  ||| S:30510 E:30513 ||| VB
predicted  ||| S:30513 E:30523 ||| VBN
to  ||| S:30523 E:30526 ||| TO
disrupt  ||| S:30526 E:30542 ||| VB
productive  ||| S:30542 E:30553 ||| JJ
interactions  ||| S:30553 E:30566 ||| NNS
with  ||| S:30566 E:30571 ||| IN
GPCRs ||| S:30571 E:30576 ||| JJ
.  ||| S:30576 E:30578 ||| .
Third ||| S:30578 E:30583 ||| JJ
,  ||| S:30583 E:30585 ||| ,
even  ||| S:30585 E:30590 ||| RB
though  ||| S:30590 E:30597 ||| IN
βγ  ||| S:30597 E:30608 ||| NNS
can  ||| S:30608 E:30612 ||| MD
promote  ||| S:30612 E:30620 ||| VB
PM  ||| S:30620 E:30623 ||| JJ
localization  ||| S:30623 E:30636 ||| NN
of  ||| S:30636 E:30639 ||| IN
sα  ||| S:30639 E:30651 ||| JJ
i2  ||| S:30651 E:30654 ||| NN
in  ||| S:30654 E:30657 ||| IN
the  ||| S:30657 E:30661 ||| DT
overexpression  ||| S:30661 E:30676 ||| JJ
system  ||| S:30676 E:30691 ||| NN
described  ||| S:30691 E:30701 ||| VBD
here ||| S:30701 E:30705 ||| RB
,  ||| S:30705 E:30707 ||| ,
sα  ||| S:30707 E:30719 ||| JJ
i2  ||| S:30719 E:30722 ||| NN
remains  ||| S:30722 E:30730 ||| VBZ
less  ||| S:30730 E:30735 ||| RBR
stable  ||| S:30735 E:30742 ||| JJ
than  ||| S:30742 E:30747 ||| IN
α  ||| S:30747 E:30758 ||| CD
i2  ||| S:30758 E:30761 ||| CD
( ||| S:30761 E:30762 ||| -LRB-
Figure  ||| S:30762 E:30769 ||| NNP
9 ||| S:30769 E:30770 ||| CD
) ||| S:30770 E:30771 ||| -RRB-
,  ||| S:30771 E:30773 ||| ,
suggesting  ||| S:30773 E:30784 ||| VBG
that  ||| S:30784 E:30789 ||| IN
such  ||| S:30789 E:30802 ||| JJ
instability  ||| S:30802 E:30814 ||| NN
may  ||| S:30814 E:30818 ||| MD
also  ||| S:30818 E:30823 ||| RB
impair  ||| S:30823 E:30830 ||| VB
productive  ||| S:30830 E:30841 ||| JJ
interactions  ||| S:30841 E:30854 ||| NNS
with  ||| S:30854 E:30867 ||| IN
GPCRs ||| S:30867 E:30872 ||| JJ
.  ||| S:30872 E:30882 ||| .
On  ||| S:30882 E:30885 ||| IN
the  ||| S:30885 E:30889 ||| DT
other  ||| S:30889 E:30895 ||| JJ
hand ||| S:30895 E:30899 ||| NN
,  ||| S:30899 E:30901 ||| ,
unknown  ||| S:30901 E:30909 ||| JJ
protein ||| S:30909 E:30916 ||| NN
( ||| S:30916 E:30917 ||| -LRB-
s ||| S:30917 E:30918 ||| LS
)  ||| S:30918 E:30920 ||| -RRB-
may  ||| S:30920 E:30924 ||| MD
function  ||| S:30924 E:30933 ||| VB
to  ||| S:30933 E:30944 ||| TO
stabilize  ||| S:30944 E:30954 ||| VB
sα  ||| S:30954 E:30966 ||| JJ
i2  ||| S:30966 E:30969 ||| NN
and  ||| S:30969 E:30973 ||| CC
help  ||| S:30973 E:30978 ||| VB
direct  ||| S:30978 E:30985 ||| JJ
it  ||| S:30985 E:30988 ||| PRP
to  ||| S:30988 E:30991 ||| TO
Golgi  ||| S:30991 E:31005 ||| NNP
membranes ||| S:31005 E:31014 ||| NN
.  ||| S:31014 E:31016 ||| .
A  ||| S:31016 E:31018 ||| DT
specific  ||| S:31018 E:31027 ||| JJ
combination  ||| S:31027 E:31039 ||| NN
of  ||| S:31039 E:31042 ||| IN
β  ||| S:31042 E:31044 ||| NN
and  ||| S:31044 E:31048 ||| CC
γ  ||| S:31048 E:31050 ||| JJ
subtypes  ||| S:31050 E:31059 ||| NN
may  ||| S:31059 E:31071 ||| MD
play  ||| S:31071 E:31076 ||| VB
such  ||| S:31076 E:31081 ||| PDT
a  ||| S:31081 E:31083 ||| DT
role ||| S:31083 E:31087 ||| NN
;  ||| S:31087 E:31089 ||| :
however ||| S:31089 E:31096 ||| RB
,  ||| S:31096 E:31098 ||| ,
one  ||| S:31098 E:31102 ||| CD
thorough  ||| S:31102 E:31111 ||| JJ
study  ||| S:31111 E:31117 ||| NN
showed  ||| S:31117 E:31124 ||| VBD
a  ||| S:31124 E:31126 ||| DT
lack  ||| S:31126 E:31139 ||| NN
of  ||| S:31139 E:31142 ||| IN
βγ  ||| S:31142 E:31145 ||| NN
on  ||| S:31145 E:31148 ||| IN
Golgi  ||| S:31148 E:31154 ||| NNP
membranes  ||| S:31154 E:31164 ||| NN
of  ||| S:31164 E:31167 ||| IN
exocrine  ||| S:31167 E:31176 ||| JJ
pancreatic  ||| S:31176 E:31187 ||| JJ
cells  ||| S:31187 E:31193 ||| NNS
even  ||| S:31193 E:31206 ||| RB
though  ||| S:31206 E:31213 ||| IN
a  ||| S:31213 E:31215 ||| DT
variety  ||| S:31215 E:31223 ||| NN
of  ||| S:31223 E:31226 ||| IN
Gα  ||| S:31226 E:31229 ||| NNP
were  ||| S:31229 E:31234 ||| VBD
readily  ||| S:31234 E:31242 ||| RB
detected  ||| S:31242 E:31251 ||| VBN
in  ||| S:31251 E:31254 ||| IN
the  ||| S:31254 E:31258 ||| DT
Golgi  ||| S:31258 E:31264 ||| NNP
[  ||| S:31264 E:31274 ||| -LRB-
33  ||| S:31274 E:31277 ||| CD
]  ||| S:31277 E:31279 ||| -RRB-
.  ||| S:31279 E:31281 ||| .
Other  ||| S:31281 E:31287 ||| JJ
proteins  ||| S:31287 E:31296 ||| NNS
that  ||| S:31296 E:31301 ||| WDT
may  ||| S:31301 E:31305 ||| MD
specifically  ||| S:31305 E:31318 ||| RB
promote  ||| S:31318 E:31326 ||| VB
the  ||| S:31326 E:31338 ||| DT
intracellular  ||| S:31338 E:31352 ||| NN
targeting  ||| S:31352 E:31362 ||| VBG
of  ||| S:31362 E:31365 ||| IN
Gα  ||| S:31365 E:31368 ||| NNP
have  ||| S:31368 E:31373 ||| VBP
not  ||| S:31373 E:31377 ||| RB
been  ||| S:31377 E:31382 ||| VBN
identified ||| S:31382 E:31392 ||| VBN
.  ||| S:31392 E:31402 ||| .
It  ||| S:31402 E:31405 ||| PRP
is  ||| S:31405 E:31408 ||| VBZ
possible  ||| S:31408 E:31417 ||| JJ
that  ||| S:31417 E:31422 ||| IN
sα  ||| S:31422 E:31434 ||| CD
i2  ||| S:31434 E:31437 ||| CD
functions  ||| S:31437 E:31447 ||| NNS
as  ||| S:31447 E:31450 ||| IN
a  ||| S:31450 E:31452 ||| DT
short-lived  ||| S:31452 E:31464 ||| JJ
protein  ||| S:31464 E:31480 ||| NN
regulating  ||| S:31480 E:31491 ||| VBG
some  ||| S:31491 E:31496 ||| DT
aspect  ||| S:31496 E:31503 ||| NN
of  ||| S:31503 E:31506 ||| IN
membrane  ||| S:31506 E:31515 ||| JJ
transport  ||| S:31515 E:31525 ||| NN
pathways ||| S:31525 E:31533 ||| NNS
;  ||| S:31533 E:31543 ||| :
however ||| S:31543 E:31550 ||| RB
,  ||| S:31550 E:31552 ||| ,
no  ||| S:31552 E:31555 ||| DT
experiments  ||| S:31555 E:31567 ||| NNS
to  ||| S:31567 E:31570 ||| TO
directly  ||| S:31570 E:31579 ||| RB
support  ||| S:31579 E:31587 ||| VB
or  ||| S:31587 E:31590 ||| CC
refute  ||| S:31590 E:31597 ||| VB
this  ||| S:31597 E:31610 ||| DT
hypothesis  ||| S:31610 E:31621 ||| NNS
have  ||| S:31621 E:31626 ||| VBP
been  ||| S:31626 E:31631 ||| VBN
reported ||| S:31631 E:31639 ||| VBN
.  ||| S:31639 E:31641 ||| .
Instead ||| S:31641 E:31648 ||| RB
,  ||| S:31648 E:31650 ||| ,
it  ||| S:31650 E:31653 ||| PRP
is  ||| S:31653 E:31656 ||| VBZ
tempting  ||| S:31656 E:31665 ||| VBN
to  ||| S:31665 E:31676 ||| TO
speculate  ||| S:31676 E:31686 ||| VB
that  ||| S:31686 E:31691 ||| DT
alternative  ||| S:31691 E:31703 ||| JJ
splicing  ||| S:31703 E:31712 ||| NN
may  ||| S:31712 E:31716 ||| MD
be  ||| S:31716 E:31719 ||| VB
a  ||| S:31719 E:31721 ||| DT
mechanism  ||| S:31721 E:31731 ||| NN
to  ||| S:31731 E:31742 ||| TO
regulate  ||| S:31742 E:31751 ||| VB
cellular  ||| S:31751 E:31760 ||| JJ
levels  ||| S:31760 E:31767 ||| NNS
of  ||| S:31767 E:31770 ||| IN
α  ||| S:31770 E:31781 ||| CD
i2  ||| S:31781 E:31784 ||| CD
.  ||| S:31784 E:31786 ||| .
In  ||| S:31786 E:31789 ||| IN
this  ||| S:31789 E:31794 ||| DT
model ||| S:31794 E:31799 ||| NN
,  ||| S:31799 E:31801 ||| ,
certain  ||| S:31801 E:31809 ||| JJ
conditions  ||| S:31809 E:31828 ||| NNS
may  ||| S:31828 E:31832 ||| MD
favor  ||| S:31832 E:31838 ||| VB
the  ||| S:31838 E:31842 ||| DT
formation  ||| S:31842 E:31852 ||| NN
of  ||| S:31852 E:31855 ||| IN
sα  ||| S:31855 E:31867 ||| NNS
i2  ||| S:31867 E:31870 ||| VBP
compared  ||| S:31870 E:31879 ||| VBN
to  ||| S:31879 E:31882 ||| TO
α  ||| S:31882 E:31893 ||| CD
i2  ||| S:31893 E:31896 ||| CD
,  ||| S:31896 E:31898 ||| ,
and  ||| S:31898 E:31902 ||| CC
the  ||| S:31902 E:31906 ||| DT
resulting  ||| S:31906 E:31916 ||| VBG
rapid  ||| S:31916 E:31922 ||| JJ
degradation  ||| S:31922 E:31942 ||| NN
of  ||| S:31942 E:31945 ||| IN
sα  ||| S:31945 E:31957 ||| JJ
i2  ||| S:31957 E:31960 ||| NN
would  ||| S:31960 E:31966 ||| MD
decrease  ||| S:31966 E:31975 ||| VB
the  ||| S:31975 E:31979 ||| DT
cellular  ||| S:31979 E:31988 ||| JJ
content  ||| S:31988 E:32004 ||| NN
of  ||| S:32004 E:32007 ||| IN
α  ||| S:32007 E:32018 ||| CD
i2  ||| S:32018 E:32021 ||| CD
.  ||| S:32021 E:32023 ||| .
A  ||| S:32023 E:32025 ||| DT
precedent  ||| S:32025 E:32035 ||| NN
for  ||| S:32035 E:32039 ||| IN
such  ||| S:32039 E:32044 ||| JJ
alternative  ||| S:32044 E:32064 ||| JJ
splicing-dependent  ||| S:32064 E:32083 ||| JJ
regulation  ||| S:32083 E:32094 ||| NN
of  ||| S:32094 E:32097 ||| IN
expression  ||| S:32097 E:32108 ||| NN
has  ||| S:32108 E:32112 ||| VBZ
been  ||| S:32112 E:32125 ||| VBN
described  ||| S:32125 E:32135 ||| VBN
for  ||| S:32135 E:32139 ||| IN
H-ras  ||| S:32139 E:32145 ||| NNP
[  ||| S:32145 E:32147 ||| -LRB-
34  ||| S:32147 E:32150 ||| CD
]  ||| S:32150 E:32152 ||| -RRB-
.  ||| S:32152 E:32154 ||| .
Alternative  ||| S:32154 E:32166 ||| JJ
splicing  ||| S:32166 E:32175 ||| NN
occurs  ||| S:32175 E:32182 ||| VBZ
in  ||| S:32182 E:32193 ||| IN
H-ras ||| S:32193 E:32198 ||| NNP
,  ||| S:32198 E:32200 ||| ,
and  ||| S:32200 E:32204 ||| CC
the  ||| S:32204 E:32208 ||| DT
alternative  ||| S:32208 E:32220 ||| JJ
spliced  ||| S:32220 E:32228 ||| JJ
form  ||| S:32228 E:32233 ||| NN
is  ||| S:32233 E:32236 ||| VBZ
predicted  ||| S:32236 E:32246 ||| VBN
to  ||| S:32246 E:32257 ||| TO
encode  ||| S:32257 E:32264 ||| VB
an  ||| S:32264 E:32267 ||| DT
unstable  ||| S:32267 E:32276 ||| JJ
transcript  ||| S:32276 E:32287 ||| NN
and  ||| S:32287 E:32291 ||| CC
a  ||| S:32291 E:32293 ||| DT
protein  ||| S:32293 E:32301 ||| NN
product  ||| S:32301 E:32309 ||| NN
that  ||| S:32309 E:32322 ||| WDT
lacks  ||| S:32322 E:32328 ||| VBZ
the  ||| S:32328 E:32332 ||| DT
ability  ||| S:32332 E:32340 ||| NN
to  ||| S:32340 E:32343 ||| TO
oncogenically  ||| S:32343 E:32357 ||| VB
transform  ||| S:32357 E:32367 ||| JJ
cells ||| S:32367 E:32372 ||| NNS
.  ||| S:32372 E:32374 ||| .
A  ||| S:32374 E:32384 ||| DT
mutation  ||| S:32384 E:32393 ||| NN
was  ||| S:32393 E:32397 ||| VBD
identified  ||| S:32397 E:32408 ||| VBN
that  ||| S:32408 E:32413 ||| IN
abolishes  ||| S:32413 E:32423 ||| VBG
the  ||| S:32423 E:32427 ||| DT
alternatively  ||| S:32427 E:32449 ||| JJ
spliced  ||| S:32449 E:32457 ||| JJ
form ||| S:32457 E:32461 ||| NN
,  ||| S:32461 E:32463 ||| ,
and  ||| S:32463 E:32467 ||| CC
this  ||| S:32467 E:32472 ||| DT
mutation  ||| S:32472 E:32481 ||| NN
leads  ||| S:32481 E:32487 ||| VBZ
to  ||| S:32487 E:32490 ||| TO
an  ||| S:32490 E:32493 ||| DT
increase  ||| S:32493 E:32502 ||| NN
in  ||| S:32502 E:32513 ||| IN
H-ras  ||| S:32513 E:32519 ||| JJ
expression  ||| S:32519 E:32530 ||| NN
and  ||| S:32530 E:32534 ||| CC
transforming  ||| S:32534 E:32547 ||| JJ
ability ||| S:32547 E:32554 ||| NN
.  ||| S:32554 E:32556 ||| .
Thus ||| S:32556 E:32560 ||| RB
,  ||| S:32560 E:32562 ||| ,
it  ||| S:32562 E:32565 ||| PRP
was  ||| S:32565 E:32577 ||| VBD
demonstrated  ||| S:32577 E:32590 ||| VBN
that  ||| S:32590 E:32595 ||| IN
alternative  ||| S:32595 E:32607 ||| JJ
splicing  ||| S:32607 E:32616 ||| NN
is  ||| S:32616 E:32619 ||| VBZ
a  ||| S:32619 E:32621 ||| DT
mechanism  ||| S:32621 E:32631 ||| NN
that  ||| S:32631 E:32644 ||| IN
cells  ||| S:32644 E:32650 ||| NNS
use  ||| S:32650 E:32654 ||| VBP
to  ||| S:32654 E:32657 ||| TO
control  ||| S:32657 E:32665 ||| VB
expression  ||| S:32665 E:32676 ||| NN
of  ||| S:32676 E:32679 ||| IN
H-ras  ||| S:32679 E:32685 ||| NNP
[  ||| S:32685 E:32687 ||| -LRB-
34  ||| S:32687 E:32690 ||| CD
]  ||| S:32690 E:32692 ||| -RRB-
.  ||| S:32692 E:32702 ||| .
Alternative  ||| S:32702 E:32714 ||| JJ
splicing  ||| S:32714 E:32723 ||| NN
may  ||| S:32723 E:32727 ||| MD
similarly  ||| S:32727 E:32737 ||| RB
play  ||| S:32737 E:32742 ||| VB
an  ||| S:32742 E:32745 ||| DT
important  ||| S:32745 E:32755 ||| JJ
role  ||| S:32755 E:32768 ||| NN
in  ||| S:32768 E:32771 ||| IN
regulating  ||| S:32771 E:32782 ||| VBG
expression  ||| S:32782 E:32793 ||| NN
of  ||| S:32793 E:32796 ||| IN
α  ||| S:32796 E:32807 ||| CD
i2  ||| S:32807 E:32810 ||| CD
.  ||| S:32810 E:32812 ||| .
Testing  ||| S:32812 E:32820 ||| NN
of  ||| S:32820 E:32823 ||| IN
this  ||| S:32823 E:32828 ||| DT
idea  ||| S:32828 E:32833 ||| NN
will  ||| S:32833 E:32838 ||| MD
require  ||| S:32838 E:32846 ||| VB
a  ||| S:32846 E:32856 ||| DT
comparison  ||| S:32856 E:32867 ||| NN
of  ||| S:32867 E:32870 ||| IN
sα  ||| S:32870 E:32882 ||| JJ
i2  ||| S:32882 E:32885 ||| NN
and  ||| S:32885 E:32889 ||| CC
α  ||| S:32889 E:32900 ||| CD
i2  ||| S:32900 E:32903 ||| CD
transcript  ||| S:32903 E:32914 ||| NN
levels ||| S:32914 E:32920 ||| NNS
,  ||| S:32920 E:32922 ||| ,
and  ||| S:32922 E:32926 ||| CC
an  ||| S:32926 E:32929 ||| DT
analysis  ||| S:32929 E:32938 ||| NN
of  ||| S:32938 E:32949 ||| IN
whether  ||| S:32949 E:32957 ||| IN
relative  ||| S:32957 E:32966 ||| JJ
expression  ||| S:32966 E:32977 ||| NN
is  ||| S:32977 E:32980 ||| VBZ
affected  ||| S:32980 E:32989 ||| VBN
in  ||| S:32989 E:32992 ||| IN
response  ||| S:32992 E:33001 ||| NN
to  ||| S:33001 E:33012 ||| TO
physiological  ||| S:33012 E:33026 ||| VB
changes ||| S:33026 E:33033 ||| NNS
,  ||| S:33033 E:33035 ||| ,
such  ||| S:33035 E:33040 ||| JJ
as  ||| S:33040 E:33043 ||| IN
extracellular  ||| S:33043 E:33057 ||| JJ
stimuli  ||| S:33057 E:33065 ||| NNS
or  ||| S:33065 E:33076 ||| CC
cell  ||| S:33076 E:33081 ||| NN
differentiation ||| S:33081 E:33096 ||| NN
.  ||| S:33096 E:33120 ||| .
Conclusions  ||| S:33120 E:33140 ||| NNS
In  ||| S:33140 E:33143 ||| IN
summary ||| S:33143 E:33150 ||| NN
,  ||| S:33150 E:33152 ||| ,
the  ||| S:33152 E:33156 ||| DT
results  ||| S:33156 E:33164 ||| NNS
presented  ||| S:33164 E:33174 ||| VBD
here  ||| S:33174 E:33179 ||| RB
demonstrate  ||| S:33179 E:33191 ||| VB
that  ||| S:33191 E:33204 ||| IN
sα  ||| S:33204 E:33216 ||| CD
i2  ||| S:33216 E:33219 ||| CD
,  ||| S:33219 E:33221 ||| ,
a  ||| S:33221 E:33223 ||| DT
novel  ||| S:33223 E:33229 ||| NN
splice  ||| S:33229 E:33236 ||| NN
variant  ||| S:33236 E:33244 ||| NN
of  ||| S:33244 E:33247 ||| IN
α  ||| S:33247 E:33258 ||| CD
i2  ||| S:33258 E:33261 ||| CD
,  ||| S:33261 E:33263 ||| ,
is  ||| S:33263 E:33266 ||| VBZ
rapidly  ||| S:33266 E:33274 ||| RB
degraded  ||| S:33274 E:33283 ||| VB
when  ||| S:33283 E:33288 ||| WRB
expressed  ||| S:33288 E:33306 ||| VBN
in  ||| S:33306 E:33309 ||| IN
cells ||| S:33309 E:33314 ||| NNS
.  ||| S:33314 E:33316 ||| .
Such  ||| S:33316 E:33321 ||| JJ
instability  ||| S:33321 E:33333 ||| NN
is  ||| S:33333 E:33336 ||| VBZ
consistent  ||| S:33336 E:33347 ||| JJ
with  ||| S:33347 E:33352 ||| IN
known  ||| S:33352 E:33366 ||| VBN
structure-function  ||| S:33366 E:33385 ||| JJ
data  ||| S:33385 E:33390 ||| NNS
regarding  ||| S:33390 E:33400 ||| VBG
the  ||| S:33400 E:33404 ||| DT
importance  ||| S:33404 E:33415 ||| NN
of  ||| S:33415 E:33418 ||| IN
the  ||| S:33418 E:33430 ||| DT
C-terminus  ||| S:33430 E:33441 ||| JJ
of  ||| S:33441 E:33444 ||| IN
Gα  ||| S:33444 E:33447 ||| NNP
subunits ||| S:33447 E:33455 ||| NN
.  ||| S:33455 E:33457 ||| .
The  ||| S:33457 E:33461 ||| DT
observed  ||| S:33461 E:33470 ||| JJ
intracellular  ||| S:33470 E:33492 ||| JJ
localization  ||| S:33492 E:33505 ||| NN
of  ||| S:33505 E:33508 ||| IN
sα  ||| S:33508 E:33520 ||| JJ
i2  ||| S:33520 E:33523 ||| NN
is  ||| S:33523 E:33526 ||| VBZ
due ||| S:33526 E:33529 ||| JJ
,  ||| S:33529 E:33531 ||| ,
at  ||| S:33531 E:33534 ||| IN
least  ||| S:33534 E:33540 ||| JJS
in  ||| S:33540 E:33543 ||| IN
part ||| S:33543 E:33547 ||| NN
,  ||| S:33547 E:33549 ||| ,
to  ||| S:33549 E:33552 ||| TO
its  ||| S:33552 E:33564 ||| PRP$
instability ||| S:33564 E:33575 ||| NN
.  ||| S:33575 E:33577 ||| .
Moreover ||| S:33577 E:33585 ||| RB
,  ||| S:33585 E:33587 ||| ,
the  ||| S:33587 E:33591 ||| DT
data  ||| S:33591 E:33596 ||| NNS
presented  ||| S:33596 E:33606 ||| VBN
in  ||| S:33606 E:33609 ||| IN
this  ||| S:33609 E:33614 ||| DT
study  ||| S:33614 E:33628 ||| NN
argue  ||| S:33628 E:33634 ||| VBP
against  ||| S:33634 E:33642 ||| IN
the  ||| S:33642 E:33646 ||| DT
novel  ||| S:33646 E:33652 ||| NN
C-terminus  ||| S:33652 E:33663 ||| NN
of  ||| S:33663 E:33666 ||| IN
sα  ||| S:33666 E:33678 ||| CD
i2  ||| S:33678 E:33681 ||| CD
functioning  ||| S:33681 E:33693 ||| NN
as  ||| S:33693 E:33696 ||| IN
a  ||| S:33696 E:33698 ||| DT
specific  ||| S:33698 E:33707 ||| JJ
Golgi  ||| S:33707 E:33721 ||| NNS
targeting  ||| S:33721 E:33731 ||| VBG
motif ||| S:33731 E:33736 ||| NN
.  ||| S:33736 E:33746 ||| .
In  ||| S:33746 E:33749 ||| IN
addition ||| S:33749 E:33757 ||| NN
,  ||| S:33757 E:33759 ||| ,
similarly  ||| S:33759 E:33769 ||| RB
to  ||| S:33769 E:33772 ||| TO
sα  ||| S:33772 E:33784 ||| CD
i2  ||| S:33784 E:33787 ||| CD
,  ||| S:33787 E:33789 ||| ,
an  ||| S:33789 E:33792 ||| DT
α  ||| S:33792 E:33803 ||| JJ
i2  ||| S:33803 E:33806 ||| CD
mutant ||| S:33806 E:33812 ||| NN
,  ||| S:33812 E:33814 ||| ,
α  ||| S:33814 E:33825 ||| CD
i2  ||| S:33825 E:33828 ||| CD
A327S ||| S:33828 E:33833 ||| CD
,  ||| S:33833 E:33835 ||| ,
previously  ||| S:33835 E:33846 ||| RB
demonstrated  ||| S:33846 E:33859 ||| VBN
to  ||| S:33859 E:33862 ||| TO
be  ||| S:33862 E:33873 ||| VB
unstable  ||| S:33873 E:33891 ||| JJ
in  ||| S:33891 E:33894 ||| IN
vitro  ||| S:33894 E:33900 ||| NN
,  ||| S:33900 E:33902 ||| ,
displays  ||| S:33902 E:33911 ||| VBZ
a  ||| S:33911 E:33913 ||| DT
defect  ||| S:33913 E:33920 ||| NN
in  ||| S:33920 E:33931 ||| IN
plasma  ||| S:33931 E:33938 ||| JJ
membrane  ||| S:33938 E:33947 ||| JJ
localization  ||| S:33947 E:33960 ||| NN
when  ||| S:33960 E:33965 ||| WRB
expressed  ||| S:33965 E:33975 ||| VBN
in  ||| S:33975 E:33978 ||| IN
cells ||| S:33978 E:33983 ||| NNS
.  ||| S:33983 E:33985 ||| .
These  ||| S:33985 E:33999 ||| DT
results  ||| S:33999 E:34007 ||| NNS
suggest  ||| S:34007 E:34015 ||| VBP
that  ||| S:34015 E:34020 ||| IN
both  ||| S:34020 E:34025 ||| DT
sα  ||| S:34025 E:34037 ||| JJ
i2  ||| S:34037 E:34040 ||| NN
and  ||| S:34040 E:34044 ||| CC
α  ||| S:34044 E:34055 ||| JJ
i2  ||| S:34055 E:34058 ||| NNP
A327S  ||| S:34058 E:34064 ||| NNP
may  ||| S:34064 E:34068 ||| MD
prove  ||| S:34068 E:34074 ||| VB
valuable  ||| S:34074 E:34083 ||| JJ
in  ||| S:34083 E:34086 ||| IN
future  ||| S:34086 E:34101 ||| JJ
studies  ||| S:34101 E:34109 ||| NNS
of  ||| S:34109 E:34112 ||| IN
mechanisms  ||| S:34112 E:34123 ||| NNS
of  ||| S:34123 E:34126 ||| IN
degradation  ||| S:34126 E:34138 ||| NN
of  ||| S:34138 E:34141 ||| IN
Gα ||| S:34141 E:34143 ||| NNP
.  ||| S:34143 E:34167 ||| .
Materials  ||| S:34167 E:34177 ||| NNS
and  ||| S:34177 E:34181 ||| CC
methods  ||| S:34181 E:34208 ||| JJ
Materials  ||| S:34208 E:34228 ||| NNPS
Cell  ||| S:34228 E:34233 ||| NNP
culture  ||| S:34233 E:34241 ||| NN
reagents  ||| S:34241 E:34250 ||| NNS
were  ||| S:34250 E:34255 ||| VBD
obtained  ||| S:34255 E:34264 ||| VBN
from  ||| S:34264 E:34269 ||| IN
Mediatech.  ||| S:34269 E:34290 ||| NNP
[ ||| S:34290 E:34291 ||| -LRB-
9,10-  ||| S:34291 E:34297 ||| NNP
3H ||| S:34297 E:34299 ||| NNP
] ||| S:34299 E:34300 ||| -RRB-
palmitic  ||| S:34300 E:34309 ||| JJ
acid ||| S:34309 E:34313 ||| NN
,  ||| S:34313 E:34315 ||| ,
[ ||| S:34315 E:34316 ||| -LRB-
9,10-  ||| S:34316 E:34322 ||| NNP
3H ||| S:34322 E:34324 ||| NNP
] ||| S:34324 E:34325 ||| -RRB-
myristic  ||| S:34325 E:34334 ||| JJ
acid ||| S:34334 E:34338 ||| NN
,  ||| S:34338 E:34340 ||| ,
and  ||| S:34340 E:34344 ||| CC
35S  ||| S:34344 E:34358 ||| NNP
Express  ||| S:34358 E:34366 ||| NNP
labeling  ||| S:34366 E:34375 ||| JJ
mix  ||| S:34375 E:34379 ||| NN
were  ||| S:34379 E:34384 ||| VBD
from  ||| S:34384 E:34389 ||| IN
NEN ||| S:34389 E:34392 ||| NNP
.  ||| S:34392 E:34404 ||| .
Acetyl-leucyl-leucyl-norleucinal  ||| S:34404 E:34437 ||| NNP
( ||| S:34437 E:34438 ||| -LRB-
ALLN ||| S:34438 E:34442 ||| NNP
)  ||| S:34442 E:34444 ||| -RRB-
and  ||| S:34444 E:34448 ||| CC
MG-132  ||| S:34448 E:34455 ||| NNP
were  ||| S:34455 E:34470 ||| VBD
from  ||| S:34470 E:34475 ||| IN
Calbiochem ||| S:34475 E:34485 ||| NNP
.  ||| S:34485 E:34487 ||| .
The  ||| S:34487 E:34491 ||| DT
EE  ||| S:34491 E:34494 ||| NNP
monoclonal  ||| S:34494 E:34505 ||| JJ
antibody  ||| S:34505 E:34514 ||| NN
was  ||| S:34514 E:34518 ||| VBD
a  ||| S:34518 E:34520 ||| DT
gift  ||| S:34520 E:34535 ||| NN
from  ||| S:34535 E:34540 ||| IN
H.  ||| S:34540 E:34543 ||| NNP
Bourne ||| S:34543 E:34549 ||| NNP
.  ||| S:34549 E:34551 ||| .
Other  ||| S:34551 E:34557 ||| JJ
reagents  ||| S:34557 E:34566 ||| NN
were  ||| S:34566 E:34571 ||| VBD
obtained  ||| S:34571 E:34580 ||| VBN
from  ||| S:34580 E:34585 ||| IN
Fisher  ||| S:34585 E:34602 ||| NNP
and  ||| S:34602 E:34606 ||| CC
Sigma ||| S:34606 E:34611 ||| NNP
.  ||| S:34611 E:34641 ||| .
Expression  ||| S:34641 E:34652 ||| FW
plasmids  ||| S:34652 E:34671 ||| FW
EE-α  ||| S:34671 E:34687 ||| FW
i2  ||| S:34687 E:34690 ||| FW
-pcDNAI  ||| S:34690 E:34698 ||| NNP
was  ||| S:34698 E:34702 ||| VBD
obtained  ||| S:34702 E:34711 ||| VBN
from  ||| S:34711 E:34716 ||| IN
H.  ||| S:34716 E:34719 ||| NNP
Bourne  ||| S:34719 E:34736 ||| NNP
( ||| S:34736 E:34737 ||| -LRB-
UCSF ||| S:34737 E:34741 ||| NNP
) ||| S:34741 E:34742 ||| -RRB-
.  ||| S:34742 E:34744 ||| .
In  ||| S:34744 E:34747 ||| IN
this  ||| S:34747 E:34752 ||| DT
plasmid ||| S:34752 E:34759 ||| NN
,  ||| S:34759 E:34761 ||| ,
mouse  ||| S:34761 E:34767 ||| FW
α  ||| S:34767 E:34780 ||| FW
i2  ||| S:34780 E:34783 ||| FW
cDNA  ||| S:34783 E:34788 ||| FW
contains  ||| S:34788 E:34797 ||| VBZ
the  ||| S:34797 E:34801 ||| DT
EE  ||| S:34801 E:34804 ||| FW
epitope  ||| S:34804 E:34822 ||| FW
sequence  ||| S:34822 E:34831 ||| FW
EEYMPTE  ||| S:34831 E:34839 ||| NNP
at  ||| S:34839 E:34842 ||| IN
codons  ||| S:34842 E:34849 ||| CD
166  ||| S:34849 E:34853 ||| CD
to  ||| S:34853 E:34856 ||| TO
172  ||| S:34856 E:34860 ||| CD
[  ||| S:34860 E:34862 ||| -LRB-
11  ||| S:34862 E:34865 ||| CD
]  ||| S:34865 E:34867 ||| -RRB-
.  ||| S:34867 E:34869 ||| .
Mouse  ||| S:34869 E:34875 ||| FW
sα  ||| S:34875 E:34889 ||| FW
i2  ||| S:34889 E:34892 ||| FW
cDNA  ||| S:34892 E:34897 ||| NNP
was  ||| S:34897 E:34901 ||| VBD
provided  ||| S:34901 E:34910 ||| VBN
by  ||| S:34910 E:34913 ||| IN
E.  ||| S:34913 E:34916 ||| NNP
Borrelli  ||| S:34916 E:34935 ||| NNP
( ||| S:34935 E:34936 ||| -LRB-
Strasbourg ||| S:34936 E:34946 ||| NNP
)  ||| S:34946 E:34948 ||| -RRB-
in  ||| S:34948 E:34951 ||| IN
the  ||| S:34951 E:34955 ||| DT
plasmid  ||| S:34955 E:34963 ||| FW
pSVsGi2.  ||| S:34963 E:34972 ||| FW
sα  ||| S:34972 E:34986 ||| FW
i2  ||| S:34986 E:34989 ||| NNP
was  ||| S:34989 E:34993 ||| VBD
excised  ||| S:34993 E:35001 ||| VBN
from  ||| S:35001 E:35006 ||| IN
pSVsGi2  ||| S:35006 E:35014 ||| CD
using  ||| S:35014 E:35030 ||| VBG
EcoRI  ||| S:35030 E:35036 ||| JJ
and  ||| S:35036 E:35040 ||| CC
SmaI  ||| S:35040 E:35045 ||| JJ
and  ||| S:35045 E:35049 ||| CC
subcloned  ||| S:35049 E:35059 ||| NN
into  ||| S:35059 E:35064 ||| IN
the  ||| S:35064 E:35068 ||| DT
EcoRI  ||| S:35068 E:35074 ||| JJ
and  ||| S:35074 E:35078 ||| CC
EcoRV  ||| S:35078 E:35094 ||| JJ
sites  ||| S:35094 E:35100 ||| NNS
of  ||| S:35100 E:35103 ||| IN
pcDNAI  ||| S:35103 E:35110 ||| JJ
to  ||| S:35110 E:35113 ||| TO
produce  ||| S:35113 E:35121 ||| VB
sα  ||| S:35121 E:35135 ||| JJ
i2  ||| S:35135 E:35138 ||| NNP
-pcDNAI ||| S:35138 E:35145 ||| NNP
.  ||| S:35145 E:35147 ||| .
EE-tagged  ||| S:35147 E:35157 ||| JJ
sα  ||| S:35157 E:35171 ||| JJ
i2  ||| S:35171 E:35174 ||| NN
was  ||| S:35174 E:35178 ||| VBD
constructed  ||| S:35178 E:35190 ||| VBN
by  ||| S:35190 E:35193 ||| IN
subcloning  ||| S:35193 E:35204 ||| VBG
a  ||| S:35204 E:35216 ||| DT
EcoRI-BglII  ||| S:35216 E:35228 ||| JJ
fragment  ||| S:35228 E:35237 ||| NN
from  ||| S:35237 E:35242 ||| IN
EE-α  ||| S:35242 E:35258 ||| NNP
i2  ||| S:35258 E:35261 ||| NNP
-pcDNAI  ||| S:35261 E:35269 ||| NNP
into  ||| S:35269 E:35274 ||| IN
sα  ||| S:35274 E:35288 ||| CD
i2  ||| S:35288 E:35291 ||| CD
-pcDNAI ||| S:35291 E:35298 ||| NN
.  ||| S:35298 E:35300 ||| .
EE-tagged  ||| S:35300 E:35310 ||| JJ
α  ||| S:35310 E:35323 ||| JJ
i2  ||| S:35323 E:35326 ||| NNP
A327S-pcDNAI  ||| S:35326 E:35339 ||| NNP
was  ||| S:35339 E:35343 ||| VBD
obtained  ||| S:35343 E:35352 ||| VBN
from  ||| S:35352 E:35357 ||| IN
J.  ||| S:35357 E:35370 ||| NNP
Morales  ||| S:35370 E:35378 ||| NNP
( ||| S:35378 E:35379 ||| -LRB-
UCSF ||| S:35379 E:35383 ||| NNP
) ||| S:35383 E:35384 ||| -RRB-
.  ||| S:35384 E:35386 ||| .
EE-tagged  ||| S:35386 E:35396 ||| FW
α  ||| S:35396 E:35409 ||| FW
i2  ||| S:35409 E:35412 ||| FW
( ||| S:35412 E:35413 ||| -LRB-
1-331 ||| S:35413 E:35418 ||| NNP
) ||| S:35418 E:35419 ||| -RRB-
-pcDNA3  ||| S:35419 E:35427 ||| NNP
was  ||| S:35427 E:35431 ||| VBD
constructed  ||| S:35431 E:35443 ||| VBN
by  ||| S:35443 E:35456 ||| IN
by  ||| S:35456 E:35459 ||| IN
PCR  ||| S:35459 E:35463 ||| NNP
amplification  ||| S:35463 E:35477 ||| NN
of  ||| S:35477 E:35480 ||| IN
the  ||| S:35480 E:35484 ||| DT
coding  ||| S:35484 E:35491 ||| JJ
region  ||| S:35491 E:35498 ||| NN
for  ||| S:35498 E:35502 ||| IN
the  ||| S:35502 E:35506 ||| DT
amino  ||| S:35506 E:35522 ||| JJ
acids  ||| S:35522 E:35528 ||| NN
1  ||| S:35528 E:35530 ||| CD
to  ||| S:35530 E:35533 ||| TO
331  ||| S:35533 E:35537 ||| CD
of  ||| S:35537 E:35540 ||| IN
α  ||| S:35540 E:35553 ||| NNS
i2  ||| S:35553 E:35556 ||| VBP
using  ||| S:35556 E:35562 ||| VBG
the  ||| S:35562 E:35566 ||| DT
T7  ||| S:35566 E:35569 ||| JJ
primer  ||| S:35569 E:35576 ||| NN
as  ||| S:35576 E:35579 ||| IN
the  ||| S:35579 E:35583 ||| DT
5 ||| S:35583 E:35584 ||| CD
'  ||| S:35584 E:35596 ||| POS
primer  ||| S:35596 E:35603 ||| NN
and  ||| S:35603 E:35607 ||| CC
5 ||| S:35607 E:35608 ||| CD
' ||| S:35608 E:35609 ||| POS
-ccggctcgagtcacttggtgtcggtggcgcatg-3 ||| S:35609 E:35645 ||| NNP
'  ||| S:35645 E:35647 ||| POS
as  ||| S:35647 E:35650 ||| IN
the  ||| S:35650 E:35664 ||| DT
3 ||| S:35664 E:35665 ||| CD
'  ||| S:35665 E:35667 ||| POS
primer  ||| S:35667 E:35674 ||| NN
and  ||| S:35674 E:35678 ||| CC
using  ||| S:35678 E:35684 ||| VBG
EE-α  ||| S:35684 E:35700 ||| JJ
i2  ||| S:35700 E:35703 ||| CD
-pcDNA3  ||| S:35703 E:35711 ||| CD
as  ||| S:35711 E:35714 ||| IN
the  ||| S:35714 E:35718 ||| DT
template ||| S:35718 E:35726 ||| NN
.  ||| S:35726 E:35728 ||| .
The  ||| S:35728 E:35732 ||| DT
PCR  ||| S:35732 E:35746 ||| NNP
amplified  ||| S:35746 E:35756 ||| JJ
product  ||| S:35756 E:35764 ||| NN
was  ||| S:35764 E:35768 ||| VBD
digested  ||| S:35768 E:35777 ||| VBN
with  ||| S:35777 E:35782 ||| IN
HindIII  ||| S:35782 E:35790 ||| JJ
and  ||| S:35790 E:35794 ||| CC
XhoI  ||| S:35794 E:35799 ||| JJ
and  ||| S:35799 E:35813 ||| CC
subcloned  ||| S:35813 E:35823 ||| NN
into  ||| S:35823 E:35828 ||| IN
the  ||| S:35828 E:35832 ||| DT
correspondingly  ||| S:35832 E:35848 ||| FW
digested  ||| S:35848 E:35857 ||| FW
EE-α  ||| S:35857 E:35873 ||| FW
i2  ||| S:35873 E:35876 ||| FW
-pcDNA3 ||| S:35876 E:35883 ||| FW
.  ||| S:35883 E:35885 ||| .
GFP-sα  ||| S:35885 E:35903 ||| NNP
i2  ||| S:35903 E:35906 ||| NNP
35aa  ||| S:35906 E:35911 ||| NNP
was  ||| S:35911 E:35915 ||| VBD
constructed  ||| S:35915 E:35927 ||| VBN
by  ||| S:35927 E:35930 ||| IN
PCR  ||| S:35930 E:35944 ||| NNP
amplification  ||| S:35944 E:35958 ||| NN
of  ||| S:35958 E:35961 ||| IN
the  ||| S:35961 E:35965 ||| DT
coding  ||| S:35965 E:35972 ||| JJ
region  ||| S:35972 E:35979 ||| NN
for  ||| S:35979 E:35983 ||| IN
the  ||| S:35983 E:35987 ||| DT
C-terminal  ||| S:35987 E:35998 ||| JJ
35  ||| S:35998 E:36011 ||| CD
amino  ||| S:36011 E:36017 ||| CD
acids  ||| S:36017 E:36023 ||| NNS
of  ||| S:36023 E:36026 ||| IN
sα  ||| S:36026 E:36040 ||| NNS
i2  ||| S:36040 E:36043 ||| VBP
using  ||| S:36043 E:36049 ||| VBG
the  ||| S:36049 E:36053 ||| DT
5 ||| S:36053 E:36054 ||| CD
'  ||| S:36054 E:36056 ||| POS
primer  ||| S:36056 E:36073 ||| JJ
5 ||| S:36073 E:36074 ||| CD
' ||| S:36074 E:36075 ||| POS
-cgcagatctagaaaactttttaga-3 ||| S:36075 E:36102 ||| NNP
'  ||| S:36102 E:36104 ||| POS
and  ||| S:36104 E:36108 ||| CC
the  ||| S:36108 E:36112 ||| DT
3 ||| S:36112 E:36113 ||| CD
'  ||| S:36113 E:36115 ||| POS
primer  ||| S:36115 E:36132 ||| JJ
5 ||| S:36132 E:36133 ||| CD
' ||| S:36133 E:36134 ||| POS
-cgcaagcttactcaaggcacggaatc-3 ||| S:36134 E:36163 ||| NNP
' ||| S:36163 E:36164 ||| POS
.  ||| S:36164 E:36166 ||| .
The  ||| S:36166 E:36170 ||| DT
PCR  ||| S:36170 E:36174 ||| NNP
fragment  ||| S:36174 E:36183 ||| NN
was  ||| S:36183 E:36197 ||| VBD
digested  ||| S:36197 E:36206 ||| VBN
with  ||| S:36206 E:36211 ||| IN
BglII  ||| S:36211 E:36217 ||| JJ
and  ||| S:36217 E:36221 ||| CC
HindIII  ||| S:36221 E:36229 ||| JJ
and  ||| S:36229 E:36233 ||| CC
subcloned  ||| S:36233 E:36243 ||| NN
into  ||| S:36243 E:36248 ||| IN
the  ||| S:36248 E:36262 ||| DT
correspondingly  ||| S:36262 E:36278 ||| FW
digested  ||| S:36278 E:36287 ||| FW
pEGFP-C1  ||| S:36287 E:36296 ||| FW
( ||| S:36296 E:36297 ||| -LRB-
Clontech ||| S:36297 E:36305 ||| NNP
) ||| S:36305 E:36306 ||| -RRB-
.  ||| S:36306 E:36308 ||| .
α  ||| S:36308 E:36321 ||| FW
i2  ||| S:36321 E:36324 ||| FW
( ||| S:36324 E:36325 ||| -LRB-
1-10 ||| S:36325 E:36329 ||| NNP
) ||| S:36329 E:36330 ||| -RRB-
-GFP  ||| S:36330 E:36335 ||| NNP
was  ||| S:36335 E:36339 ||| VBD
constructed  ||| S:36339 E:36351 ||| VBN
by  ||| S:36351 E:36364 ||| IN
annealing  ||| S:36364 E:36374 ||| VBG
the  ||| S:36374 E:36378 ||| DT
complementary  ||| S:36378 E:36392 ||| JJ
oligonucleotides  ||| S:36392 E:36419 ||| NN
5 ||| S:36419 E:36420 ||| CD
' ||| S:36420 E:36421 ||| POS
-ctagcaccatgggctgcaccgtgtcggccgaggacaag-3 ||| S:36421 E:36462 ||| NNP
'  ||| S:36462 E:36464 ||| POS
and  ||| S:36464 E:36478 ||| CC
5 ||| S:36478 E:36479 ||| CD
' ||| S:36479 E:36480 ||| POS
-ccggcttgtcctcggacacggtgcagcccatggtg-3 ||| S:36480 E:36518 ||| NNP
'  ||| S:36518 E:36520 ||| POS
( ||| S:36520 E:36521 ||| -LRB-
corresponding  ||| S:36521 E:36545 ||| JJ
to  ||| S:36545 E:36548 ||| TO
amino  ||| S:36548 E:36554 ||| VB
acids  ||| S:36554 E:36560 ||| JJ
1-10  ||| S:36560 E:36565 ||| NN
of  ||| S:36565 E:36568 ||| IN
α  ||| S:36568 E:36581 ||| CD
i2  ||| S:36581 E:36584 ||| CD
)  ||| S:36584 E:36586 ||| -RRB-
and  ||| S:36586 E:36590 ||| CC
ligating  ||| S:36590 E:36599 ||| NN
into  ||| S:36599 E:36604 ||| IN
AgeI-NheI  ||| S:36604 E:36624 ||| JJ
digested  ||| S:36624 E:36633 ||| JJ
pEGFP-N1 ||| S:36633 E:36641 ||| NN
.  ||| S:36641 E:36643 ||| .
Human  ||| S:36643 E:36649 ||| NNP
β  ||| S:36649 E:36662 ||| VBD
1  ||| S:36662 E:36664 ||| CD
-pCMV5  ||| S:36664 E:36671 ||| CD
and  ||| S:36671 E:36675 ||| CC
bovine  ||| S:36675 E:36682 ||| JJ
γ  ||| S:36682 E:36695 ||| NN
2  ||| S:36695 E:36697 ||| CD
-pcDNAI  ||| S:36697 E:36705 ||| NNS
have  ||| S:36705 E:36710 ||| VBP
been  ||| S:36710 E:36715 ||| VBN
described  ||| S:36715 E:36725 ||| VBN
[  ||| S:36725 E:36727 ||| -LRB-
35  ||| S:36727 E:36730 ||| CD
]  ||| S:36730 E:36742 ||| -RRB-
.  ||| S:36742 E:36772 ||| .
Cell  ||| S:36772 E:36777 ||| NN
culture  ||| S:36777 E:36785 ||| NN
and  ||| S:36785 E:36789 ||| CC
transfection  ||| S:36789 E:36812 ||| JJ
BHK ||| S:36812 E:36815 ||| NNP
,  ||| S:36815 E:36817 ||| ,
HEK293 ||| S:36817 E:36823 ||| NNP
,  ||| S:36823 E:36825 ||| ,
and  ||| S:36825 E:36829 ||| CC
COS-7  ||| S:36829 E:36835 ||| CD
cells  ||| S:36835 E:36841 ||| NNS
were  ||| S:36841 E:36846 ||| VBD
cultured  ||| S:36846 E:36855 ||| VBN
in  ||| S:36855 E:36858 ||| IN
DMEM  ||| S:36858 E:36873 ||| NNP
containing  ||| S:36873 E:36884 ||| VBG
10 ||| S:36884 E:36886 ||| CD
%  ||| S:36886 E:36888 ||| NN
fetal  ||| S:36888 E:36894 ||| JJ
bovine  ||| S:36894 E:36901 ||| JJ
serum ||| S:36901 E:36906 ||| NN
.  ||| S:36906 E:36908 ||| .
Transfections  ||| S:36908 E:36922 ||| NNP
were  ||| S:36922 E:36937 ||| VBD
performed  ||| S:36937 E:36947 ||| VBN
in  ||| S:36947 E:36950 ||| IN
6-well  ||| S:36950 E:36957 ||| CD
plates  ||| S:36957 E:36964 ||| NNS
or  ||| S:36964 E:36967 ||| CC
6  ||| S:36967 E:36969 ||| CD
cm  ||| S:36969 E:36972 ||| JJ
culture  ||| S:36972 E:36980 ||| NN
dishes  ||| S:36980 E:36987 ||| NNS
using  ||| S:36987 E:37003 ||| VBG
Lipofectamine  ||| S:37003 E:37017 ||| NNP
( ||| S:37017 E:37018 ||| -LRB-
GibcoBRL ||| S:37018 E:37026 ||| NNP
)  ||| S:37026 E:37028 ||| -RRB-
or  ||| S:37028 E:37031 ||| CC
FuGene6  ||| S:37031 E:37039 ||| NNP
( ||| S:37039 E:37040 ||| -LRB-
Roche ||| S:37040 E:37045 ||| NNP
)  ||| S:37045 E:37047 ||| -RRB-
according  ||| S:37047 E:37057 ||| VBG
to  ||| S:37057 E:37070 ||| TO
the  ||| S:37070 E:37074 ||| DT
manufacturer ||| S:37074 E:37086 ||| NN
's  ||| S:37086 E:37089 ||| POS
protocol ||| S:37089 E:37097 ||| NN
.  ||| S:37097 E:37127 ||| .
Immunofluorescence  ||| S:37127 E:37146 ||| NNP
localization  ||| S:37146 E:37169 ||| VBD
Cells  ||| S:37169 E:37175 ||| NNP
were  ||| S:37175 E:37180 ||| VBD
transfected  ||| S:37180 E:37192 ||| VBN
in  ||| S:37192 E:37195 ||| IN
6-well  ||| S:37195 E:37202 ||| CD
plates  ||| S:37202 E:37209 ||| NN
with  ||| S:37209 E:37214 ||| IN
1  ||| S:37214 E:37216 ||| CD
μg  ||| S:37216 E:37219 ||| NN
of  ||| S:37219 E:37232 ||| IN
the  ||| S:37232 E:37236 ||| DT
indicated  ||| S:37236 E:37246 ||| JJ
expression  ||| S:37246 E:37257 ||| NN
plasmid ||| S:37257 E:37264 ||| NN
.  ||| S:37264 E:37266 ||| .
In  ||| S:37266 E:37269 ||| IN
experiments  ||| S:37269 E:37281 ||| NNS
where  ||| S:37281 E:37287 ||| WRB
β  ||| S:37287 E:37300 ||| JJ
1  ||| S:37300 E:37302 ||| CD
and  ||| S:37302 E:37306 ||| CC
γ  ||| S:37306 E:37319 ||| CD
2  ||| S:37319 E:37321 ||| CD
expression  ||| S:37321 E:37332 ||| NN
plasmids  ||| S:37332 E:37341 ||| NNS
were  ||| S:37341 E:37356 ||| VBD
co-transfected  ||| S:37356 E:37371 ||| JJ
with  ||| S:37371 E:37376 ||| IN
α  ||| S:37376 E:37389 ||| JJ
i2  ||| S:37389 E:37392 ||| NN
or  ||| S:37392 E:37395 ||| CC
sα  ||| S:37395 E:37409 ||| CD
i2  ||| S:37409 E:37412 ||| CD
,  ||| S:37412 E:37414 ||| ,
the  ||| S:37414 E:37418 ||| DT
amounts  ||| S:37418 E:37426 ||| NNS
of  ||| S:37426 E:37429 ||| IN
α ||| S:37429 E:37430 ||| NN
,  ||| S:37430 E:37432 ||| ,
β ||| S:37432 E:37433 ||| NN
,  ||| S:37433 E:37435 ||| ,
and  ||| S:37435 E:37439 ||| CC
γ  ||| S:37439 E:37451 ||| NNS
plasmids  ||| S:37451 E:37460 ||| VBP
used  ||| S:37460 E:37465 ||| VBN
were  ||| S:37465 E:37470 ||| VBD
0.7 ||| S:37470 E:37473 ||| CD
,  ||| S:37473 E:37475 ||| ,
0.2 ||| S:37475 E:37478 ||| CD
,  ||| S:37478 E:37480 ||| ,
and  ||| S:37480 E:37484 ||| CC
0.1  ||| S:37484 E:37488 ||| CD
μg ||| S:37488 E:37490 ||| NN
,  ||| S:37490 E:37492 ||| ,
respectively.  ||| S:37492 E:37506 ||| CD
24  ||| S:37506 E:37519 ||| CD
h  ||| S:37519 E:37521 ||| NN
after  ||| S:37521 E:37527 ||| IN
transfection ||| S:37527 E:37539 ||| NN
,  ||| S:37539 E:37541 ||| ,
cells  ||| S:37541 E:37547 ||| NNS
were  ||| S:37547 E:37552 ||| VBD
replated  ||| S:37552 E:37561 ||| VBN
onto  ||| S:37561 E:37566 ||| IN
glass  ||| S:37566 E:37582 ||| NN
coverslips  ||| S:37582 E:37593 ||| NNS
and  ||| S:37593 E:37597 ||| CC
grown  ||| S:37597 E:37603 ||| VBN
for  ||| S:37603 E:37607 ||| IN
an  ||| S:37607 E:37610 ||| DT
additional  ||| S:37610 E:37621 ||| JJ
24  ||| S:37621 E:37624 ||| CD
h  ||| S:37624 E:37626 ||| NN
before  ||| S:37626 E:37633 ||| IN
fixing  ||| S:37633 E:37650 ||| VBG
in  ||| S:37650 E:37653 ||| IN
methanol  ||| S:37653 E:37662 ||| NN
at  ||| S:37662 E:37665 ||| IN
-20°C  ||| S:37665 E:37671 ||| CD
for  ||| S:37671 E:37675 ||| IN
20  ||| S:37675 E:37678 ||| CD
min ||| S:37678 E:37681 ||| NNS
.  ||| S:37681 E:37683 ||| .
Cells  ||| S:37683 E:37689 ||| NNS
were  ||| S:37689 E:37694 ||| VBD
washed  ||| S:37694 E:37701 ||| VBN
with  ||| S:37701 E:37716 ||| IN
PBS  ||| S:37716 E:37720 ||| NNP
and  ||| S:37720 E:37724 ||| CC
then  ||| S:37724 E:37729 ||| RB
incubated  ||| S:37729 E:37739 ||| VBN
in  ||| S:37739 E:37742 ||| IN
blocking  ||| S:37742 E:37751 ||| VBG
buffer  ||| S:37751 E:37758 ||| NN
consisting  ||| S:37758 E:37769 ||| VBG
of  ||| S:37769 E:37782 ||| IN
TBS  ||| S:37782 E:37786 ||| NNP
( ||| S:37786 E:37787 ||| -LRB-
50  ||| S:37787 E:37790 ||| CD
mM  ||| S:37790 E:37793 ||| JJ
Tris ||| S:37793 E:37797 ||| NNP
,  ||| S:37797 E:37799 ||| ,
pH  ||| S:37799 E:37802 ||| JJ
7.5 ||| S:37802 E:37805 ||| CD
,  ||| S:37805 E:37807 ||| ,
150  ||| S:37807 E:37811 ||| CD
mM  ||| S:37811 E:37814 ||| JJ
NaCl ||| S:37814 E:37818 ||| NN
)  ||| S:37818 E:37820 ||| -RRB-
with  ||| S:37820 E:37825 ||| IN
1 ||| S:37825 E:37826 ||| CD
%  ||| S:37826 E:37828 ||| NN
Triton  ||| S:37828 E:37845 ||| NNP
X-100  ||| S:37845 E:37851 ||| NNP
and  ||| S:37851 E:37855 ||| CC
2.5 ||| S:37855 E:37858 ||| CD
%  ||| S:37858 E:37860 ||| NN
nonfat  ||| S:37860 E:37867 ||| NN
milk ||| S:37867 E:37871 ||| NN
.  ||| S:37871 E:37873 ||| .
Coverslips  ||| S:37873 E:37884 ||| NNP
were  ||| S:37884 E:37889 ||| VBD
then  ||| S:37889 E:37904 ||| RB
incubated  ||| S:37904 E:37914 ||| VBN
in  ||| S:37914 E:37917 ||| IN
blocking  ||| S:37917 E:37926 ||| VBG
buffer  ||| S:37926 E:37933 ||| NN
containing  ||| S:37933 E:37944 ||| VBG
20  ||| S:37944 E:37947 ||| CD
μg ||| S:37947 E:37949 ||| FW
/ ||| S:37949 E:37950 ||| FW
ml  ||| S:37950 E:37953 ||| FW
EE  ||| S:37953 E:37966 ||| FW
monoclonal  ||| S:37966 E:37977 ||| FW
antibody  ||| S:37977 E:37986 ||| NN
for  ||| S:37986 E:37990 ||| IN
1  ||| S:37990 E:37992 ||| CD
h ||| S:37992 E:37993 ||| NNS
.  ||| S:37993 E:37995 ||| .
For  ||| S:37995 E:37999 ||| IN
dual  ||| S:37999 E:38004 ||| JJ
localization  ||| S:38004 E:38027 ||| JJ
experiments ||| S:38027 E:38038 ||| NNS
,  ||| S:38038 E:38040 ||| ,
a  ||| S:38040 E:38042 ||| DT
1 ||| S:38042 E:38043 ||| CD
: ||| S:38043 E:38044 ||| :
1000  ||| S:38044 E:38049 ||| CD
dilution  ||| S:38049 E:38058 ||| NN
of  ||| S:38058 E:38061 ||| IN
a  ||| S:38061 E:38063 ||| DT
rabbit  ||| S:38063 E:38070 ||| JJ
polyclonal  ||| S:38070 E:38091 ||| JJ
anti-β-coatomer  ||| S:38091 E:38107 ||| JJ
protein  ||| S:38107 E:38115 ||| NN
( ||| S:38115 E:38116 ||| -LRB-
β-COP ||| S:38116 E:38121 ||| NNP
)  ||| S:38121 E:38123 ||| -RRB-
antibody  ||| S:38123 E:38132 ||| NN
( ||| S:38132 E:38133 ||| -LRB-
Affinity  ||| S:38133 E:38152 ||| NNP
BioReagents ||| S:38152 E:38163 ||| NNP
)  ||| S:38163 E:38165 ||| -RRB-
or  ||| S:38165 E:38168 ||| CC
a  ||| S:38168 E:38170 ||| DT
1 ||| S:38170 E:38171 ||| CD
: ||| S:38171 E:38172 ||| :
200  ||| S:38172 E:38176 ||| CD
dilution  ||| S:38176 E:38185 ||| NN
of  ||| S:38185 E:38188 ||| IN
a  ||| S:38188 E:38190 ||| DT
rabbit  ||| S:38190 E:38197 ||| FW
polyclonal  ||| S:38197 E:38218 ||| FW
anti-protein  ||| S:38218 E:38231 ||| FW
disulfide  ||| S:38231 E:38241 ||| FW
isomerase  ||| S:38241 E:38251 ||| FW
( ||| S:38251 E:38252 ||| -LRB-
PDI ||| S:38252 E:38255 ||| NNP
)  ||| S:38255 E:38257 ||| -RRB-
antibody  ||| S:38257 E:38276 ||| NN
( ||| S:38276 E:38277 ||| -LRB-
StressGen  ||| S:38277 E:38287 ||| NNP
Biotechnologies ||| S:38287 E:38302 ||| NNP
)  ||| S:38302 E:38304 ||| -RRB-
was  ||| S:38304 E:38308 ||| VBD
included  ||| S:38308 E:38317 ||| VBN
with  ||| S:38317 E:38322 ||| IN
the  ||| S:38322 E:38326 ||| DT
EE  ||| S:38326 E:38339 ||| NNP
mouse  ||| S:38339 E:38345 ||| NN
monoclonal ||| S:38345 E:38355 ||| NN
.  ||| S:38355 E:38357 ||| .
Following  ||| S:38357 E:38367 ||| VBG
washes  ||| S:38367 E:38374 ||| NN
with  ||| S:38374 E:38379 ||| IN
blocking  ||| S:38379 E:38388 ||| VBG
buffer ||| S:38388 E:38394 ||| NN
,  ||| S:38394 E:38406 ||| ,
cells  ||| S:38406 E:38412 ||| NNS
were  ||| S:38412 E:38417 ||| VBD
incubated  ||| S:38417 E:38427 ||| VBN
in  ||| S:38427 E:38430 ||| IN
a  ||| S:38430 E:38432 ||| DT
1 ||| S:38432 E:38433 ||| CD
: ||| S:38433 E:38434 ||| :
100  ||| S:38434 E:38438 ||| CD
dilution  ||| S:38438 E:38447 ||| NN
of  ||| S:38447 E:38450 ||| IN
the  ||| S:38450 E:38454 ||| DT
indicated  ||| S:38454 E:38474 ||| JJ
secondary  ||| S:38474 E:38484 ||| JJ
antibody ||| S:38484 E:38492 ||| NN
,  ||| S:38492 E:38494 ||| ,
either  ||| S:38494 E:38501 ||| CC
Alexa  ||| S:38501 E:38507 ||| NNP
Fluor  ||| S:38507 E:38513 ||| NNP
488  ||| S:38513 E:38517 ||| CD
or  ||| S:38517 E:38520 ||| CC
594  ||| S:38520 E:38524 ||| CD
goat  ||| S:38524 E:38539 ||| CD
anti-mouse  ||| S:38539 E:38550 ||| NNS
( ||| S:38550 E:38551 ||| -LRB-
Molecular  ||| S:38551 E:38561 ||| NNP
Probes ||| S:38561 E:38567 ||| NNP
)  ||| S:38567 E:38569 ||| -RRB-
or  ||| S:38569 E:38572 ||| CC
Texas  ||| S:38572 E:38578 ||| NNP
Red  ||| S:38578 E:38582 ||| NNP
donkey  ||| S:38582 E:38599 ||| FW
anti-mouse  ||| S:38599 E:38610 ||| FW
( ||| S:38610 E:38611 ||| -LRB-
Jackson  ||| S:38611 E:38619 ||| NNP
Immunoresearch ||| S:38619 E:38633 ||| NNP
)  ||| S:38633 E:38635 ||| -RRB-
or  ||| S:38635 E:38638 ||| CC
Alexa  ||| S:38638 E:38644 ||| NNP
Fluor  ||| S:38644 E:38650 ||| NNP
488  ||| S:38650 E:38664 ||| CD
goat  ||| S:38664 E:38669 ||| CD
anti-rabbit  ||| S:38669 E:38681 ||| NNS
( ||| S:38681 E:38682 ||| -LRB-
Molecular  ||| S:38682 E:38692 ||| NNP
Probes ||| S:38692 E:38698 ||| NNP
) ||| S:38698 E:38699 ||| -RRB-
,  ||| S:38699 E:38701 ||| ,
for  ||| S:38701 E:38705 ||| IN
30  ||| S:38705 E:38708 ||| CD
min ||| S:38708 E:38711 ||| NNS
.  ||| S:38711 E:38713 ||| .
The  ||| S:38713 E:38727 ||| DT
coverslips  ||| S:38727 E:38738 ||| NN
were  ||| S:38738 E:38743 ||| VBD
washed  ||| S:38743 E:38750 ||| VBN
and  ||| S:38750 E:38754 ||| CC
mounted  ||| S:38754 E:38762 ||| VBN
on  ||| S:38762 E:38765 ||| IN
glass  ||| S:38765 E:38771 ||| NN
slides  ||| S:38771 E:38778 ||| NNS
with  ||| S:38778 E:38793 ||| IN
Prolong  ||| S:38793 E:38801 ||| NNP
Antifade  ||| S:38801 E:38810 ||| NNP
reagent  ||| S:38810 E:38818 ||| NNS
( ||| S:38818 E:38819 ||| -LRB-
Molecular  ||| S:38819 E:38829 ||| NNP
Probes ||| S:38829 E:38835 ||| NNP
,  ||| S:38835 E:38837 ||| ,
Eugene ||| S:38837 E:38843 ||| NNP
,  ||| S:38843 E:38845 ||| ,
OR ||| S:38845 E:38847 ||| NNP
) ||| S:38847 E:38848 ||| -RRB-
,  ||| S:38848 E:38860 ||| ,
and  ||| S:38860 E:38864 ||| CC
microscopy  ||| S:38864 E:38875 ||| NNS
was  ||| S:38875 E:38879 ||| VBD
performed  ||| S:38879 E:38889 ||| VBN
with  ||| S:38889 E:38894 ||| IN
an  ||| S:38894 E:38897 ||| DT
Olympus  ||| S:38897 E:38905 ||| NNP
BX60  ||| S:38905 E:38920 ||| NNP
microscope  ||| S:38920 E:38931 ||| VBD
equipped  ||| S:38931 E:38940 ||| VBN
with  ||| S:38940 E:38945 ||| IN
a  ||| S:38945 E:38947 ||| DT
Sony  ||| S:38947 E:38952 ||| NNP
DKC-5000  ||| S:38952 E:38961 ||| NNP
digital  ||| S:38961 E:38969 ||| JJ
camera ||| S:38969 E:38975 ||| NN
.  ||| S:38975 E:38987 ||| .
A  ||| S:38987 E:38989 ||| DT
minimum  ||| S:38989 E:38997 ||| NN
of  ||| S:38997 E:39000 ||| IN
50  ||| S:39000 E:39003 ||| CD
cells  ||| S:39003 E:39009 ||| NNS
were  ||| S:39009 E:39014 ||| VBD
examined  ||| S:39014 E:39023 ||| VBN
for  ||| S:39023 E:39027 ||| IN
each  ||| S:39027 E:39042 ||| DT
transfection ||| S:39042 E:39054 ||| NN
.  ||| S:39054 E:39056 ||| .
Transfections  ||| S:39056 E:39070 ||| NNP
were  ||| S:39070 E:39075 ||| VBD
repeated  ||| S:39075 E:39084 ||| VBN
and  ||| S:39084 E:39098 ||| CC
representative  ||| S:39098 E:39113 ||| JJ
pictures  ||| S:39113 E:39122 ||| NNS
were  ||| S:39122 E:39127 ||| VBD
taken  ||| S:39127 E:39133 ||| VBN
of  ||| S:39133 E:39136 ||| IN
cells  ||| S:39136 E:39142 ||| NNS
displaying  ||| S:39142 E:39153 ||| VBG
a  ||| S:39153 E:39165 ||| DT
typical  ||| S:39165 E:39173 ||| JJ
expression  ||| S:39173 E:39184 ||| NN
pattern  ||| S:39184 E:39192 ||| NN
for  ||| S:39192 E:39196 ||| IN
each  ||| S:39196 E:39201 ||| DT
transfection ||| S:39201 E:39213 ||| NN
.  ||| S:39213 E:39215 ||| .
Only  ||| S:39215 E:39230 ||| JJ
cells  ||| S:39230 E:39236 ||| NNS
displaying  ||| S:39236 E:39247 ||| VBG
low  ||| S:39247 E:39251 ||| JJ
to  ||| S:39251 E:39254 ||| TO
intermediate  ||| S:39254 E:39267 ||| JJ
levels  ||| S:39267 E:39274 ||| NNS
of  ||| S:39274 E:39277 ||| IN
expression  ||| S:39277 E:39298 ||| NN
were  ||| S:39298 E:39303 ||| VBD
utilized ||| S:39303 E:39311 ||| VBN
.  ||| S:39311 E:39313 ||| .
Images  ||| S:39313 E:39320 ||| NNS
were  ||| S:39320 E:39325 ||| VBD
processed  ||| S:39325 E:39335 ||| VBN
with  ||| S:39335 E:39340 ||| IN
Adobe  ||| S:39340 E:39356 ||| NNP
Photoshop ||| S:39356 E:39365 ||| NNP
.  ||| S:39365 E:39395 ||| .
Subcellular  ||| S:39395 E:39407 ||| NNP
Fractionation  ||| S:39407 E:39431 ||| NNP
Soluble  ||| S:39431 E:39439 ||| NNP
and  ||| S:39439 E:39443 ||| CC
particulate  ||| S:39443 E:39455 ||| JJ
fractions  ||| S:39455 E:39465 ||| NNS
were  ||| S:39465 E:39470 ||| VBD
isolated  ||| S:39470 E:39479 ||| VBN
as  ||| S:39479 E:39492 ||| IN
previously  ||| S:39492 E:39503 ||| RB
described  ||| S:39503 E:39513 ||| VBN
[  ||| S:39513 E:39515 ||| -LRB-
29  ||| S:39515 E:39518 ||| CD
]  ||| S:39518 E:39520 ||| -RRB-
.  ||| S:39520 E:39522 ||| .
BHK  ||| S:39522 E:39526 ||| NNP
or  ||| S:39526 E:39529 ||| CC
COS-7  ||| S:39529 E:39535 ||| CD
cells  ||| S:39535 E:39541 ||| NNS
were  ||| S:39541 E:39556 ||| VBD
transfected  ||| S:39556 E:39568 ||| VBN
in  ||| S:39568 E:39571 ||| IN
6  ||| S:39571 E:39573 ||| CD
cm  ||| S:39573 E:39576 ||| JJ
plates  ||| S:39576 E:39583 ||| NN
with  ||| S:39583 E:39588 ||| IN
3  ||| S:39588 E:39590 ||| CD
μg  ||| S:39590 E:39593 ||| NN
of  ||| S:39593 E:39596 ||| IN
the  ||| S:39596 E:39600 ||| DT
indicated  ||| S:39600 E:39620 ||| JJ
expression  ||| S:39620 E:39631 ||| NN
plasmid.  ||| S:39631 E:39640 ||| CD
24  ||| S:39640 E:39643 ||| CD
h  ||| S:39643 E:39645 ||| NN
after  ||| S:39645 E:39651 ||| IN
transfection ||| S:39651 E:39663 ||| NN
,  ||| S:39663 E:39665 ||| ,
the  ||| S:39665 E:39669 ||| DT
cells  ||| S:39669 E:39685 ||| NNS
were  ||| S:39685 E:39690 ||| VBD
transferred  ||| S:39690 E:39702 ||| VBN
to  ||| S:39702 E:39705 ||| TO
10-cm  ||| S:39705 E:39711 ||| CD
plates  ||| S:39711 E:39718 ||| NNS
and  ||| S:39718 E:39722 ||| CC
grown  ||| S:39722 E:39728 ||| VBN
for  ||| S:39728 E:39732 ||| IN
another  ||| S:39732 E:39740 ||| DT
24  ||| S:39740 E:39753 ||| CD
h ||| S:39753 E:39754 ||| NNS
.  ||| S:39754 E:39756 ||| .
Cells  ||| S:39756 E:39762 ||| NNS
were  ||| S:39762 E:39767 ||| VBD
washed  ||| S:39767 E:39774 ||| VBN
with  ||| S:39774 E:39779 ||| IN
phosphate-buffered  ||| S:39779 E:39798 ||| JJ
saline  ||| S:39798 E:39805 ||| NN
and  ||| S:39805 E:39819 ||| CC
then  ||| S:39819 E:39824 ||| RB
lysed  ||| S:39824 E:39830 ||| VBN
in  ||| S:39830 E:39833 ||| IN
0.5  ||| S:39833 E:39837 ||| CD
ml  ||| S:39837 E:39840 ||| NNS
hypotonic  ||| S:39840 E:39850 ||| VBP
lysis  ||| S:39850 E:39856 ||| JJ
buffer  ||| S:39856 E:39863 ||| NN
by  ||| S:39863 E:39866 ||| IN
10  ||| S:39866 E:39879 ||| CD
passages  ||| S:39879 E:39888 ||| NNS
through  ||| S:39888 E:39896 ||| IN
a  ||| S:39896 E:39898 ||| DT
27-gauge  ||| S:39898 E:39907 ||| JJ
needle ||| S:39907 E:39913 ||| NN
.  ||| S:39913 E:39915 ||| .
Cells  ||| S:39915 E:39921 ||| NNS
were  ||| S:39921 E:39936 ||| VBD
centrifuged  ||| S:39936 E:39948 ||| VBN
at  ||| S:39948 E:39951 ||| IN
200  ||| S:39951 E:39955 ||| CD
×  ||| S:39955 E:39957 ||| CD
g  ||| S:39957 E:39959 ||| NN
for  ||| S:39959 E:39963 ||| IN
5  ||| S:39963 E:39965 ||| CD
min  ||| S:39965 E:39969 ||| NN
to  ||| S:39969 E:39972 ||| TO
pellet  ||| S:39972 E:39979 ||| VB
nuclei  ||| S:39979 E:39986 ||| NNS
and  ||| S:39986 E:40000 ||| CC
intact  ||| S:40000 E:40007 ||| JJ
cells ||| S:40007 E:40012 ||| NNS
,  ||| S:40012 E:40014 ||| ,
and  ||| S:40014 E:40018 ||| CC
the  ||| S:40018 E:40022 ||| DT
supernatant  ||| S:40022 E:40034 ||| NN
was  ||| S:40034 E:40038 ||| VBD
then  ||| S:40038 E:40043 ||| RB
centrifuged  ||| S:40043 E:40055 ||| VBN
at  ||| S:40055 E:40068 ||| IN
150,000  ||| S:40068 E:40076 ||| CD
×  ||| S:40076 E:40078 ||| CD
g  ||| S:40078 E:40080 ||| NN
for  ||| S:40080 E:40084 ||| IN
20  ||| S:40084 E:40087 ||| CD
min  ||| S:40087 E:40091 ||| NN
to  ||| S:40091 E:40094 ||| TO
obtain  ||| S:40094 E:40101 ||| VB
soluble  ||| S:40101 E:40109 ||| JJ
and  ||| S:40109 E:40113 ||| CC
particulate  ||| S:40113 E:40135 ||| JJ
fractions ||| S:40135 E:40144 ||| NNS
.  ||| S:40144 E:40146 ||| .
Fractions  ||| S:40146 E:40156 ||| NNP
were  ||| S:40156 E:40161 ||| VBD
resolved  ||| S:40161 E:40170 ||| VBN
by  ||| S:40170 E:40173 ||| IN
12 ||| S:40173 E:40175 ||| CD
%  ||| S:40175 E:40177 ||| NN
SDS-PAGE ||| S:40177 E:40185 ||| NN
,  ||| S:40185 E:40197 ||| ,
transferred  ||| S:40197 E:40209 ||| VBN
onto  ||| S:40209 E:40214 ||| IN
PVDF-Plus  ||| S:40214 E:40224 ||| NNP
( ||| S:40224 E:40225 ||| -LRB-
Micron  ||| S:40225 E:40232 ||| NNP
Separations ||| S:40232 E:40243 ||| NNP
,  ||| S:40243 E:40245 ||| ,
Inc ||| S:40245 E:40248 ||| NNP
)  ||| S:40248 E:40250 ||| -RRB-
and  ||| S:40250 E:40264 ||| CC
probed  ||| S:40264 E:40271 ||| NN
with  ||| S:40271 E:40276 ||| IN
EE  ||| S:40276 E:40279 ||| NNP
monoclonal  ||| S:40279 E:40290 ||| JJ
antibody ||| S:40290 E:40298 ||| NN
.  ||| S:40298 E:40300 ||| .
Bands  ||| S:40300 E:40306 ||| NNP
were  ||| S:40306 E:40311 ||| VBD
visualized  ||| S:40311 E:40332 ||| VBN
by  ||| S:40332 E:40335 ||| IN
chemiluminescence ||| S:40335 E:40352 ||| NN
.  ||| S:40352 E:40382 ||| .
Metabolic  ||| S:40382 E:40392 ||| JJ
labeling  ||| S:40392 E:40401 ||| NN
and  ||| S:40401 E:40405 ||| CC
immunoprecipitation  ||| S:40405 E:40435 ||| CD
COS-7  ||| S:40435 E:40441 ||| CD
cells  ||| S:40441 E:40447 ||| NNS
were  ||| S:40447 E:40452 ||| VBD
transfected  ||| S:40452 E:40464 ||| VBN
in  ||| S:40464 E:40467 ||| IN
6  ||| S:40467 E:40469 ||| CD
cm  ||| S:40469 E:40472 ||| JJ
plates  ||| S:40472 E:40479 ||| NN
with  ||| S:40479 E:40484 ||| IN
3  ||| S:40484 E:40486 ||| CD
μg  ||| S:40486 E:40499 ||| NN
of  ||| S:40499 E:40502 ||| IN
the  ||| S:40502 E:40506 ||| DT
indicated  ||| S:40506 E:40516 ||| JJ
expression  ||| S:40516 E:40527 ||| NN
plasmid.  ||| S:40527 E:40536 ||| CD
24  ||| S:40536 E:40539 ||| CD
h  ||| S:40539 E:40541 ||| NN
after  ||| S:40541 E:40557 ||| IN
transfection ||| S:40557 E:40569 ||| NN
,  ||| S:40569 E:40571 ||| ,
cells  ||| S:40571 E:40577 ||| NNS
were  ||| S:40577 E:40582 ||| VBD
replated  ||| S:40582 E:40591 ||| VBN
into  ||| S:40591 E:40596 ||| IN
6  ||| S:40596 E:40598 ||| CD
cm  ||| S:40598 E:40601 ||| CD
plates ||| S:40601 E:40607 ||| NNS
.  ||| S:40607 E:40609 ||| .
For  ||| S:40609 E:40623 ||| IN
fatty  ||| S:40623 E:40629 ||| JJ
acid  ||| S:40629 E:40634 ||| NN
labeling  ||| S:40634 E:40643 ||| NN
experiments  ||| S:40643 E:40655 ||| NNS
[  ||| S:40655 E:40657 ||| -LRB-
36  ||| S:40657 E:40660 ||| CD
]  ||| S:40660 E:40662 ||| -RRB-
,  ||| S:40662 E:40664 ||| ,
one  ||| S:40664 E:40668 ||| CD
transfection  ||| S:40668 E:40691 ||| NNS
was  ||| S:40691 E:40695 ||| VBD
replated  ||| S:40695 E:40704 ||| VBN
into  ||| S:40704 E:40709 ||| IN
two  ||| S:40709 E:40713 ||| CD
6  ||| S:40713 E:40715 ||| CD
cm  ||| S:40715 E:40718 ||| CD
plates ||| S:40718 E:40724 ||| NNS
.  ||| S:40724 E:40726 ||| .
For  ||| S:40726 E:40730 ||| IN
35S  ||| S:40730 E:40734 ||| CD
labeling  ||| S:40734 E:40753 ||| CD
experiments ||| S:40753 E:40764 ||| NNS
,  ||| S:40764 E:40766 ||| ,
cells  ||| S:40766 E:40772 ||| NNS
from  ||| S:40772 E:40777 ||| IN
two  ||| S:40777 E:40781 ||| CD
or  ||| S:40781 E:40784 ||| CC
three  ||| S:40784 E:40790 ||| CD
identical  ||| S:40790 E:40810 ||| JJ
transfections  ||| S:40810 E:40824 ||| NN
were  ||| S:40824 E:40829 ||| VBD
combined  ||| S:40829 E:40838 ||| VBN
before  ||| S:40838 E:40845 ||| IN
replating  ||| S:40845 E:40855 ||| NN
in  ||| S:40855 E:40858 ||| IN
multiple  ||| S:40858 E:40877 ||| JJ
6  ||| S:40877 E:40879 ||| CD
cm  ||| S:40879 E:40882 ||| CD
plates ||| S:40882 E:40888 ||| NNS
.  ||| S:40888 E:40890 ||| .
Incubation  ||| S:40890 E:40901 ||| NNP
with  ||| S:40901 E:40906 ||| IN
radioisotope  ||| S:40906 E:40919 ||| NN
was  ||| S:40919 E:40923 ||| VBD
then  ||| S:40923 E:40938 ||| RB
performed  ||| S:40938 E:40948 ||| VBD
48  ||| S:40948 E:40951 ||| CD
h  ||| S:40951 E:40953 ||| NN
after  ||| S:40953 E:40959 ||| IN
transfection ||| S:40959 E:40971 ||| NN
.  ||| S:40971 E:40983 ||| .
For  ||| S:40983 E:40987 ||| IN
fatty  ||| S:40987 E:40993 ||| JJ
acid  ||| S:40993 E:40998 ||| NN
labeling ||| S:40998 E:41006 ||| NN
,  ||| S:41006 E:41008 ||| ,
cells  ||| S:41008 E:41014 ||| NNS
in  ||| S:41014 E:41017 ||| IN
a  ||| S:41017 E:41019 ||| DT
6  ||| S:41019 E:41021 ||| CD
cm  ||| S:41021 E:41024 ||| JJ
dish  ||| S:41024 E:41029 ||| NN
were  ||| S:41029 E:41044 ||| VBD
incubated  ||| S:41044 E:41054 ||| VBN
with  ||| S:41054 E:41059 ||| IN
1  ||| S:41059 E:41061 ||| CD
ml  ||| S:41061 E:41064 ||| NN
of  ||| S:41064 E:41067 ||| IN
DMEM  ||| S:41067 E:41072 ||| NNP
containing  ||| S:41072 E:41083 ||| VBG
10 ||| S:41083 E:41085 ||| CD
%  ||| S:41085 E:41087 ||| NN
dialyzed  ||| S:41087 E:41096 ||| FW
fetal  ||| S:41096 E:41112 ||| FW
bovine  ||| S:41112 E:41119 ||| FW
serum ||| S:41119 E:41124 ||| FW
,  ||| S:41124 E:41126 ||| ,
5  ||| S:41126 E:41128 ||| CD
mM  ||| S:41128 E:41131 ||| JJ
sodium  ||| S:41131 E:41138 ||| JJ
pyruvate ||| S:41138 E:41146 ||| NN
,  ||| S:41146 E:41148 ||| ,
and  ||| S:41148 E:41152 ||| CC
[ ||| S:41152 E:41153 ||| -LRB-
9,10-  ||| S:41153 E:41169 ||| NNP
3H ||| S:41169 E:41171 ||| NNP
] ||| S:41171 E:41172 ||| -RRB-
palmitic  ||| S:41172 E:41181 ||| JJ
acid  ||| S:41181 E:41186 ||| NN
( ||| S:41186 E:41187 ||| -LRB-
1  ||| S:41187 E:41189 ||| CD
mCi ||| S:41189 E:41192 ||| JJ
/ ||| S:41192 E:41193 ||| CD
ml ||| S:41193 E:41195 ||| CD
)  ||| S:41195 E:41197 ||| -RRB-
or  ||| S:41197 E:41200 ||| CC
[ ||| S:41200 E:41201 ||| -LRB-
9,10-  ||| S:41201 E:41207 ||| NNP
3H ||| S:41207 E:41209 ||| NNP
] ||| S:41209 E:41210 ||| -RRB-
myristate  ||| S:41210 E:41220 ||| NNS
( ||| S:41220 E:41221 ||| -LRB-
0.5  ||| S:41221 E:41235 ||| CD
mCi ||| S:41235 E:41238 ||| JJ
/ ||| S:41238 E:41239 ||| CD
ml ||| S:41239 E:41241 ||| CD
)  ||| S:41241 E:41243 ||| -RRB-
for  ||| S:41243 E:41247 ||| IN
2  ||| S:41247 E:41249 ||| CD
h ||| S:41249 E:41250 ||| NNS
.  ||| S:41250 E:41252 ||| .
For  ||| S:41252 E:41256 ||| IN
35S  ||| S:41256 E:41260 ||| CD
pulse-chase  ||| S:41260 E:41272 ||| JJ
labeling ||| S:41272 E:41280 ||| NN
,  ||| S:41280 E:41282 ||| ,
cells  ||| S:41282 E:41288 ||| NNS
in  ||| S:41288 E:41291 ||| IN
a  ||| S:41291 E:41303 ||| DT
6  ||| S:41303 E:41305 ||| CD
cm  ||| S:41305 E:41308 ||| JJ
dish  ||| S:41308 E:41313 ||| NN
were  ||| S:41313 E:41318 ||| VBD
washed  ||| S:41318 E:41325 ||| VBN
with  ||| S:41325 E:41330 ||| IN
DMEM  ||| S:41330 E:41335 ||| NNP
( ||| S:41335 E:41336 ||| -LRB-
without  ||| S:41336 E:41344 ||| IN
methionine ||| S:41344 E:41354 ||| CD
) ||| S:41354 E:41355 ||| -RRB-
,  ||| S:41355 E:41357 ||| ,
and  ||| S:41357 E:41371 ||| CC
then  ||| S:41371 E:41376 ||| RB
incubated  ||| S:41376 E:41386 ||| VBN
in  ||| S:41386 E:41389 ||| IN
DMEM  ||| S:41389 E:41394 ||| NNP
( ||| S:41394 E:41395 ||| -LRB-
without  ||| S:41395 E:41403 ||| IN
methionine ||| S:41403 E:41413 ||| CD
)  ||| S:41413 E:41415 ||| -RRB-
containing  ||| S:41415 E:41436 ||| VBG
10 ||| S:41436 E:41438 ||| CD
%  ||| S:41438 E:41440 ||| NN
dialyzed  ||| S:41440 E:41449 ||| VBZ
fetal  ||| S:41449 E:41455 ||| JJ
bovine  ||| S:41455 E:41462 ||| JJ
serum  ||| S:41462 E:41468 ||| NN
at  ||| S:41468 E:41471 ||| IN
37°C  ||| S:41471 E:41476 ||| CD
for  ||| S:41476 E:41480 ||| IN
1  ||| S:41480 E:41482 ||| CD
h ||| S:41482 E:41483 ||| NNS
.  ||| S:41483 E:41485 ||| .
Next ||| S:41485 E:41489 ||| JJ
,  ||| S:41489 E:41501 ||| ,
cells  ||| S:41501 E:41507 ||| NNS
were  ||| S:41507 E:41512 ||| VBD
incubated  ||| S:41512 E:41522 ||| VBN
in  ||| S:41522 E:41525 ||| IN
DMEM  ||| S:41525 E:41530 ||| NNP
( ||| S:41530 E:41531 ||| -LRB-
without  ||| S:41531 E:41539 ||| IN
methionine ||| S:41539 E:41549 ||| CD
)  ||| S:41549 E:41561 ||| -RRB-
containing  ||| S:41561 E:41572 ||| VBG
10 ||| S:41572 E:41574 ||| CD
%  ||| S:41574 E:41576 ||| NN
dialyzed  ||| S:41576 E:41585 ||| VBZ
fetal  ||| S:41585 E:41591 ||| JJ
bovine  ||| S:41591 E:41598 ||| JJ
serum  ||| S:41598 E:41604 ||| NN
and  ||| S:41604 E:41608 ||| CC
0.1  ||| S:41608 E:41612 ||| CD
mCi ||| S:41612 E:41615 ||| JJ
/ ||| S:41615 E:41616 ||| FW
ml  ||| S:41616 E:41629 ||| FW
35S  ||| S:41629 E:41633 ||| FW
Express  ||| S:41633 E:41641 ||| NNP
mix  ||| S:41641 E:41645 ||| NN
for  ||| S:41645 E:41649 ||| IN
10  ||| S:41649 E:41652 ||| CD
min ||| S:41652 E:41655 ||| NNS
.  ||| S:41655 E:41657 ||| .
After  ||| S:41657 E:41663 ||| IN
the  ||| S:41663 E:41667 ||| DT
10  ||| S:41667 E:41670 ||| CD
min  ||| S:41670 E:41674 ||| JJ
pulse  ||| S:41674 E:41690 ||| NN
labeling ||| S:41690 E:41698 ||| NN
,  ||| S:41698 E:41700 ||| ,
cells  ||| S:41700 E:41706 ||| NNS
were  ||| S:41706 E:41711 ||| VBD
either  ||| S:41711 E:41718 ||| RB
immediately  ||| S:41718 E:41730 ||| RB
lysed  ||| S:41730 E:41736 ||| JJ
( ||| S:41736 E:41737 ||| -LRB-
see  ||| S:41737 E:41741 ||| VB
below ||| S:41741 E:41746 ||| IN
)  ||| S:41746 E:41758 ||| -RRB-
or  ||| S:41758 E:41761 ||| CC
washed  ||| S:41761 E:41768 ||| VBN
with  ||| S:41768 E:41773 ||| IN
normal  ||| S:41773 E:41780 ||| JJ
growth  ||| S:41780 E:41787 ||| NN
media  ||| S:41787 E:41793 ||| NNS
and  ||| S:41793 E:41797 ||| CC
then  ||| S:41797 E:41802 ||| RB
"chased ||| S:41802 E:41809 ||| JJ
"  ||| S:41809 E:41811 ||| ''
by  ||| S:41811 E:41824 ||| IN
incubation  ||| S:41824 E:41835 ||| NN
in  ||| S:41835 E:41838 ||| IN
normal  ||| S:41838 E:41845 ||| JJ
growth  ||| S:41845 E:41852 ||| NN
media  ||| S:41852 E:41858 ||| NNS
for  ||| S:41858 E:41862 ||| IN
the  ||| S:41862 E:41866 ||| DT
indicated  ||| S:41866 E:41886 ||| JJ
times ||| S:41886 E:41891 ||| NNS
.  ||| S:41891 E:41903 ||| .
Fatty  ||| S:41903 E:41909 ||| JJ
acid  ||| S:41909 E:41914 ||| NN
labeled  ||| S:41914 E:41922 ||| VBN
and  ||| S:41922 E:41926 ||| CC
35S  ||| S:41926 E:41930 ||| FW
methionine ||| S:41930 E:41940 ||| FW
/ ||| S:41940 E:41941 ||| FW
cysteine  ||| S:41941 E:41950 ||| FW
labeled  ||| S:41950 E:41968 ||| FW
samples  ||| S:41968 E:41976 ||| NNS
were  ||| S:41976 E:41981 ||| VBD
then  ||| S:41981 E:41986 ||| RB
identically  ||| S:41986 E:41998 ||| VB
processed  ||| S:41998 E:42008 ||| VBN
by  ||| S:42008 E:42021 ||| IN
immunoprecipitation ||| S:42021 E:42040 ||| NN
.  ||| S:42040 E:42042 ||| .
Cells  ||| S:42042 E:42048 ||| NNS
were  ||| S:42048 E:42053 ||| VBD
washed  ||| S:42053 E:42060 ||| VBN
once  ||| S:42060 E:42065 ||| RB
with  ||| S:42065 E:42070 ||| IN
ice-cold  ||| S:42070 E:42089 ||| NNP
PBS  ||| S:42089 E:42093 ||| NNP
and  ||| S:42093 E:42097 ||| CC
lysed  ||| S:42097 E:42103 ||| NN
in  ||| S:42103 E:42106 ||| IN
1  ||| S:42106 E:42108 ||| CD
ml  ||| S:42108 E:42111 ||| NN
of  ||| S:42111 E:42114 ||| IN
Extraction  ||| S:42114 E:42125 ||| NNP
buffer  ||| S:42125 E:42132 ||| NN
( ||| S:42132 E:42133 ||| -LRB-
50  ||| S:42133 E:42136 ||| CD
mM  ||| S:42136 E:42139 ||| JJ
HEPES ||| S:42139 E:42144 ||| NNP
,  ||| S:42144 E:42156 ||| ,
pH  ||| S:42156 E:42159 ||| JJ
8 ||| S:42159 E:42160 ||| CD
,  ||| S:42160 E:42162 ||| ,
50  ||| S:42162 E:42165 ||| CD
mM  ||| S:42165 E:42168 ||| JJ
NaCl ||| S:42168 E:42172 ||| NN
,  ||| S:42172 E:42174 ||| ,
10  ||| S:42174 E:42177 ||| CD
μM  ||| S:42177 E:42180 ||| JJ
β-mercaptoethanol ||| S:42180 E:42197 ||| NN
,  ||| S:42197 E:42199 ||| ,
1 ||| S:42199 E:42200 ||| CD
%  ||| S:42200 E:42202 ||| NN
Triton  ||| S:42202 E:42219 ||| NNP
X-100 ||| S:42219 E:42224 ||| NNP
,  ||| S:42224 E:42226 ||| ,
1 ||| S:42226 E:42227 ||| CD
%  ||| S:42227 E:42229 ||| NN
sodium  ||| S:42229 E:42236 ||| NN
cholate ||| S:42236 E:42243 ||| NN
,  ||| S:42243 E:42245 ||| ,
1  ||| S:42245 E:42247 ||| CD
mM  ||| S:42247 E:42250 ||| JJ
PMSF ||| S:42250 E:42254 ||| NNP
,  ||| S:42254 E:42256 ||| ,
2  ||| S:42256 E:42258 ||| CD
μg ||| S:42258 E:42260 ||| CD
/ ||| S:42260 E:42261 ||| CD
ml  ||| S:42261 E:42264 ||| JJ
leupeptin ||| S:42264 E:42273 ||| NN
,  ||| S:42273 E:42285 ||| ,
and  ||| S:42285 E:42289 ||| CC
2  ||| S:42289 E:42291 ||| CD
μg ||| S:42291 E:42293 ||| CD
/ ||| S:42293 E:42294 ||| CD
ml  ||| S:42294 E:42297 ||| CD
aprotinin ||| S:42297 E:42306 ||| CD
) ||| S:42306 E:42307 ||| -RRB-
.  ||| S:42307 E:42309 ||| .
Cell  ||| S:42309 E:42314 ||| NN
extracts  ||| S:42314 E:42323 ||| NNS
were  ||| S:42323 E:42328 ||| VBD
tumbled  ||| S:42328 E:42336 ||| VBD
for  ||| S:42336 E:42340 ||| IN
1  ||| S:42340 E:42352 ||| CD
h  ||| S:42352 E:42354 ||| NN
at  ||| S:42354 E:42357 ||| IN
4°C ||| S:42357 E:42360 ||| NNP
,  ||| S:42360 E:42362 ||| ,
and  ||| S:42362 E:42366 ||| CC
nuclei  ||| S:42366 E:42373 ||| NNS
and  ||| S:42373 E:42377 ||| CC
insoluble  ||| S:42377 E:42387 ||| JJ
material  ||| S:42387 E:42396 ||| NN
were  ||| S:42396 E:42401 ||| VBD
removed  ||| S:42401 E:42419 ||| VBN
by  ||| S:42419 E:42422 ||| IN
microcentrifugation  ||| S:42422 E:42442 ||| NN
at  ||| S:42442 E:42445 ||| IN
16,000  ||| S:42445 E:42452 ||| CD
×  ||| S:42452 E:42454 ||| CD
g  ||| S:42454 E:42456 ||| NN
for  ||| S:42456 E:42460 ||| IN
3  ||| S:42460 E:42462 ||| CD
min ||| S:42462 E:42465 ||| NNS
.  ||| S:42465 E:42467 ||| .
Samples  ||| S:42467 E:42485 ||| NNS
were  ||| S:42485 E:42490 ||| VBD
adjusted  ||| S:42490 E:42499 ||| VBN
to  ||| S:42499 E:42502 ||| TO
0.5 ||| S:42502 E:42505 ||| CD
%  ||| S:42505 E:42507 ||| NN
SDS.  ||| S:42507 E:42512 ||| CD
10  ||| S:42512 E:42515 ||| CD
μg  ||| S:42515 E:42518 ||| NN
of  ||| S:42518 E:42521 ||| IN
EE  ||| S:42521 E:42524 ||| NNP
antibody  ||| S:42524 E:42533 ||| NN
was  ||| S:42533 E:42547 ||| VBD
added ||| S:42547 E:42552 ||| VBN
,  ||| S:42552 E:42554 ||| ,
and  ||| S:42554 E:42558 ||| CC
the  ||| S:42558 E:42562 ||| DT
samples  ||| S:42562 E:42570 ||| NNS
were  ||| S:42570 E:42575 ||| VBD
tumbled  ||| S:42575 E:42583 ||| VBD
for  ||| S:42583 E:42587 ||| IN
2  ||| S:42587 E:42589 ||| CD
h  ||| S:42589 E:42591 ||| NN
at  ||| S:42591 E:42594 ||| IN
4°C ||| S:42594 E:42597 ||| CD
.  ||| S:42597 E:42599 ||| .
Next ||| S:42599 E:42603 ||| JJ
,  ||| S:42603 E:42615 ||| ,
20  ||| S:42615 E:42618 ||| CD
μl  ||| S:42618 E:42621 ||| NN
of  ||| S:42621 E:42624 ||| IN
Protein  ||| S:42624 E:42632 ||| NNP
A ||| S:42632 E:42633 ||| NNP
/ ||| S:42633 E:42634 ||| NNP
G  ||| S:42634 E:42636 ||| NNP
PLUS  ||| S:42636 E:42641 ||| NNP
agarose  ||| S:42641 E:42649 ||| NNS
( ||| S:42649 E:42650 ||| -LRB-
Santa  ||| S:42650 E:42656 ||| NNP
Cruz  ||| S:42656 E:42671 ||| NNP
Biotechnology ||| S:42671 E:42684 ||| NNP
,  ||| S:42684 E:42686 ||| ,
Santa  ||| S:42686 E:42692 ||| NNP
Cruz ||| S:42692 E:42696 ||| NNP
,  ||| S:42696 E:42698 ||| ,
CA ||| S:42698 E:42700 ||| NNP
)  ||| S:42700 E:42702 ||| -RRB-
was  ||| S:42702 E:42706 ||| VBD
added ||| S:42706 E:42711 ||| VBN
,  ||| S:42711 E:42713 ||| ,
and  ||| S:42713 E:42717 ||| CC
the  ||| S:42717 E:42721 ||| DT
sample  ||| S:42721 E:42738 ||| NN
was  ||| S:42738 E:42742 ||| VBD
tumbled  ||| S:42742 E:42750 ||| VBD
overnight  ||| S:42750 E:42760 ||| JJ
at  ||| S:42760 E:42763 ||| IN
4°C ||| S:42763 E:42766 ||| CD
.  ||| S:42766 E:42768 ||| .
The  ||| S:42768 E:42772 ||| DT
sample  ||| S:42772 E:42779 ||| NN
was  ||| S:42779 E:42783 ||| VBD
centrifuged  ||| S:42783 E:42805 ||| VBN
for  ||| S:42805 E:42809 ||| IN
30  ||| S:42809 E:42812 ||| CD
s  ||| S:42812 E:42814 ||| NN
at  ||| S:42814 E:42817 ||| IN
200  ||| S:42817 E:42821 ||| CD
×  ||| S:42821 E:42823 ||| CD
g  ||| S:42823 E:42825 ||| NN
to  ||| S:42825 E:42828 ||| TO
pellet  ||| S:42828 E:42835 ||| VB
the  ||| S:42835 E:42839 ||| DT
beads ||| S:42839 E:42844 ||| NN
.  ||| S:42844 E:42846 ||| .
The  ||| S:42846 E:42850 ||| DT
supernatant  ||| S:42850 E:42872 ||| NN
was  ||| S:42872 E:42876 ||| VBD
discarded ||| S:42876 E:42885 ||| VBN
,  ||| S:42885 E:42887 ||| ,
and  ||| S:42887 E:42891 ||| CC
the  ||| S:42891 E:42895 ||| DT
beads  ||| S:42895 E:42901 ||| NN
were  ||| S:42901 E:42906 ||| VBD
washed  ||| S:42906 E:42913 ||| VBN
3  ||| S:42913 E:42915 ||| CD
times  ||| S:42915 E:42921 ||| NNS
with  ||| S:42921 E:42926 ||| IN
1  ||| S:42926 E:42938 ||| CD
ml  ||| S:42938 E:42941 ||| CD
Extraction  ||| S:42941 E:42952 ||| JJ
buffer ||| S:42952 E:42958 ||| NN
.  ||| S:42958 E:42960 ||| .
SDS-PAGE  ||| S:42960 E:42969 ||| JJ
sample  ||| S:42969 E:42976 ||| NN
buffer  ||| S:42976 E:42983 ||| NN
containing  ||| S:42983 E:43004 ||| VBG
10  ||| S:43004 E:43007 ||| CD
mM  ||| S:43007 E:43010 ||| JJ
DTT  ||| S:43010 E:43014 ||| NNP
was  ||| S:43014 E:43018 ||| VBD
added  ||| S:43018 E:43024 ||| VBN
to  ||| S:43024 E:43027 ||| TO
the  ||| S:43027 E:43031 ||| DT
washed  ||| S:43031 E:43038 ||| JJ
beads ||| S:43038 E:43043 ||| NN
,  ||| S:43043 E:43045 ||| ,
and  ||| S:43045 E:43049 ||| CC
the  ||| S:43049 E:43053 ||| DT
samples  ||| S:43053 E:43071 ||| NNS
were  ||| S:43071 E:43076 ||| VBD
heated  ||| S:43076 E:43083 ||| VBN
at  ||| S:43083 E:43086 ||| IN
65°C  ||| S:43086 E:43091 ||| CD
for  ||| S:43091 E:43095 ||| IN
1  ||| S:43095 E:43097 ||| CD
min  ||| S:43097 E:43101 ||| NNS
(  ||| S:43101 E:43103 ||| -LRB-
3H  ||| S:43103 E:43106 ||| FW
fatty  ||| S:43106 E:43112 ||| FW
acid  ||| S:43112 E:43117 ||| FW
labeled  ||| S:43117 E:43135 ||| FW
samples ||| S:43135 E:43142 ||| FW
)  ||| S:43142 E:43144 ||| -RRB-
or  ||| S:43144 E:43147 ||| CC
boiled  ||| S:43147 E:43154 ||| NN
for  ||| S:43154 E:43158 ||| IN
5  ||| S:43158 E:43160 ||| CD
min  ||| S:43160 E:43164 ||| NNS
(  ||| S:43164 E:43166 ||| -LRB-
35S  ||| S:43166 E:43170 ||| FW
methionine ||| S:43170 E:43180 ||| FW
/ ||| S:43180 E:43181 ||| FW
cysteine  ||| S:43181 E:43200 ||| FW
labeled  ||| S:43200 E:43208 ||| FW
samples ||| S:43208 E:43215 ||| FW
) ||| S:43215 E:43216 ||| -RRB-
.  ||| S:43216 E:43218 ||| .
An  ||| S:43218 E:43221 ||| DT
aliquot  ||| S:43221 E:43229 ||| NN
was  ||| S:43229 E:43233 ||| VBD
analyzed  ||| S:43233 E:43242 ||| VBN
by  ||| S:43242 E:43245 ||| IN
10 ||| S:43245 E:43247 ||| CD
%  ||| S:43247 E:43259 ||| NN
SDS-PAGE ||| S:43259 E:43267 ||| NN
.  ||| S:43267 E:43269 ||| .
Gels  ||| S:43269 E:43274 ||| NNP
were  ||| S:43274 E:43279 ||| VBD
incubated  ||| S:43279 E:43289 ||| VBN
for  ||| S:43289 E:43293 ||| IN
20  ||| S:43293 E:43296 ||| CD
min  ||| S:43296 E:43300 ||| NN
in  ||| S:43300 E:43303 ||| IN
an  ||| S:43303 E:43306 ||| DT
aqueous  ||| S:43306 E:43324 ||| JJ
solution  ||| S:43324 E:43333 ||| NN
of  ||| S:43333 E:43336 ||| IN
50 ||| S:43336 E:43338 ||| CD
%  ||| S:43338 E:43340 ||| NN
methanol ||| S:43340 E:43348 ||| VBD
/ ||| S:43348 E:43349 ||| CD
10 ||| S:43349 E:43351 ||| CD
%  ||| S:43351 E:43353 ||| NN
acetic  ||| S:43353 E:43360 ||| NN
acid ||| S:43360 E:43364 ||| NN
,  ||| S:43364 E:43366 ||| ,
followed  ||| S:43366 E:43375 ||| VBN
by  ||| S:43375 E:43378 ||| IN
10 ||| S:43378 E:43380 ||| CD
%  ||| S:43380 E:43392 ||| NN
ethanol ||| S:43392 E:43399 ||| VBD
/ ||| S:43399 E:43400 ||| CD
10 ||| S:43400 E:43402 ||| CD
%  ||| S:43402 E:43404 ||| NN
acetic  ||| S:43404 E:43411 ||| NN
acid  ||| S:43411 E:43416 ||| NN
for  ||| S:43416 E:43420 ||| IN
20  ||| S:43420 E:43423 ||| CD
min ||| S:43423 E:43426 ||| NN
,  ||| S:43426 E:43428 ||| ,
and ||| S:43428 E:43431 ||| CC
,  ||| S:43431 E:43433 ||| ,
finally ||| S:43433 E:43440 ||| RB
,  ||| S:43440 E:43442 ||| ,
Amplify  ||| S:43442 E:43460 ||| NNP
( ||| S:43460 E:43461 ||| -LRB-
Amersham ||| S:43461 E:43469 ||| NNP
)  ||| S:43469 E:43471 ||| -RRB-
for  ||| S:43471 E:43475 ||| IN
20  ||| S:43475 E:43478 ||| CD
min ||| S:43478 E:43481 ||| NNS
.  ||| S:43481 E:43483 ||| .
Gels  ||| S:43483 E:43488 ||| NNP
were  ||| S:43488 E:43493 ||| VBD
dried  ||| S:43493 E:43499 ||| VBN
and  ||| S:43499 E:43503 ||| CC
subjected  ||| S:43503 E:43513 ||| VBN
to  ||| S:43513 E:43526 ||| TO
fluorography  ||| S:43526 E:43539 ||| VB
at  ||| S:43539 E:43542 ||| IN
-80°C  ||| S:43542 E:43548 ||| CD
using  ||| S:43548 E:43554 ||| VBG
Hyperfilm  ||| S:43554 E:43564 ||| NNP
MP  ||| S:43564 E:43567 ||| NNP
( ||| S:43567 E:43568 ||| -LRB-
Amersham ||| S:43568 E:43576 ||| NNP
) ||| S:43576 E:43577 ||| -RRB-
.  ||| S:43577 E:43579 ||| .
For  ||| S:43579 E:43593 ||| IN
35S  ||| S:43593 E:43597 ||| CD
pulse-chase  ||| S:43597 E:43609 ||| JJ
experiments ||| S:43609 E:43620 ||| NNS
,  ||| S:43620 E:43622 ||| ,
intensity  ||| S:43622 E:43632 ||| NN
of  ||| S:43632 E:43635 ||| IN
each  ||| S:43635 E:43640 ||| DT
labeled  ||| S:43640 E:43658 ||| JJ
band  ||| S:43658 E:43663 ||| NN
was  ||| S:43663 E:43667 ||| VBD
quantitated  ||| S:43667 E:43679 ||| VBN
by  ||| S:43679 E:43682 ||| IN
densitometry ||| S:43682 E:43694 ||| NN
.  ||| S:43694 E:43696 ||| .
Results  ||| S:43696 E:43704 ||| NNS
were  ||| S:43704 E:43719 ||| VBD
analyzed  ||| S:43719 E:43728 ||| VBN
with  ||| S:43728 E:43733 ||| IN
GraphPad  ||| S:43733 E:43742 ||| NNP
Prizm  ||| S:43742 E:43748 ||| NNP
software  ||| S:43748 E:43757 ||| NN
to  ||| S:43757 E:43760 ||| TO
determine  ||| S:43760 E:43770 ||| VB
a  ||| S:43770 E:43782 ||| DT
half-life ||| S:43782 E:43791 ||| NN
.  ||| S:43791 E:43817 ||| .
